data_2l25_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l25 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.41 ' C ' ' H ' ' A' ' 33' ' ' THR . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.424 HD21 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.424 ' CH2' HD21 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.724 0.774 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CE1' ' HE1' ' A' ' 101' ' ' MET . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ASN . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 96' ' ' PRO . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE1' ' CE1' ' A' ' 11' ' ' PHE . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.486 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.413 ' H ' HD11 ' A' ' 77' ' ' ILE . 1.8 m-70 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 117.272 -1.346 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.559 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 96' ' ' PRO . 2.0 m-80 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.555 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.496 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 HH21 ' NE2' ' A' ' 86' ' ' GLN . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' NE2' HH21 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' GLN . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.251 0.548 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.409 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.535 ' HA ' ' CD1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.482 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.459 HH11 HD23 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 HD23 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' C ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 98' ' ' ASN . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' PRO . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.495 0.664 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.796 0.808 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' ASN . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' PRO . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ARG . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 80' ' ' GLY . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 22' ' ' ARG . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' H ' ' A' ' 137' ' ' GLN . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 29.1 pt20 . . . . . 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 98' ' ' ASN . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 96' ' ' PRO . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.464 ' CB ' ' HD1' ' A' ' 126' ' ' HIS . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.464 ' HD1' ' CB ' ' A' ' 119' ' ' PRO . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 . . . . . 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' ' NE ' ' A' ' 22' ' ' ARG . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB3' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 31' ' ' GLN . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.455 0.645 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 98' ' ' ASN . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 96' ' ' PRO . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 . . . . . 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 117.49 -1.243 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.5 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.458 -0.073 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.461 ' H ' HG21 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 117.015 -1.469 . . . . 0.0 113.303 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' HH ' ' A' ' 134' ' ' TYR . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.488 ' HH ' ' CG2' ' A' ' 48' ' ' VAL . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 117.22 -1.372 . . . . 0.0 114.286 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.421 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' NH1' ' H ' ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.41 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.463 ' H ' HG11 ' A' ' 136' ' ' VAL . 14.0 m-30 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' CD1' ' HG2' ' A' ' 101' ' ' MET . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.423 ' HG2' ' CD1' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 65' ' ' TYR . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.486 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -142.14 157.63 44.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.34 1.856 . . . . 0.0 108.876 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m 45.35 -79.91 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 129.157 2.983 . . . . 0.0 113.621 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' C ' ' H ' ' A' ' 33' ' ' THR . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.2 144.69 48.42 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.55 98.44 3.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -69.47 -170.57 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.015 0.926 . . . . 0.0 109.647 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.97 14.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 120.604 -1.31 . . . . 0.0 110.893 164.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 52.7 -154.35 0.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.705 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 52.74 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.218 2.207 . . . . 0.0 111.677 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.97 -174.69 3.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.44 4.93 6.91 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.5 3.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.085 2.154 . . . . 0.0 106.258 164.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 35.59 2.45 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 123.648 0.642 . . . . 0.0 111.594 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -149.69 107.56 3.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.06 0.15 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.508 1.523 . . . . 0.0 109.106 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.65 170.33 0.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.421 1.488 . . . . 0.0 110.423 154.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.67 4.54 1.53 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.695 1.198 . . . . 0.0 111.855 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 41.7 43.28 2.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.388 2.675 . . . . 0.0 114.093 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -74.84 170.24 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.1 39.71 0.85 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.908 2.483 . . . . 0.0 111.172 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -57.33 150.38 43.36 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.788 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.74 149.75 61.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.548 1.499 . . . . 0.0 110.427 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.363 1.065 . . . . 0.0 110.588 166.628 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.889 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.9 mmt -126.54 -73.07 0.63 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.075 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m 63.53 -71.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.81 1.244 . . . . 0.0 112.701 -172.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD21 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.424 ' CH2' HD21 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.85 149.4 31.49 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.23 13.91 2.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 113.367 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -88.24 42.74 1.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 110.527 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.26 128.5 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t 64.6 179.97 0.18 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.825 2.45 . . . . 0.0 111.183 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 62.39 13.95 6.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.349 1.859 . . . . 0.0 113.25 -171.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.13 152.84 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.333 0.653 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.19 63.91 0.28 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.74 1.216 . . . . 0.0 110.235 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.88 14.33 0.22 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.059 0.944 . . . . 0.0 112.446 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.13 42.72 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 120.728 -1.233 . . . . 0.0 110.556 -159.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.36 -14.66 10.39 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.72 1.608 . . . . 0.0 112.409 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.15 128.4 33.66 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 59.08 20.53 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.422 1.489 . . . . 0.0 113.054 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -88.19 110.23 20.53 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 119.771 -1.831 . . . . 0.0 107.61 169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.87 140.7 29.35 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.855 0.862 . . . . 0.0 109.029 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -155.47 157.02 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.95 4.27 38.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 112.596 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 166.15 0.11 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 127.964 2.506 . . . . 0.0 110.193 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.24 172.94 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.566 1.511 . . . . 0.0 109.819 173.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.245 0.846 0 C-N-CA 126.563 1.945 . . . . 0.0 111.8 -171.463 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.0 ttt -87.84 43.3 1.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.149 -1.207 . . . . 0.0 111.19 -164.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t 65.7 -69.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 110.914 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CE1' ' HE1' ' A' ' 101' ' ' MET . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.47 8.98 31.07 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.96 135.97 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.37 2.668 . . . . 0.0 111.746 -169.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -74.97 63.58 1.23 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.521 1.528 . . . . 0.0 110.944 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.293 0.7 OUTLIER -121.43 104.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 1 C-N-CA 132.572 4.349 . . . . 0.0 107.022 179.107 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -171.69 177.83 3.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 124.65 1.218 . . . . 0.0 108.682 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -103.79 91.13 3.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 171.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.9 171.7 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 164.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.12 26.27 4.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.243 1.017 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.97 149.17 28.6 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.216 1.406 . . . . 0.0 109.124 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.75 65.86 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 125.007 1.289 . . . . 0.0 113.628 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -143.02 40.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.939 0.869 . . . . 0.0 109.51 -159.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.19 151.33 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.447 1.099 . . . . 0.0 108.929 167.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.24 -167.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.819 1.647 . . . . 0.0 111.536 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.35 171.21 12.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.39 1.476 . . . . 0.0 108.976 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.18 168.83 9.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.786 1.634 . . . . 0.0 110.892 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ASN . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 96' ' ' PRO . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE1' ' CE1' ' A' ' 11' ' ' PHE . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.486 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' H ' HD11 ' A' ' 77' ' ' ILE . 1.8 m-70 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -138.78 160.47 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -73.03 -11.62 60.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.043 0.838 . . . . 0.0 111.133 167.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.3 t80 58.74 61.33 4.96 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 127.467 2.307 . . . . 0.0 111.234 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.41 139.87 67.12 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.948 1.765 . . . . 0.0 110.718 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.564 2.346 . . . . 0.0 111.109 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.968 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 57.5 mtm -153.78 66.01 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.277 1.431 . . . . 0.0 109.717 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.4 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.429 1.891 . . . . 0.0 112.413 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.02 -177.05 3.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.93 59.98 4.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.765 2.026 . . . . 0.0 110.609 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -71.38 -179.14 2.35 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.284 1.034 . . . . 0.0 109.32 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.1 mt -54.58 140.96 11.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -150.53 178.42 9.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.014 1.726 . . . . 0.0 108.01 168.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.65 13.57 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.339 1.056 . . . . 0.0 110.964 167.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -130.9 164.28 25.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.06 15.56 1.05 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.39 1.076 . . . . 0.0 113.43 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -17.56 63.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.893 0.877 . . . . 0.0 113.21 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.86 2.5 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.297 1.904 . . . . 0.0 112.019 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t70 63.04 102.03 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 131.187 3.795 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -69.59 159.71 32.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.382 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 61.91 15.09 6.87 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.174 1.79 . . . . 0.0 115.16 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -132.2 95.05 3.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.025 1.33 . . . . 0.0 110.215 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.05 172.27 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.776 1.23 . . . . 0.0 107.908 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -157.63 161.93 38.67 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.71 94.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.931 1.692 . . . . 0.0 108.66 -164.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -66.87 157.05 85.57 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.14 152.06 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.575 1.517 . . . . 0.0 110.113 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.245 0.838 0 C-N-CA 126.318 1.847 . . . . 0.0 108.246 177.343 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.252 0.0 OUTLIER -139.79 84.14 1.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.644 1.222 . . . . 0.0 109.981 166.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m 49.87 -83.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.991 2.917 . . . . 0.0 113.785 170.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.17 147.61 2.91 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.81 35.77 4.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 111.547 -168.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 t -140.64 35.91 1.82 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.945 0.898 . . . . 0.0 111.837 -153.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mt -57.13 135.2 21.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.483 0.713 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.66 -154.87 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.525 1.93 . . . . 0.0 108.447 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -108.92 10.48 26.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.066 0.947 . . . . 0.0 113.107 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -73.55 -179.95 3.78 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.009 0.524 . . . . 0.0 109.714 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.75 12.72 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.031 1.333 . . . . 0.0 113.285 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.68 175.53 7.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.93 2.092 . . . . 0.0 110.771 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.84 32.78 4.31 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.878 1.228 . . . . 0.0 112.809 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.28 127.44 12.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.183 2.193 . . . . 0.0 106.275 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -141.39 -178.03 5.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.478 1.511 . . . . 0.0 112.244 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.397 1.079 . . . . 0.0 109.389 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 68.85 158.15 0.15 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 131.387 3.875 . . . . 0.0 113.99 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.23 164.33 18.95 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.158 1.383 . . . . 0.0 110.324 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 96' ' ' PRO . 2.0 m-80 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.555 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.496 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 -149.02 -179.66 7.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -144.06 165.68 27.12 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 167.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -136.54 165.48 35.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.443 2.297 . . . . 0.0 108.864 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.13 144.11 74.12 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.287 1.325 . . . . 0.0 109.022 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.298 20.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 127.324 2.25 . . . . 0.0 113.317 -165.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptm -129.27 63.59 1.5 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.008 1.323 . . . . 0.0 109.734 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -154.9 -82.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.384 0.673 . . . . 0.0 111.263 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.81 35.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.8 71.5 0.26 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.698 2.399 . . . . 0.0 112.938 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 t -66.26 116.99 7.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.02 137.88 41.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -75.04 177.0 6.69 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 124.235 0.959 . . . . 0.0 110.665 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 75.38 112.02 0.07 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.173 2.989 . . . . 0.0 108.632 -153.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.16 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.619 2.768 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 58.88 18.2 5.93 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.483 1.113 . . . . 0.0 112.468 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 169.2 3.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.819 2.048 . . . . 0.0 111.65 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.95 51.54 4.44 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 126.252 1.882 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -161.34 131.77 5.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.612 3.165 . . . . 0.0 104.164 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -162.43 -27.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -159.72 173.07 16.59 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 127.664 2.386 . . . . 0.0 106.112 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.286 19.9 pt20 45.28 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 111.768 -169.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -120.87 178.12 4.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.709 1.603 . . . . 0.0 109.899 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -120.86 122.78 41.01 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.3 116.27 29.46 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 158.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -72.07 160.84 81.6 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 163.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.48 151.35 85.19 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.347 -1.787 . . . . 0.0 108.046 -176.175 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.722 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 48.65 58.65 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.882 1.273 . . . . 0.0 110.099 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -146.82 -85.99 0.1 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 HH21 ' NE2' ' A' ' 86' ' ' GLN . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.57 81.82 0.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.97 135.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.605 3.162 . . . . 0.0 112.87 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 p -94.19 47.55 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.792 0.837 . . . . 0.0 112.421 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.7 mt -120.81 12.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.315 -0.865 . . . . 0.0 111.719 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -175.01 171.41 3.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.277 1.831 . . . . 0.0 108.35 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -136.13 34.42 2.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.185 1.394 . . . . 0.0 111.315 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.07 145.18 47.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.964 1.306 . . . . 0.0 111.2 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -173.67 72.49 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.314 2.245 . . . . 0.0 109.372 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.89 -0.43 29.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.693 1.197 . . . . 0.0 113.828 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.76 34.11 80.91 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.17 -77.55 0.09 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.111 -1.229 . . . . 0.0 109.027 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -71.04 119.4 15.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.64 -169.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.568 0.747 . . . . 0.0 111.816 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.82 169.87 21.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.256 1.022 . . . . 0.0 109.475 -163.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.03 121.13 38.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.308 1.043 . . . . 0.0 110.204 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' NE2' HH21 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.42 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -100.29 2.25 42.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.948 0.899 . . . . 0.0 110.54 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.7 t80 44.34 65.69 5.77 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 129.208 3.003 . . . . 0.0 112.813 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.2 148.12 84.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.968 1.779 . . . . 0.0 110.164 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.772 160.159 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 81.9 mtp -135.7 32.45 3.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.066 0.946 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m 59.29 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.007 1.323 . . . . 0.0 112.491 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' GLN . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 52' ' ' ALA . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.98 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' PRO . . . 43.37 83.49 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.846 2.458 . . . . 0.0 114.118 155.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.2 t -52.07 95.39 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.163 1.785 . . . . 0.0 112.885 -172.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.6 mt -141.35 158.64 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 129.083 2.953 . . . . 0.0 104.447 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -137.2 143.99 42.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 155.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -160.52 15.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.452 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -103.96 166.77 10.2 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.039 -1.038 . . . . 0.0 111.255 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.45 21.0 2.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 127.011 2.125 . . . . 0.0 110.601 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.08 -168.73 2.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.248 2.219 . . . . 0.0 107.441 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.48 169.37 39.22 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 159.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -135.06 -65.44 0.62 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.848 0.824 . . . . 0.0 109.506 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.49 165.82 34.66 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.283 1.433 . . . . 0.0 107.385 172.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 53.67 -177.01 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.849 2.06 . . . . 0.0 113.493 159.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -155.02 11.8 0.36 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -106.0 151.15 24.99 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.482 -0.761 . . . . 0.0 110.033 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -126.29 152.98 45.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.36 121.55 37.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -65.94 164.93 24.07 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.998 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 140.16 57.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.299 1.999 . . . . 0.0 109.676 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 152.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.6 mmm -103.34 -10.09 18.94 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.566 1.146 . . . . 0.0 113.095 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m 47.21 -82.05 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.809 2.444 . . . . 0.0 113.655 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.74 108.56 0.46 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.85 19.51 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.209 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -53.11 148.62 7.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -129.77 135.66 60.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -159.08 -158.0 0.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.287 1.835 . . . . 0.0 106.967 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -74.42 5.02 5.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.002 1.321 . . . . 0.0 113.542 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -102.85 171.09 7.6 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.638 1.575 . . . . 0.0 109.719 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.01 49.48 0.51 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.24 1.416 . . . . 0.0 109.913 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.69 32.71 0.58 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -163.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.47 -62.13 4.61 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.7 t70 63.67 105.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.703 1 C-N-CA 133.223 4.609 . . . . 0.0 108.997 170.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -68.8 160.79 29.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.717 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -47.36 120.5 3.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.895 1.678 . . . . 0.0 109.929 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -146.92 168.85 20.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 127.433 2.293 . . . . 0.0 107.197 172.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.32 -15.88 3.18 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.535 ' HA ' ' CD1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.45 175.45 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.93 140.21 19.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -119.16 74.67 14.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 109.194 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.2 167.75 24.1 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.059 1.173 . . . . 0.0 109.99 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.355 1.862 . . . . 0.0 109.499 -164.25 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.5 ttt -132.04 -8.2 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.413 1.107 . . . . 0.0 112.63 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 54.03 -78.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.345 1.458 . . . . 0.0 113.186 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.482 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.459 HH11 HD23 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 HD23 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 81.74 2.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.54 15.68 5.98 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.134 0.974 . . . . 0.0 112.856 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.4 p -140.98 43.35 1.81 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.834 1.254 . . . . 0.0 110.693 -162.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.69 133.25 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.278 1.831 . . . . 0.0 107.247 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t 61.16 -173.27 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.027 2.931 . . . . 0.0 112.358 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -89.41 40.37 0.99 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.718 1.607 . . . . 0.0 109.088 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -143.51 169.55 17.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.8 76.33 1.29 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.51 -1.15 10.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.896 1.278 . . . . 0.0 112.028 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.9 14.27 16.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.686 1.136 . . . . 0.0 114.197 -172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t0 44.48 19.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.028 3.331 . . . . 0.0 112.824 -161.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.53 2.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.125 1.77 . . . . 0.0 114.992 -161.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.46 13.19 0.74 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -140.4 23.19 2.35 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 128.175 2.59 . . . . 0.0 111.74 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.11 79.33 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 164.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -145.48 172.56 13.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -81.63 -11.7 59.0 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.522 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.7 t80 51.33 67.09 4.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.315 1.846 . . . . 0.0 112.032 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.21 121.61 9.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.703 2.269 . . . . 0.0 109.96 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 . . . . . 0 C--O 1.247 0.969 0 C-N-CA 124.546 1.139 . . . . 0.0 108.78 166.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt 53.42 -163.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.676 -164.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m 48.41 43.35 19.52 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 111.587 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.66 132.2 54.4 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 89.02 1.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.076 0.951 . . . . 0.0 109.02 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -67.52 158.23 32.43 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.807 173.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.2 mt -89.22 128.64 41.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -150.98 168.83 23.36 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.643 1.977 . . . . 0.0 107.043 164.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -121.63 4.58 10.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -167.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.68 153.19 10.55 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 128.346 2.658 . . . . 0.0 104.795 -163.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.51 11.86 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.104 1.762 . . . . 0.0 114.988 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.32 170.9 0.07 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.846 2.858 . . . . 0.0 112.99 -164.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.85 34.19 4.66 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.293 1.425 . . . . 0.0 109.782 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.27 132.03 17.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -158.27 -36.28 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.429 159.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -155.38 26.78 0.4 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.782 -169.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -131.58 7.53 4.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 0.0 113.664 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.39 136.18 33.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.402 0.681 . . . . 0.0 109.543 -174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -136.13 162.8 31.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -143.77 141.49 30.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -130.4 150.9 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.69 65.97 8.87 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.418 2.746 . . . . 0.0 110.172 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.241 0.635 0 C-N-CA 128.066 2.546 . . . . 0.0 111.566 -157.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.3 mtp -72.13 -24.64 61.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.029 1.914 . . . . 0.0 111.132 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m 64.73 -66.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.109 2.163 . . . . 0.0 113.419 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' C ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.3 168.63 15.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 52.81 74.15 0.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.061 2.144 . . . . 0.0 113.234 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -71.1 116.35 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -130.6 159.39 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.51 1.524 . . . . 0.0 107.167 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 m -142.17 176.03 9.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.43 2.292 . . . . 0.0 108.482 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER 46.03 39.86 6.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.608 1.563 . . . . 0.0 112.923 -172.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -148.28 171.04 16.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.804 1.642 . . . . 0.0 107.343 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.97 29.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.914 1.286 . . . . 0.0 110.084 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.7 -163.25 1.46 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.924 1.69 . . . . 0.0 109.877 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.08 -76.29 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 106.127 -2.789 . . . . 0.0 106.127 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.01 -68.25 0.13 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 130.576 3.551 . . . . 0.0 107.226 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.59 -178.21 4.63 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.755 1.622 . . . . 0.0 112.937 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 177.22 0.25 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.913 2.085 . . . . 0.0 111.454 166.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.46 134.98 47.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.381 1.072 . . . . 0.0 109.309 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.58 152.79 39.23 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 163.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 98' ' ' ASN . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' PRO . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -136.08 160.05 39.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.36 157.74 36.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -154.13 158.18 32.43 Favored Pre-proline 0 N--CA 1.442 -0.844 0 C-N-CA 123.992 0.917 . . . . 0.0 109.292 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.32 172.49 13.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.996 2.464 . . . . 0.0 111.358 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.408 1.883 . . . . 0.0 107.556 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.63 -164.57 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 117.995 0.897 . . . . 0.0 109.821 -164.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 62.98 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.687 1.595 . . . . 0.0 112.645 163.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.74 103.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.99 62.2 1.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 109.105 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 156.49 17.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 152.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.62 170.32 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 -167.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t 65.41 -154.38 0.27 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.763 0.825 . . . . 0.0 109.838 173.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -91.02 23.65 3.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 112.667 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.55 -169.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.663 1.985 . . . . 0.0 110.265 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 82.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.79 -168.68 1.08 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.929 2.091 . . . . 0.0 111.938 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.89 177.92 17.82 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.58 1.562 . . . . 0.0 109.453 164.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -155.35 -82.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.838 1.655 . . . . 0.0 107.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -36.83 69.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -161.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -176.6 122.63 0.15 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.031 2.132 . . . . 0.0 107.62 -166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -154.73 149.94 27.06 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.992 1.317 . . . . 0.0 108.491 167.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -144.21 8.95 1.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.733 0.813 . . . . 0.0 111.224 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -145.11 153.59 41.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -147.71 130.63 16.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -64.01 162.02 34.13 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 162.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -56.21 143.04 86.44 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 162.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 147.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.41 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.1 mtt 60.9 -63.76 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.802 2.441 . . . . 0.0 111.089 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m 67.32 -65.77 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.342 2.257 . . . . 0.0 109.43 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.19 164.73 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.11 31.89 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.031 0.932 . . . . 0.0 112.687 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.59 68.24 1.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.246 -0.909 . . . . 0.0 110.821 -169.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.4 mt -135.28 141.43 42.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.2 m -70.92 -165.66 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.14 1.776 . . . . 0.0 111.972 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -129.6 24.99 5.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.899 2.08 . . . . 0.0 108.511 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.41 171.53 13.93 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.529 1.932 . . . . 0.0 108.772 -151.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 38.76 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.347 1.059 . . . . 0.0 111.243 168.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -0.54 1.9 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.229 2.212 . . . . 0.0 113.876 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.77 -25.27 8.73 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.324 1.44 . . . . 0.0 112.629 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 46.43 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 131.029 3.732 . . . . 0.0 111.665 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -57.23 -35.75 70.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.061 -170.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.89 137.35 11.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.57 1.548 . . . . 0.0 110.057 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -72.27 -175.98 1.7 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.418 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.3 136.65 57.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 111.637 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' ASN . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' PRO . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -103.58 178.37 4.58 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -150.03 112.51 4.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.95 86.22 59.32 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 127.371 2.268 . . . . 0.0 106.996 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.2 -175.71 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.234 2.623 . . . . 0.0 111.011 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.224 1.81 . . . . 0.0 110.259 175.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -126.51 157.92 37.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 108.216 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.92 -85.07 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.143 2.577 . . . . 0.0 112.46 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.85 16.24 0.31 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.1 123.79 11.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.238 1.815 . . . . 0.0 109.003 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 160.56 24.96 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 158.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.31 130.59 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -153.13 -168.09 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.866 2.067 . . . . 0.0 107.152 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.15 5.13 18.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.885 1.274 . . . . 0.0 111.873 167.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 50.22 169.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 129.553 3.141 . . . . 0.0 112.738 -164.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.62 11.58 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.918 -1.114 . . . . 0.0 113.643 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.62 -174.01 4.03 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 128.082 2.553 . . . . 0.0 105.546 166.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.61 170.62 19.41 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 162.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.31 133.2 4.98 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.913 2.485 . . . . 0.0 105.301 171.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -164.75 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.017 1.727 . . . . 0.0 111.126 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.29 -173.17 0.14 Allowed 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.52 -0.738 . . . . 0.0 110.162 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -124.37 174.34 7.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.46 171.83 1.01 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 175.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ARG . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 80' ' ' GLY . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 22' ' ' ARG . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' H ' ' A' ' 137' ' ' GLN . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 29.1 pt20 -148.43 -175.47 4.93 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.91 128.51 24.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -129.43 78.55 75.51 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.54 118.77 5.62 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.458 2.105 . . . . 0.0 107.139 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.303 1.041 . . . . 0.0 109.815 -169.509 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.763 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 48.0 mtt -84.99 36.61 0.63 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.694 1.998 . . . . 0.0 111.895 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t 72.64 -68.23 0.23 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.149 1.78 . . . . 0.0 109.679 -168.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . -69.85 163.41 25.95 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 27.48 0.33 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.664 1.586 . . . . 0.0 111.274 165.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.55 152.4 43.0 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.183 -0.948 . . . . 0.0 110.536 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.478 HG21 ' H ' ' A' ' 55' ' ' SER . 5.9 mm -72.67 -174.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 107.862 167.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.478 ' H ' HG21 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -56.46 108.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 107.913 164.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -153.49 37.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.583 1.553 . . . . 0.0 107.742 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -132.47 160.65 35.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 108.513 -158.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.66 64.89 6.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.442 1.497 . . . . 0.0 110.889 -162.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.36 44.02 30.26 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.577 1.951 . . . . 0.0 111.517 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.44 -52.27 4.64 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 126.152 1.834 . . . . 0.0 110.663 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.452 2.701 . . . . 0.0 108.295 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.65 -30.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 111.94 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.19 144.06 49.19 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 124.429 1.091 . . . . 0.0 109.513 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -144.19 40.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.642 1.577 . . . . 0.0 109.01 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -76.12 105.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 98' ' ' ASN . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 96' ' ' PRO . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.464 ' CB ' ' HD1' ' A' ' 126' ' ' HIS . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.464 ' HD1' ' CB ' ' A' ' 119' ' ' PRO . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -111.19 173.88 6.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.93 39.05 0.22 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.658 2.783 . . . . 0.0 109.656 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -60.38 157.3 35.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 O-C-N 121.556 -0.715 . . . . 0.0 110.811 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.85 125.84 15.52 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.889 1.726 . . . . 0.0 108.514 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 123.903 0.881 . . . . 0.0 111.393 178.115 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.65 161.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 111.098 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m 68.73 -69.88 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.046 1.739 . . . . 0.0 109.8 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' ' NE ' ' A' ' 22' ' ' ARG . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB3' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 31' ' ' GLN . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.77 133.11 50.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 92.9 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.694 1.997 . . . . 0.0 107.41 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -62.04 150.43 38.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.742 1.217 . . . . 0.0 109.685 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.426 ' CD1' ' H ' ' A' ' 54' ' ' ILE . 2.9 mp -75.93 133.7 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.7 m -74.8 4.35 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.257 4.7 ppt_? -140.58 21.69 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.408 1.883 . . . . 0.0 113.393 170.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.24 175.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.205 2.202 . . . . 0.0 112.571 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.45 71.28 0.38 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.122 1.369 . . . . 0.0 109.813 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 51.52 -154.53 0.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.944 1.297 . . . . 0.0 113.282 165.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.72 10.69 5.47 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.598 1.57 . . . . 0.0 112.538 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.76 -21.19 10.3 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.978 1.311 . . . . 0.0 112.289 -164.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -130.61 -8.01 4.09 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.657 0.783 . . . . 0.0 112.574 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 145.09 15.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.181 -0.949 . . . . 0.0 111.153 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.22 177.0 8.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.892 1.277 . . . . 0.0 111.82 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.47 165.53 6.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.578 1.151 . . . . 0.0 110.555 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 98' ' ' ASN . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 96' ' ' PRO . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -124.97 145.82 49.69 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -67.1 -20.41 65.78 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 140' ' ' PRO . 1.0 OUTLIER 59.98 144.07 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 130.72 3.608 . . . . 0.0 110.788 -167.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.421 ' HD2' ' CD2' ' A' ' 139' ' ' TYR . 57.2 Cg_endo -72.31 158.62 51.27 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.562 2.175 . . . . 0.0 112.412 -175.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.441 0 C-N-CA 127.337 2.255 . . . . 0.0 110.904 -177.632 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.759 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.31 162.87 40.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.978 0.511 . . . . 0.0 109.755 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m 45.31 -85.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.278 2.231 . . . . 0.0 114.122 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.88 148.99 32.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.82 55.64 1.72 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.288 1.435 . . . . 0.0 107.941 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 t -137.56 126.72 24.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -140.92 140.04 33.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.93 7.29 3.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.153 2.181 . . . . 0.0 114.955 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -131.7 81.4 1.97 Allowed 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 129.282 3.033 . . . . 0.0 106.474 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -146.02 160.82 41.34 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.14 14.69 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -172.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 163.53 25.47 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.138 0.881 . . . . 0.0 109.31 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.33 42.02 2.54 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.92 171.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -163.89 145.33 8.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.496 2.319 . . . . 0.0 105.898 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 163.54 20.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.226 1.41 . . . . 0.0 112.148 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 63.63 -174.92 0.16 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.038 1.735 . . . . 0.0 111.794 166.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.58 173.52 12.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.588 1.955 . . . . 0.0 106.473 164.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.01 172.63 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 144.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.461 ' H ' HG21 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -140.61 169.73 17.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -125.94 156.33 39.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -127.23 81.25 70.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.593 1.957 . . . . 0.0 106.399 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.75 -171.27 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.802 2.334 . . . . 0.0 109.274 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 153.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -176.69 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m 45.89 -85.53 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.927 2.091 . . . . 0.0 113.303 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' HH ' ' A' ' 134' ' ' TYR . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.58 103.04 4.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 31.43 0.07 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.648 1.179 . . . . 0.0 112.469 169.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 p -112.78 174.81 5.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.574 1.55 . . . . 0.0 109.291 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.2 mt -66.39 142.56 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 O-C-N 120.9 -1.125 . . . . 0.0 108.635 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.29 12.47 3.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.084 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -101.63 4.87 41.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.642 1.577 . . . . 0.0 112.74 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 128.75 53.48 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 55.43 7.17 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.21 167.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 131.488 3.915 . . . . 0.0 115.829 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.26 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.882 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 56.82 12.68 1.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.015 2.926 . . . . 0.0 111.023 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.98 4.49 0.64 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.854 1.261 . . . . 0.0 113.04 168.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.09 -170.16 3.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.073 1.306 . . . . 0.0 111.327 -164.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.257 3.2 pt20 57.18 36.54 27.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.81 2.844 . . . . 0.0 116.51 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -70.02 144.63 52.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.718 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.488 ' HH ' ' CG2' ' A' ' 48' ' ' VAL . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -148.17 150.27 33.49 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.199 2.2 . . . . 0.0 112.925 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 67.96 154.0 0.14 Allowed Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 130.058 3.343 . . . . 0.0 115.102 171.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.36 64.6 3.62 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.634 2.89 . . . . 0.0 110.67 162.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.257 12.0 pt-20 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 131.238 3.815 . . . . 0.0 117.128 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.444 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 53.87 -163.12 0.11 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.227 1.013 . . . . 0.0 110.739 -175.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 2' ' ' MET . 0.2 OUTLIER 55.39 -85.28 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.742 2.017 . . . . 0.0 114.286 169.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.421 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' NH1' ' H ' ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.41 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.89 121.61 10.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 69.28 1.3 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.586 0.708 . . . . 0.0 109.469 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 t -66.82 -164.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.565 1.174 . . . . 0.0 109.64 165.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -44.84 141.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 127.748 2.419 . . . . 0.0 110.811 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.41 17.95 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.917 2.487 . . . . 0.0 110.893 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -80.99 3.55 22.6 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 170.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.81 139.81 5.39 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 128.048 2.539 . . . . 0.0 105.297 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 47.55 17.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.629 3.171 . . . . 0.0 117.875 162.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.2 174.89 0.3 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.927 2.891 . . . . 0.0 112.694 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.31 27.4 15.68 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.726 1.631 . . . . 0.0 111.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.77 146.33 24.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 129.998 3.319 . . . . 0.0 104.771 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -152.63 -37.93 0.11 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 170.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.46 14.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -173.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -148.41 138.02 22.15 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.739 1.216 . . . . 0.0 108.477 169.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.463 ' H ' HG11 ' A' ' 136' ' ' VAL . 14.0 m-30 -112.96 91.83 3.79 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.58 2.352 . . . . 0.0 105.237 173.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' CD1' ' HG2' ' A' ' 101' ' ' MET . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.423 ' HG2' ' CD1' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 65' ' ' TYR . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.486 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 0.8 OUTLIER -106.53 161.84 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.26 131.1 55.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -122.84 82.78 49.6 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 -171.8 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.581 1.521 . . . . 0.0 109.351 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 118.3 -0.857 . . . . 0.0 108.772 164.465 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.656 HD11 HD23 ' A' ' 106' ' ' LEU . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 30' ' ' TRP . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.401 HH11 HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 23' ' ' THR 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 HH11 ' A' ' 22' ' ' ARG . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD23 ' A' ' 15' ' ' LEU . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.496 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 114' ' ' ILE . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.459 ' HD2' ' OD2' ' A' ' 135' ' ' ASP . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 95' ' ' PHE . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 111' ' ' ARG . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.459 ' HA ' HD12 ' A' ' 6' ' ' LEU . 14.9 m . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 3' ' ' SER . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' A' ' 68' ' ' VAL . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.724 0.774 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 49' ' ' MET . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 6' ' ' LEU . 12.3 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' SER . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 106' ' ' LEU . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.55 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 127' ' ' THR . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.485 ' H ' HD11 ' A' ' 77' ' ' ILE . 3.5 m80 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' THR . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 137' ' ' GLN . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.575 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.0 tt0 . . . . . 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 117.272 -1.346 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' HD12 ' A' ' 7' ' ' ILE . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 4' ' ' GLN . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CG ' HD22 ' A' ' 94' ' ' LEU . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 30' ' ' TRP . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 36' ' ' THR . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.559 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 18' ' ' TRP . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 99' ' ' LEU . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 96' ' ' PRO . 4.8 m120 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.487 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.484 ' HB ' HD22 ' A' ' 99' ' ' LEU . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.604 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 110' ' ' VAL . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.487 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.616 HD12 ' C ' ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 106' ' ' LEU . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CG ' HD22 ' A' ' 94' ' ' LEU . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 36' ' ' THR . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 18' ' ' TRP . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 136' ' ' VAL . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 132' ' ' LEU . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 HD23 ' A' ' 132' ' ' LEU . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD13 HG23 ' A' ' 110' ' ' VAL . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 106' ' ' LEU . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 100' ' ' VAL . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 106' ' ' LEU . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.434 ' CZ3' HD21 ' A' ' 91' ' ' LEU . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.492 HH11 HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HH11 ' A' ' 22' ' ' ARG . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.251 0.548 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 18' ' ' TRP . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 7' ' ' ILE . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 136' ' ' VAL . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' ASP . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 106' ' ' LEU . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.454 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD2' HD13 ' A' ' 7' ' ' ILE . 42.2 m-85 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.696 HG22 ' HE ' ' A' ' 109' ' ' ARG . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.576 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.696 ' HE ' HG22 ' A' ' 100' ' ' VAL . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' CE1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 110' ' ' VAL . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 127' ' ' THR . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 120' ' ' THR . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.57 HD23 ' CD1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.825 ' CE1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 99' ' ' LEU . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 101' ' ' MET . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 100' ' ' VAL . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.498 ' HG3' HD12 ' A' ' 99' ' ' LEU . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 HD13 HD12 ' A' ' 132' ' ' LEU . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 122' ' ' GLY 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 121' ' ' THR . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 105' ' ' GLY . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 106' ' ' LEU . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 HH11 HD11 ' A' ' 26' ' ' LEU . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HH11 ' A' ' 22' ' ' ARG . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 ' HD3' ' A' ' 50' ' ' PRO . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.647 ' HD3' HG12 ' A' ' 48' ' ' VAL . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 99' ' ' LEU . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.6 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 7' ' ' ILE . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.64 ' HB ' HD22 ' A' ' 99' ' ' LEU . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' CH2' ' A' ' 30' ' ' TRP . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.55 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.406 ' CH2' HD23 ' A' ' 15' ' ' LEU . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.55 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 132' ' ' LEU . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.584 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 106' ' ' LEU . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 36' ' ' THR . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.495 0.664 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 66' ' ' ARG . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 114' ' ' ILE . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.608 ' HD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.608 HD11 ' HD2' ' A' ' 95' ' ' PHE . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 132' ' ' LEU . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.796 0.808 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 91' ' ' LEU . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 87' ' ' VAL . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' A' ' 110' ' ' VAL . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 132' ' ' LEU . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.647 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 110' ' ' VAL . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD21 ' HA3' ' A' ' 105' ' ' GLY . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 103' ' ' SER . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.427 ' CG ' HD22 ' A' ' 94' ' ' LEU . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD23 HH11 ' A' ' 22' ' ' ARG . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.42 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 48' ' ' VAL . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 43' ' ' TYR . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG12 HD12 ' A' ' 91' ' ' LEU . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.508 HD12 HG12 ' A' ' 87' ' ' VAL . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 18' ' ' TRP . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 100' ' ' VAL . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 98' ' ' ASN . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 132' ' ' LEU . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD23 ' CH2' ' A' ' 30' ' ' TRP . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CH2' HD23 ' A' ' 15' ' ' LEU . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' VAL . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 131' ' ' SER . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 70' ' ' GLN . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 . . . . . 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.863 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.455 0.645 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HB ' HD22 ' A' ' 99' ' ' LEU . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 122' ' ' GLY . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' H ' HG22 ' A' ' 121' ' ' THR . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 84' ' ' ALA . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 . . . . . 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 117.49 -1.243 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' CA ' ' A' ' 105' ' ' GLY . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.735 ' NH2' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.735 HD12 ' NH2' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 44' ' ' LEU . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.458 -0.073 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.625 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 100' ' ' VAL . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.502 ' HE2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.471 ' CA ' HD13 ' A' ' 6' ' ' LEU . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 101' ' ' MET . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' HB ' HD22 ' A' ' 99' ' ' LEU . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.429 HD13 HG23 ' A' ' 110' ' ' VAL . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 117.015 -1.469 . . . . 0.0 113.303 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 106' ' ' LEU . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CB ' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 ' HE1' ' A' ' 101' ' ' MET . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.653 ' HE1' HD13 ' A' ' 99' ' ' LEU . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.639 ' HB ' HD12 ' A' ' 99' ' ' LEU . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 117.22 -1.372 . . . . 0.0 114.286 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 105' ' ' GLY . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 106' ' ' LEU . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.781 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.781 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.598 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.527 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.479 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.819 HD13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.586 HG23 HD13 ' A' ' 132' ' ' LEU . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 95' ' ' PHE . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 122' ' ' GLY . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.561 ' H ' HG22 ' A' ' 121' ' ' THR . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 84' ' ' ALA . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 137' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -142.14 157.63 44.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.34 1.856 . . . . 0.0 108.876 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m 45.35 -79.91 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 129.157 2.983 . . . . 0.0 113.621 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.656 HD11 HD23 ' A' ' 106' ' ' LEU . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 30' ' ' TRP . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.401 HH11 HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 23' ' ' THR 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 HH11 ' A' ' 22' ' ' ARG . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD23 ' A' ' 15' ' ' LEU . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.496 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . -72.2 144.69 48.42 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.55 98.44 3.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -69.47 -170.57 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.015 0.926 . . . . 0.0 109.647 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.97 14.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 120.604 -1.31 . . . . 0.0 110.893 164.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 52.7 -154.35 0.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.705 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 52.74 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.218 2.207 . . . . 0.0 111.677 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.97 -174.69 3.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.44 4.93 6.91 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.5 3.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.085 2.154 . . . . 0.0 106.258 164.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 35.59 2.45 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 123.648 0.642 . . . . 0.0 111.594 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -149.69 107.56 3.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -171.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.06 0.15 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.508 1.523 . . . . 0.0 109.106 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.65 170.33 0.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.421 1.488 . . . . 0.0 110.423 154.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.67 4.54 1.53 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.695 1.198 . . . . 0.0 111.855 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 41.7 43.28 2.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.388 2.675 . . . . 0.0 114.093 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 114' ' ' ILE . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.459 ' HD2' ' OD2' ' A' ' 135' ' ' ASP . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 95' ' ' PHE . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 111' ' ' ARG . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -74.84 170.24 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.1 39.71 0.85 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.908 2.483 . . . . 0.0 111.172 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -57.33 150.38 43.36 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.788 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.74 149.75 61.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.548 1.499 . . . . 0.0 110.427 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.363 1.065 . . . . 0.0 110.588 166.628 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.889 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.9 mmt -126.54 -73.07 0.63 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.075 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.459 ' HA ' HD12 ' A' ' 6' ' ' LEU . 14.9 m 63.53 -71.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.81 1.244 . . . . 0.0 112.701 -172.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 3' ' ' SER . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' A' ' 68' ' ' VAL . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.85 149.4 31.49 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.23 13.91 2.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 113.367 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -88.24 42.74 1.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 110.527 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.26 128.5 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t 64.6 179.97 0.18 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.825 2.45 . . . . 0.0 111.183 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 62.39 13.95 6.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.349 1.859 . . . . 0.0 113.25 -171.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.13 152.84 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.333 0.653 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.19 63.91 0.28 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.74 1.216 . . . . 0.0 110.235 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.88 14.33 0.22 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.059 0.944 . . . . 0.0 112.446 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.13 42.72 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 120.728 -1.233 . . . . 0.0 110.556 -159.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.36 -14.66 10.39 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.72 1.608 . . . . 0.0 112.409 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.15 128.4 33.66 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 59.08 20.53 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.422 1.489 . . . . 0.0 113.054 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -88.19 110.23 20.53 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 119.771 -1.831 . . . . 0.0 107.61 169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.87 140.7 29.35 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.855 0.862 . . . . 0.0 109.029 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 49' ' ' MET . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -155.47 157.02 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.95 4.27 38.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 112.596 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 166.15 0.11 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 127.964 2.506 . . . . 0.0 110.193 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.24 172.94 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.566 1.511 . . . . 0.0 109.819 173.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.245 0.846 0 C-N-CA 126.563 1.945 . . . . 0.0 111.8 -171.463 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.0 ttt -87.84 43.3 1.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.149 -1.207 . . . . 0.0 111.19 -164.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 6' ' ' LEU . 12.3 t 65.7 -69.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 110.914 -170.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' SER . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 106' ' ' LEU . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.47 8.98 31.07 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.96 135.97 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.37 2.668 . . . . 0.0 111.746 -169.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -74.97 63.58 1.23 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.521 1.528 . . . . 0.0 110.944 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.293 0.7 OUTLIER -121.43 104.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 1 C-N-CA 132.572 4.349 . . . . 0.0 107.022 179.107 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -171.69 177.83 3.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 124.65 1.218 . . . . 0.0 108.682 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -103.79 91.13 3.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 171.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.9 171.7 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 164.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.12 26.27 4.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.243 1.017 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.97 149.17 28.6 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.216 1.406 . . . . 0.0 109.124 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.75 65.86 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 125.007 1.289 . . . . 0.0 113.628 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -143.02 40.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.939 0.869 . . . . 0.0 109.51 -159.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.19 151.33 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.447 1.099 . . . . 0.0 108.929 167.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.24 -167.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.819 1.647 . . . . 0.0 111.536 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.35 171.21 12.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.39 1.476 . . . . 0.0 108.976 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.18 168.83 9.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.786 1.634 . . . . 0.0 110.892 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.55 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 127' ' ' THR . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.485 ' H ' HD11 ' A' ' 77' ' ' ILE . 3.5 m80 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' THR . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -138.78 160.47 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -73.03 -11.62 60.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.043 0.838 . . . . 0.0 111.133 167.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.3 t80 58.74 61.33 4.96 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 127.467 2.307 . . . . 0.0 111.234 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.41 139.87 67.12 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.948 1.765 . . . . 0.0 110.718 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.564 2.346 . . . . 0.0 111.109 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.968 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 57.5 mtm -153.78 66.01 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.277 1.431 . . . . 0.0 109.717 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.4 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.429 1.891 . . . . 0.0 112.413 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.02 -177.05 3.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.93 59.98 4.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.765 2.026 . . . . 0.0 110.609 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -71.38 -179.14 2.35 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.284 1.034 . . . . 0.0 109.32 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.1 mt -54.58 140.96 11.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -150.53 178.42 9.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.014 1.726 . . . . 0.0 108.01 168.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.65 13.57 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.339 1.056 . . . . 0.0 110.964 167.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -130.9 164.28 25.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.06 15.56 1.05 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.39 1.076 . . . . 0.0 113.43 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -17.56 63.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.893 0.877 . . . . 0.0 113.21 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.86 2.5 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.297 1.904 . . . . 0.0 112.019 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t70 63.04 102.03 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 131.187 3.795 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -69.59 159.71 32.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.382 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 61.91 15.09 6.87 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.174 1.79 . . . . 0.0 115.16 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -132.2 95.05 3.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.025 1.33 . . . . 0.0 110.215 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.05 172.27 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.776 1.23 . . . . 0.0 107.908 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 137' ' ' GLN . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.575 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.0 tt0 -157.63 161.93 38.67 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.71 94.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.931 1.692 . . . . 0.0 108.66 -164.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -66.87 157.05 85.57 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.14 152.06 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.575 1.517 . . . . 0.0 110.113 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.245 0.838 0 C-N-CA 126.318 1.847 . . . . 0.0 108.246 177.343 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.252 0.0 OUTLIER -139.79 84.14 1.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.644 1.222 . . . . 0.0 109.981 166.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m 49.87 -83.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.991 2.917 . . . . 0.0 113.785 170.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' HD12 ' A' ' 7' ' ' ILE . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 4' ' ' GLN . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CG ' HD22 ' A' ' 94' ' ' LEU . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 30' ' ' TRP . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 36' ' ' THR . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.17 147.61 2.91 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.81 35.77 4.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 111.547 -168.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 t -140.64 35.91 1.82 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.945 0.898 . . . . 0.0 111.837 -153.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mt -57.13 135.2 21.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.483 0.713 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.66 -154.87 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.525 1.93 . . . . 0.0 108.447 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -108.92 10.48 26.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.066 0.947 . . . . 0.0 113.107 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -73.55 -179.95 3.78 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.009 0.524 . . . . 0.0 109.714 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.75 12.72 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.031 1.333 . . . . 0.0 113.285 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.68 175.53 7.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.93 2.092 . . . . 0.0 110.771 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.84 32.78 4.31 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.878 1.228 . . . . 0.0 112.809 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.28 127.44 12.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.183 2.193 . . . . 0.0 106.275 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -141.39 -178.03 5.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.478 1.511 . . . . 0.0 112.244 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.397 1.079 . . . . 0.0 109.389 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 68.85 158.15 0.15 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 131.387 3.875 . . . . 0.0 113.99 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.23 164.33 18.95 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.158 1.383 . . . . 0.0 110.324 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 18' ' ' TRP . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 99' ' ' LEU . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 96' ' ' PRO . 4.8 m120 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.484 ' HB ' HD22 ' A' ' 99' ' ' LEU . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.604 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 110' ' ' VAL . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.487 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 -149.02 -179.66 7.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -144.06 165.68 27.12 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 167.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -136.54 165.48 35.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.443 2.297 . . . . 0.0 108.864 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.13 144.11 74.12 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.287 1.325 . . . . 0.0 109.022 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.298 20.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 127.324 2.25 . . . . 0.0 113.317 -165.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptm -129.27 63.59 1.5 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.008 1.323 . . . . 0.0 109.734 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -154.9 -82.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.384 0.673 . . . . 0.0 111.263 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.616 HD12 ' C ' ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 106' ' ' LEU . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CG ' HD22 ' A' ' 94' ' ' LEU . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 36' ' ' THR . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.81 35.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.8 71.5 0.26 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.698 2.399 . . . . 0.0 112.938 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 t -66.26 116.99 7.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.02 137.88 41.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -75.04 177.0 6.69 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 124.235 0.959 . . . . 0.0 110.665 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 75.38 112.02 0.07 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.173 2.989 . . . . 0.0 108.632 -153.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.16 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.619 2.768 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 58.88 18.2 5.93 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.483 1.113 . . . . 0.0 112.468 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 169.2 3.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.819 2.048 . . . . 0.0 111.65 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.95 51.54 4.44 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 126.252 1.882 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -161.34 131.77 5.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.612 3.165 . . . . 0.0 104.164 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -162.43 -27.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -159.72 173.07 16.59 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 127.664 2.386 . . . . 0.0 106.112 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.286 19.9 pt20 45.28 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 111.768 -169.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -120.87 178.12 4.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.709 1.603 . . . . 0.0 109.899 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 18' ' ' TRP . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 136' ' ' VAL . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 132' ' ' LEU . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 HD23 ' A' ' 132' ' ' LEU . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD13 HG23 ' A' ' 110' ' ' VAL . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -120.86 122.78 41.01 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.3 116.27 29.46 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 158.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -72.07 160.84 81.6 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 163.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.48 151.35 85.19 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.347 -1.787 . . . . 0.0 108.046 -176.175 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.722 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 48.65 58.65 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.882 1.273 . . . . 0.0 110.099 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -146.82 -85.99 0.1 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 106' ' ' LEU . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.57 81.82 0.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.97 135.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.605 3.162 . . . . 0.0 112.87 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 p -94.19 47.55 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.792 0.837 . . . . 0.0 112.421 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.7 mt -120.81 12.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.315 -0.865 . . . . 0.0 111.719 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -175.01 171.41 3.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.277 1.831 . . . . 0.0 108.35 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -136.13 34.42 2.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.185 1.394 . . . . 0.0 111.315 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.07 145.18 47.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.964 1.306 . . . . 0.0 111.2 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -173.67 72.49 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.314 2.245 . . . . 0.0 109.372 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.89 -0.43 29.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.693 1.197 . . . . 0.0 113.828 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.76 34.11 80.91 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.17 -77.55 0.09 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.111 -1.229 . . . . 0.0 109.027 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -71.04 119.4 15.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.64 -169.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.568 0.747 . . . . 0.0 111.816 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.82 169.87 21.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.256 1.022 . . . . 0.0 109.475 -163.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.03 121.13 38.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.308 1.043 . . . . 0.0 110.204 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 100' ' ' VAL . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.42 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -100.29 2.25 42.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.948 0.899 . . . . 0.0 110.54 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.7 t80 44.34 65.69 5.77 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 129.208 3.003 . . . . 0.0 112.813 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.2 148.12 84.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.968 1.779 . . . . 0.0 110.164 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.772 160.159 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 81.9 mtp -135.7 32.45 3.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.066 0.946 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m 59.29 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.007 1.323 . . . . 0.0 112.491 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 106' ' ' LEU . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.434 ' CZ3' HD21 ' A' ' 91' ' ' LEU . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.492 HH11 HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HH11 ' A' ' 22' ' ' ARG . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.98 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 43.37 83.49 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.846 2.458 . . . . 0.0 114.118 155.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.2 t -52.07 95.39 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.163 1.785 . . . . 0.0 112.885 -172.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.6 mt -141.35 158.64 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 129.083 2.953 . . . . 0.0 104.447 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -137.2 143.99 42.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 155.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -160.52 15.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.452 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -103.96 166.77 10.2 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.039 -1.038 . . . . 0.0 111.255 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.45 21.0 2.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 127.011 2.125 . . . . 0.0 110.601 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.08 -168.73 2.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.248 2.219 . . . . 0.0 107.441 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.48 169.37 39.22 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 159.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -135.06 -65.44 0.62 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.848 0.824 . . . . 0.0 109.506 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.49 165.82 34.66 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.283 1.433 . . . . 0.0 107.385 172.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 53.67 -177.01 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.849 2.06 . . . . 0.0 113.493 159.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -155.02 11.8 0.36 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -106.0 151.15 24.99 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.482 -0.761 . . . . 0.0 110.033 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 18' ' ' TRP . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 7' ' ' ILE . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 136' ' ' VAL . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' ASP . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -126.29 152.98 45.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.36 121.55 37.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -65.94 164.93 24.07 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.998 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 140.16 57.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.299 1.999 . . . . 0.0 109.676 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 152.518 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.6 mmm -103.34 -10.09 18.94 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.566 1.146 . . . . 0.0 113.095 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m 47.21 -82.05 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.809 2.444 . . . . 0.0 113.655 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 106' ' ' LEU . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.454 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . -55.74 108.56 0.46 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.85 19.51 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.209 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -53.11 148.62 7.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -129.77 135.66 60.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -159.08 -158.0 0.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.287 1.835 . . . . 0.0 106.967 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -74.42 5.02 5.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.002 1.321 . . . . 0.0 113.542 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -102.85 171.09 7.6 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.638 1.575 . . . . 0.0 109.719 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.01 49.48 0.51 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.24 1.416 . . . . 0.0 109.913 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.69 32.71 0.58 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -163.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.47 -62.13 4.61 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.7 t70 63.67 105.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.703 1 C-N-CA 133.223 4.609 . . . . 0.0 108.997 170.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -68.8 160.79 29.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.717 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -47.36 120.5 3.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.895 1.678 . . . . 0.0 109.929 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -146.92 168.85 20.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 127.433 2.293 . . . . 0.0 107.197 172.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD2' HD13 ' A' ' 7' ' ' ILE . 42.2 m-85 -131.32 -15.88 3.18 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.696 HG22 ' HE ' ' A' ' 109' ' ' ARG . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.576 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.696 ' HE ' HG22 ' A' ' 100' ' ' VAL . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' CE1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 110' ' ' VAL . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 127' ' ' THR . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 120' ' ' THR . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.57 HD23 ' CD1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.825 ' CE1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.45 175.45 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.93 140.21 19.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -119.16 74.67 14.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 109.194 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.2 167.75 24.1 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.059 1.173 . . . . 0.0 109.99 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.355 1.862 . . . . 0.0 109.499 -164.25 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.5 ttt -132.04 -8.2 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.413 1.107 . . . . 0.0 112.63 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 54.03 -78.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.345 1.458 . . . . 0.0 113.186 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 81.74 2.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.54 15.68 5.98 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.134 0.974 . . . . 0.0 112.856 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.4 p -140.98 43.35 1.81 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.834 1.254 . . . . 0.0 110.693 -162.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.69 133.25 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.278 1.831 . . . . 0.0 107.247 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t 61.16 -173.27 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.027 2.931 . . . . 0.0 112.358 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -89.41 40.37 0.99 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.718 1.607 . . . . 0.0 109.088 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -143.51 169.55 17.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.8 76.33 1.29 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.51 -1.15 10.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.896 1.278 . . . . 0.0 112.028 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.9 14.27 16.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.686 1.136 . . . . 0.0 114.197 -172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t0 44.48 19.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.028 3.331 . . . . 0.0 112.824 -161.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.53 2.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.125 1.77 . . . . 0.0 114.992 -161.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.46 13.19 0.74 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -140.4 23.19 2.35 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 128.175 2.59 . . . . 0.0 111.74 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.11 79.33 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 164.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 99' ' ' LEU . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 101' ' ' MET . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 100' ' ' VAL . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.498 ' HG3' HD12 ' A' ' 99' ' ' LEU . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 HD13 HD12 ' A' ' 132' ' ' LEU . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 122' ' ' GLY 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 121' ' ' THR . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -145.48 172.56 13.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -81.63 -11.7 59.0 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.522 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.7 t80 51.33 67.09 4.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.315 1.846 . . . . 0.0 112.032 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.21 121.61 9.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.703 2.269 . . . . 0.0 109.96 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 . . . . . 0 C--O 1.247 0.969 0 C-N-CA 124.546 1.139 . . . . 0.0 108.78 166.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt 53.42 -163.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.676 -164.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m 48.41 43.35 19.52 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 111.587 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 105' ' ' GLY . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 106' ' ' LEU . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 HH11 HD11 ' A' ' 26' ' ' LEU . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HH11 ' A' ' 22' ' ' ARG . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 ' HD3' ' A' ' 50' ' ' PRO . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.647 ' HD3' HG12 ' A' ' 48' ' ' VAL . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.66 132.2 54.4 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 89.02 1.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.076 0.951 . . . . 0.0 109.02 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -67.52 158.23 32.43 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.807 173.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.2 mt -89.22 128.64 41.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -150.98 168.83 23.36 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.643 1.977 . . . . 0.0 107.043 164.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -121.63 4.58 10.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -167.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.68 153.19 10.55 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 128.346 2.658 . . . . 0.0 104.795 -163.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.51 11.86 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.104 1.762 . . . . 0.0 114.988 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.32 170.9 0.07 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.846 2.858 . . . . 0.0 112.99 -164.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.85 34.19 4.66 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.293 1.425 . . . . 0.0 109.782 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.27 132.03 17.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -158.27 -36.28 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.429 159.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -155.38 26.78 0.4 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.782 -169.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -131.58 7.53 4.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 0.0 113.664 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.39 136.18 33.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.402 0.681 . . . . 0.0 109.543 -174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 99' ' ' LEU . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.6 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 7' ' ' ILE . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.64 ' HB ' HD22 ' A' ' 99' ' ' LEU . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -136.13 162.8 31.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -143.77 141.49 30.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -130.4 150.9 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.69 65.97 8.87 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.418 2.746 . . . . 0.0 110.172 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.241 0.635 0 C-N-CA 128.066 2.546 . . . . 0.0 111.566 -157.304 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.3 mtp -72.13 -24.64 61.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.029 1.914 . . . . 0.0 111.132 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m 64.73 -66.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.109 2.163 . . . . 0.0 113.419 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' CH2' ' A' ' 30' ' ' TRP . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.55 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.406 ' CH2' HD23 ' A' ' 15' ' ' LEU . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.3 168.63 15.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 52.81 74.15 0.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.061 2.144 . . . . 0.0 113.234 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -71.1 116.35 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -130.6 159.39 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.51 1.524 . . . . 0.0 107.167 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 m -142.17 176.03 9.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.43 2.292 . . . . 0.0 108.482 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER 46.03 39.86 6.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.608 1.563 . . . . 0.0 112.923 -172.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -148.28 171.04 16.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.804 1.642 . . . . 0.0 107.343 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.97 29.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.914 1.286 . . . . 0.0 110.084 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.7 -163.25 1.46 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.924 1.69 . . . . 0.0 109.877 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.08 -76.29 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 106.127 -2.789 . . . . 0.0 106.127 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.01 -68.25 0.13 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 130.576 3.551 . . . . 0.0 107.226 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.59 -178.21 4.63 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.755 1.622 . . . . 0.0 112.937 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 177.22 0.25 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.913 2.085 . . . . 0.0 111.454 166.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.46 134.98 47.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.381 1.072 . . . . 0.0 109.309 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.58 152.79 39.23 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 163.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.55 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 132' ' ' LEU . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.584 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -136.08 160.05 39.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.36 157.74 36.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -154.13 158.18 32.43 Favored Pre-proline 0 N--CA 1.442 -0.844 0 C-N-CA 123.992 0.917 . . . . 0.0 109.292 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.32 172.49 13.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.996 2.464 . . . . 0.0 111.358 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.408 1.883 . . . . 0.0 107.556 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.63 -164.57 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 117.995 0.897 . . . . 0.0 109.821 -164.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 62.98 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.687 1.595 . . . . 0.0 112.645 163.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 106' ' ' LEU . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 36' ' ' THR . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.74 103.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.99 62.2 1.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 109.105 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 156.49 17.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 152.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.62 170.32 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 -167.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t 65.41 -154.38 0.27 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.763 0.825 . . . . 0.0 109.838 173.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -91.02 23.65 3.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 112.667 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.55 -169.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.663 1.985 . . . . 0.0 110.265 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 82.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.79 -168.68 1.08 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.929 2.091 . . . . 0.0 111.938 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.89 177.92 17.82 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.58 1.562 . . . . 0.0 109.453 164.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -155.35 -82.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.838 1.655 . . . . 0.0 107.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.27 -36.83 69.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -161.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -176.6 122.63 0.15 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.031 2.132 . . . . 0.0 107.62 -166.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -154.73 149.94 27.06 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.992 1.317 . . . . 0.0 108.491 167.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -144.21 8.95 1.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.733 0.813 . . . . 0.0 111.224 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 66' ' ' ARG . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 114' ' ' ILE . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.608 ' HD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD11 ' HD2' ' A' ' 95' ' ' PHE . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 132' ' ' LEU . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -145.11 153.59 41.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -147.71 130.63 16.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -64.01 162.02 34.13 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 162.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -56.21 143.04 86.44 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 162.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 147.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.41 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.1 mtt 60.9 -63.76 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.802 2.441 . . . . 0.0 111.089 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m 67.32 -65.77 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.342 2.257 . . . . 0.0 109.43 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.19 164.73 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.11 31.89 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.031 0.932 . . . . 0.0 112.687 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.59 68.24 1.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.246 -0.909 . . . . 0.0 110.821 -169.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.4 mt -135.28 141.43 42.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.2 m -70.92 -165.66 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.14 1.776 . . . . 0.0 111.972 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -129.6 24.99 5.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.899 2.08 . . . . 0.0 108.511 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.41 171.53 13.93 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.529 1.932 . . . . 0.0 108.772 -151.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 38.76 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.347 1.059 . . . . 0.0 111.243 168.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -0.54 1.9 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.229 2.212 . . . . 0.0 113.876 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.77 -25.27 8.73 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.324 1.44 . . . . 0.0 112.629 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 46.43 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 131.029 3.732 . . . . 0.0 111.665 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -57.23 -35.75 70.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.061 -170.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.89 137.35 11.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.57 1.548 . . . . 0.0 110.057 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -72.27 -175.98 1.7 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.418 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.3 136.65 57.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 111.637 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 91' ' ' LEU . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 87' ' ' VAL . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' A' ' 110' ' ' VAL . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 132' ' ' LEU . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.647 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 110' ' ' VAL . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -103.58 178.37 4.58 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -150.03 112.51 4.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.95 86.22 59.32 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 127.371 2.268 . . . . 0.0 106.996 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.2 -175.71 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.234 2.623 . . . . 0.0 111.011 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.224 1.81 . . . . 0.0 110.259 175.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -126.51 157.92 37.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 108.216 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.92 -85.07 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.143 2.577 . . . . 0.0 112.46 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD21 ' HA3' ' A' ' 105' ' ' GLY . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 103' ' ' SER . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.427 ' CG ' HD22 ' A' ' 94' ' ' LEU . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD23 HH11 ' A' ' 22' ' ' ARG . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.42 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.85 16.24 0.31 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.1 123.79 11.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.238 1.815 . . . . 0.0 109.003 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 160.56 24.96 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 158.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.31 130.59 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -153.13 -168.09 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.866 2.067 . . . . 0.0 107.152 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.15 5.13 18.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.885 1.274 . . . . 0.0 111.873 167.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 50.22 169.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 129.553 3.141 . . . . 0.0 112.738 -164.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.62 11.58 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.918 -1.114 . . . . 0.0 113.643 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.62 -174.01 4.03 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 128.082 2.553 . . . . 0.0 105.546 166.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.61 170.62 19.41 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 162.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.31 133.2 4.98 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.913 2.485 . . . . 0.0 105.301 171.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -164.75 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.017 1.727 . . . . 0.0 111.126 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.29 -173.17 0.14 Allowed 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.52 -0.738 . . . . 0.0 110.162 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -124.37 174.34 7.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.46 171.83 1.01 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 175.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 48' ' ' VAL . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 43' ' ' TYR . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG12 HD12 ' A' ' 91' ' ' LEU . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.508 HD12 HG12 ' A' ' 87' ' ' VAL . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 18' ' ' TRP . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 100' ' ' VAL . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 98' ' ' ASN . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 132' ' ' LEU . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -148.43 -175.47 4.93 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.91 128.51 24.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -129.43 78.55 75.51 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.54 118.77 5.62 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.458 2.105 . . . . 0.0 107.139 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.303 1.041 . . . . 0.0 109.815 -169.509 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.763 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 48.0 mtt -84.99 36.61 0.63 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.694 1.998 . . . . 0.0 111.895 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t 72.64 -68.23 0.23 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.149 1.78 . . . . 0.0 109.679 -168.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD23 ' CH2' ' A' ' 30' ' ' TRP . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CH2' HD23 ' A' ' 15' ' ' LEU . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' VAL . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . -69.85 163.41 25.95 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 27.48 0.33 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.664 1.586 . . . . 0.0 111.274 165.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.55 152.4 43.0 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.183 -0.948 . . . . 0.0 110.536 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 55' ' ' SER . 5.9 mm -72.67 -174.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 107.862 167.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -56.46 108.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 107.913 164.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -153.49 37.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.583 1.553 . . . . 0.0 107.742 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -132.47 160.65 35.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 108.513 -158.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.66 64.89 6.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.442 1.497 . . . . 0.0 110.889 -162.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.36 44.02 30.26 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.577 1.951 . . . . 0.0 111.517 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.44 -52.27 4.64 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 126.152 1.834 . . . . 0.0 110.663 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.452 2.701 . . . . 0.0 108.295 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.65 -30.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 111.94 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.19 144.06 49.19 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 124.429 1.091 . . . . 0.0 109.513 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -144.19 40.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.642 1.577 . . . . 0.0 109.01 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -76.12 105.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 131' ' ' SER . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 70' ' ' GLN . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -111.19 173.88 6.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.93 39.05 0.22 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.658 2.783 . . . . 0.0 109.656 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -60.38 157.3 35.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 O-C-N 121.556 -0.715 . . . . 0.0 110.811 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.85 125.84 15.52 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.889 1.726 . . . . 0.0 108.514 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 123.903 0.881 . . . . 0.0 111.393 178.115 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.65 161.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 111.098 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m 68.73 -69.88 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.046 1.739 . . . . 0.0 109.8 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.863 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.77 133.11 50.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 92.9 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.694 1.997 . . . . 0.0 107.41 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -62.04 150.43 38.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.742 1.217 . . . . 0.0 109.685 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 54' ' ' ILE . 2.9 mp -75.93 133.7 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.7 m -74.8 4.35 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.257 4.7 ppt_? -140.58 21.69 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.408 1.883 . . . . 0.0 113.393 170.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.24 175.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.205 2.202 . . . . 0.0 112.571 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.45 71.28 0.38 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.122 1.369 . . . . 0.0 109.813 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 51.52 -154.53 0.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.944 1.297 . . . . 0.0 113.282 165.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.72 10.69 5.47 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.598 1.57 . . . . 0.0 112.538 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.76 -21.19 10.3 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.978 1.311 . . . . 0.0 112.289 -164.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -130.61 -8.01 4.09 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.657 0.783 . . . . 0.0 112.574 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 145.09 15.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.181 -0.949 . . . . 0.0 111.153 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.22 177.0 8.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.892 1.277 . . . . 0.0 111.82 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.47 165.53 6.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.578 1.151 . . . . 0.0 110.555 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HB ' HD22 ' A' ' 99' ' ' LEU . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 122' ' ' GLY . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' H ' HG22 ' A' ' 121' ' ' THR . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 84' ' ' ALA . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -124.97 145.82 49.69 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -67.1 -20.41 65.78 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.446 ' CD2' ' HD2' ' A' ' 140' ' ' PRO . 1.0 OUTLIER 59.98 144.07 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 130.72 3.608 . . . . 0.0 110.788 -167.332 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HD2' ' CD2' ' A' ' 139' ' ' TYR . 57.2 Cg_endo -72.31 158.62 51.27 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.562 2.175 . . . . 0.0 112.412 -175.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.441 0 C-N-CA 127.337 2.255 . . . . 0.0 110.904 -177.632 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.759 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.31 162.87 40.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.978 0.511 . . . . 0.0 109.755 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m 45.31 -85.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.278 2.231 . . . . 0.0 114.122 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' CA ' ' A' ' 105' ' ' GLY . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.735 ' NH2' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.735 HD12 ' NH2' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 44' ' ' LEU . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.88 148.99 32.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.82 55.64 1.72 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.288 1.435 . . . . 0.0 107.941 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 t -137.56 126.72 24.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -140.92 140.04 33.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.93 7.29 3.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.153 2.181 . . . . 0.0 114.955 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -131.7 81.4 1.97 Allowed 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 129.282 3.033 . . . . 0.0 106.474 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -146.02 160.82 41.34 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.14 14.69 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -172.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 163.53 25.47 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.138 0.881 . . . . 0.0 109.31 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.33 42.02 2.54 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.92 171.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -163.89 145.33 8.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.496 2.319 . . . . 0.0 105.898 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 163.54 20.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.226 1.41 . . . . 0.0 112.148 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 63.63 -174.92 0.16 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.038 1.735 . . . . 0.0 111.794 166.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.58 173.52 12.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.588 1.955 . . . . 0.0 106.473 164.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.01 172.63 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 144.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.625 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 100' ' ' VAL . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.502 ' HE2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.471 ' CA ' HD13 ' A' ' 6' ' ' LEU . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 101' ' ' MET . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' HB ' HD22 ' A' ' 99' ' ' LEU . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.429 HD13 HG23 ' A' ' 110' ' ' VAL . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -140.61 169.73 17.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -125.94 156.33 39.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -127.23 81.25 70.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.593 1.957 . . . . 0.0 106.399 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.75 -171.27 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.802 2.334 . . . . 0.0 109.274 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 153.878 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -176.69 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m 45.89 -85.53 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.927 2.091 . . . . 0.0 113.303 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 106' ' ' LEU . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CB ' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.58 103.04 4.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 31.43 0.07 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.648 1.179 . . . . 0.0 112.469 169.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 p -112.78 174.81 5.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.574 1.55 . . . . 0.0 109.291 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.2 mt -66.39 142.56 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 O-C-N 120.9 -1.125 . . . . 0.0 108.635 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.29 12.47 3.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.084 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -101.63 4.87 41.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.642 1.577 . . . . 0.0 112.74 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 128.75 53.48 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 55.43 7.17 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.21 167.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 131.488 3.915 . . . . 0.0 115.829 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.26 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.882 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 56.82 12.68 1.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.015 2.926 . . . . 0.0 111.023 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.98 4.49 0.64 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.854 1.261 . . . . 0.0 113.04 168.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.09 -170.16 3.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.073 1.306 . . . . 0.0 111.327 -164.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.257 3.2 pt20 57.18 36.54 27.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.81 2.844 . . . . 0.0 116.51 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -70.02 144.63 52.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.718 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 ' HE1' ' A' ' 101' ' ' MET . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.653 ' HE1' HD13 ' A' ' 99' ' ' LEU . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' HB ' HD12 ' A' ' 99' ' ' LEU . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -148.17 150.27 33.49 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.199 2.2 . . . . 0.0 112.925 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' A' ' 140' ' ' PRO . 0.6 OUTLIER 67.96 154.0 0.14 Allowed Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 130.058 3.343 . . . . 0.0 115.102 171.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 139' ' ' TYR . 79.7 Cg_endo -72.36 64.6 3.62 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.634 2.89 . . . . 0.0 110.67 162.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.257 12.0 pt-20 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 131.238 3.815 . . . . 0.0 117.128 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.481 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 53.87 -163.12 0.11 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.227 1.013 . . . . 0.0 110.739 -175.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.481 ' H ' ' HG3' ' A' ' 2' ' ' MET . 0.2 OUTLIER 55.39 -85.28 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.742 2.017 . . . . 0.0 114.286 169.598 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 105' ' ' GLY . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 106' ' ' LEU . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.781 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.781 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.89 121.61 10.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 69.28 1.3 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.586 0.708 . . . . 0.0 109.469 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 t -66.82 -164.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.565 1.174 . . . . 0.0 109.64 165.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -44.84 141.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 127.748 2.419 . . . . 0.0 110.811 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.41 17.95 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.917 2.487 . . . . 0.0 110.893 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -80.99 3.55 22.6 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 170.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.81 139.81 5.39 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 128.048 2.539 . . . . 0.0 105.297 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 47.55 17.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.629 3.171 . . . . 0.0 117.875 162.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.2 174.89 0.3 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.927 2.891 . . . . 0.0 112.694 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.31 27.4 15.68 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.726 1.631 . . . . 0.0 111.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.77 146.33 24.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 129.998 3.319 . . . . 0.0 104.771 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -152.63 -37.93 0.11 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 170.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.46 14.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -173.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -148.41 138.02 22.15 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.739 1.216 . . . . 0.0 108.477 169.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.0 m-30 -112.96 91.83 3.79 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.58 2.352 . . . . 0.0 105.237 173.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.598 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.527 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.479 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.819 HD13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.586 HG23 HD13 ' A' ' 132' ' ' LEU . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 95' ' ' PHE . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 122' ' ' GLY . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.561 ' H ' HG22 ' A' ' 121' ' ' THR . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 84' ' ' ALA . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 65' ' ' TYR . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 137' ' ' GLN . 0.8 OUTLIER -106.53 161.84 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.26 131.1 55.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -122.84 82.78 49.6 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 -171.8 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.581 1.521 . . . . 0.0 109.351 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 118.3 -0.857 . . . . 0.0 108.772 164.465 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.656 HD11 HD23 ' A' ' 106' ' ' LEU . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 30' ' ' TRP . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.401 HH11 HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 23' ' ' THR 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 HH11 ' A' ' 22' ' ' ARG . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD23 ' A' ' 15' ' ' LEU . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.496 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 114' ' ' ILE . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.459 ' HD2' ' OD2' ' A' ' 135' ' ' ASP . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 95' ' ' PHE . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 111' ' ' ARG . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.459 ' HA ' HD12 ' A' ' 6' ' ' LEU . 14.9 m . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 3' ' ' SER . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' A' ' 68' ' ' VAL . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.724 0.774 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 49' ' ' MET . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 6' ' ' LEU . 12.3 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' SER . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 106' ' ' LEU . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.55 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 127' ' ' THR . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.485 ' H ' HD11 ' A' ' 77' ' ' ILE . 1.8 m-70 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' THR . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 137' ' ' GLN . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.575 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.0 tt0 . . . . . 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 117.272 -1.346 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' HD12 ' A' ' 7' ' ' ILE . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 4' ' ' GLN . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CG ' HD22 ' A' ' 94' ' ' LEU . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 30' ' ' TRP . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 36' ' ' THR . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.559 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 18' ' ' TRP . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 99' ' ' LEU . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 96' ' ' PRO . 2.0 m-80 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.487 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.484 ' HB ' HD22 ' A' ' 99' ' ' LEU . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.604 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 110' ' ' VAL . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.487 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 106' ' ' LEU . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CG ' HD22 ' A' ' 94' ' ' LEU . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 36' ' ' THR . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 18' ' ' TRP . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 136' ' ' VAL . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 132' ' ' LEU . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 HD23 ' A' ' 132' ' ' LEU . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD13 HG23 ' A' ' 110' ' ' VAL . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 106' ' ' LEU . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 HH21 ' NE2' ' A' ' 86' ' ' GLN . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.412 ' NE2' HH21 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 100' ' ' VAL . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 106' ' ' LEU . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.434 ' CZ3' HD21 ' A' ' 91' ' ' LEU . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.492 HH11 HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HH11 ' A' ' 22' ' ' ARG . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.251 0.548 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 18' ' ' TRP . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 7' ' ' ILE . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 136' ' ' VAL . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' ASP . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 106' ' ' LEU . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.454 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD2' HD13 ' A' ' 7' ' ' ILE . 42.2 m-85 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.696 HG22 ' HE ' ' A' ' 109' ' ' ARG . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.576 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.696 ' HE ' HG22 ' A' ' 100' ' ' VAL . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' CE1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 110' ' ' VAL . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 127' ' ' THR . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 120' ' ' THR . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.57 HD23 ' CD1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.825 ' CE1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' C ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 99' ' ' LEU . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 101' ' ' MET . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 100' ' ' VAL . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.498 ' HG3' HD12 ' A' ' 99' ' ' LEU . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 HD13 HD12 ' A' ' 132' ' ' LEU . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 122' ' ' GLY 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 121' ' ' THR . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 105' ' ' GLY . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 106' ' ' LEU . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 HH11 HD11 ' A' ' 26' ' ' LEU . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HH11 ' A' ' 22' ' ' ARG . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 ' HD3' ' A' ' 50' ' ' PRO . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.647 ' HD3' HG12 ' A' ' 48' ' ' VAL . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 99' ' ' LEU . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.6 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 7' ' ' ILE . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.64 ' HB ' HD22 ' A' ' 99' ' ' LEU . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' CH2' ' A' ' 30' ' ' TRP . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.55 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.406 ' CH2' HD23 ' A' ' 15' ' ' LEU . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.55 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 132' ' ' LEU . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.584 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 106' ' ' LEU . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 36' ' ' THR . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.495 0.664 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 66' ' ' ARG . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 114' ' ' ILE . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.608 ' HD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.608 HD11 ' HD2' ' A' ' 95' ' ' PHE . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 132' ' ' LEU . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.796 0.808 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 91' ' ' LEU . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 87' ' ' VAL . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' A' ' 110' ' ' VAL . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 132' ' ' LEU . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.647 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 110' ' ' VAL . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD21 ' HA3' ' A' ' 105' ' ' GLY . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 103' ' ' SER . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.427 ' CG ' HD22 ' A' ' 94' ' ' LEU . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD23 HH11 ' A' ' 22' ' ' ARG . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.42 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 48' ' ' VAL . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 43' ' ' TYR . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG12 HD12 ' A' ' 91' ' ' LEU . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.508 HD12 HG12 ' A' ' 87' ' ' VAL . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 18' ' ' TRP . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 100' ' ' VAL . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 98' ' ' ASN . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 132' ' ' LEU . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD23 ' CH2' ' A' ' 30' ' ' TRP . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CH2' HD23 ' A' ' 15' ' ' LEU . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' VAL . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . . . . . . 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 131' ' ' SER . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 70' ' ' GLN . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 . . . . . 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.863 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.455 0.645 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HB ' HD22 ' A' ' 99' ' ' LEU . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 122' ' ' GLY . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' H ' HG22 ' A' ' 121' ' ' THR . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 84' ' ' ALA . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 . . . . . 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 117.49 -1.243 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HA ' HE21 ' A' ' 4' ' ' GLN . 1.0 OUTLIER -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' CA ' ' A' ' 105' ' ' GLY . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.735 ' NH2' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.735 HD12 ' NH2' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 44' ' ' LEU . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.458 -0.073 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.625 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 100' ' ' VAL . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.502 ' HE2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.471 ' CA ' HD13 ' A' ' 6' ' ' LEU . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 101' ' ' MET . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' HB ' HD22 ' A' ' 99' ' ' LEU . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.429 HD13 HG23 ' A' ' 110' ' ' VAL . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 117.015 -1.469 . . . . 0.0 113.303 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 106' ' ' LEU . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CB ' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 ' HE1' ' A' ' 101' ' ' MET . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.653 ' HE1' HD13 ' A' ' 99' ' ' LEU . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.639 ' HB ' HD12 ' A' ' 99' ' ' LEU . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 117.22 -1.372 . . . . 0.0 114.286 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 105' ' ' GLY . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 106' ' ' LEU . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.781 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.781 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.598 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.527 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.479 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.819 HD13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.586 HG23 HD13 ' A' ' 132' ' ' LEU . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 95' ' ' PHE . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 122' ' ' GLY . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.561 ' H ' HG22 ' A' ' 121' ' ' THR . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 84' ' ' ALA . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.519 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -142.14 157.63 44.66 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.34 1.856 . . . . 0.0 108.876 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.27 4.9 m 45.35 -79.91 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 129.157 2.983 . . . . 0.0 113.621 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.04 -49.04 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.12 1.368 . . . . 0.0 111.369 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.27 -34.34 77.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.516 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.82 -43.29 85.64 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.077 0.951 . . . . 0.0 109.685 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.656 HD11 HD23 ' A' ' 106' ' ' LEU . 26.2 mm -50.86 -64.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.136 1.374 . . . . 0.0 108.286 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -67.79 -31.04 70.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 122.538 0.335 . . . . 0.0 111.249 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.77 -25.98 56.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.148 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.25 72.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 121.116 1.78 . . . . 0.0 111.293 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.11 -46.72 85.08 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -38.36 84.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -55.76 -36.25 67.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 126.299 1.839 . . . . 0.0 109.933 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.27 -48.4 5.92 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 124.211 0.944 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 30' ' ' TRP . 57.3 tp -73.1 -42.44 62.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.225 0.92 . . . . 0.0 112.299 -169.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 m -63.93 -41.19 97.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.324 0.966 . . . . 0.0 110.272 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.79 -31.4 72.36 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 121.206 0.527 . . . . 0.0 111.257 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -72.51 -44.38 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.7 83.05 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.591 -1.195 . . . . 0.0 111.711 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -31.0 34.88 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 112.731 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.97 73.34 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.44 0.563 . . . . 0.0 110.153 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.401 HH11 HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.57 145.18 40.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.336 0.654 . . . . 0.0 109.436 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 23' ' ' THR 0.311 0.0 OUTLIER -59.81 -52.38 74.16 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.087 1.355 . . . . 0.0 112.741 177.055 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.2 -11.12 30.81 Favored 'Trans proline' 0 C--N 1.355 0.879 0 CA-C-N 122.952 2.09 . . . . 0.0 114.201 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.21 88.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.707 0 C-N-CA 127.403 2.281 . . . . 0.0 113.567 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 HH11 ' A' ' 22' ' ' ARG . 2.7 mm? -92.43 147.64 34.82 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.99 -0.444 . . . . 0.0 111.524 -164.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.64 147.51 76.27 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.779 2.32 . . . . 0.0 110.087 167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.262 8.0 p -125.84 72.16 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.182 0.991 . . . . 0.0 109.126 -165.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 98.71 1.57 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.984 1.313 . . . . 0.0 113.384 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD23 ' A' ' 15' ' ' LEU . 94.9 m95 -86.03 173.78 9.66 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.927 1.691 . . . . 0.0 113.127 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.55 144.25 10.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.594 1.558 . . . . 0.0 111.351 168.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 50.13 -1.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.7 3.2 . . . . 0.0 114.797 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.496 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 12.4 m -104.82 156.75 17.73 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.707 2.003 . . . . 0.0 106.336 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HE2' ' C ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -126.84 153.15 46.03 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 170.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.48 128.19 25.02 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 t -164.91 154.02 11.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.52 167.1 39.42 Favored 'Cis proline' 0 CA--C 1.535 0.539 0 CA-C-N 120.893 1.355 . . . . 0.0 111.676 -4.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.43 174.99 4.55 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.084 1.189 . . . . 0.0 110.441 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 79.31 9.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 163.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 63.14 27.7 15.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.519 1.528 . . . . 0.0 112.885 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.36 -4.75 62.39 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.795 1.188 . . . . 0.0 113.182 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 t -90.66 132.9 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.55 176.22 12.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.387 0.675 . . . . 0.0 109.465 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 mt -140.49 108.4 5.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.277 1.031 . . . . 0.0 108.702 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.74 123.97 33.68 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.31 103.67 6.83 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.411 1.084 . . . . 0.0 109.899 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.31 109.07 20.64 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.02 1.328 . . . . 0.0 109.442 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.89 138.01 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.5 mtm -128.88 86.66 56.83 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 125.15 1.38 . . . . 0.0 109.14 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.42 168.56 15.96 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.463 2.109 . . . . 0.0 112.148 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . -72.2 144.69 48.42 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 161.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.55 98.44 3.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -69.47 -170.57 0.29 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.015 0.926 . . . . 0.0 109.647 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.97 14.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 120.604 -1.31 . . . . 0.0 110.893 164.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 52.7 -154.35 0.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.705 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 52.74 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.218 2.207 . . . . 0.0 111.677 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.97 -174.69 3.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.44 4.93 6.91 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.5 3.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.085 2.154 . . . . 0.0 106.258 164.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 35.59 2.45 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 123.648 0.642 . . . . 0.0 111.594 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -149.69 107.56 3.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -171.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.06 0.15 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.508 1.523 . . . . 0.0 109.106 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.65 170.33 0.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.421 1.488 . . . . 0.0 110.423 154.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.67 4.54 1.53 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.695 1.198 . . . . 0.0 111.855 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.362 1.8 t80 41.7 43.28 2.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.388 2.675 . . . . 0.0 114.093 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -82.1 171.9 13.82 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.363 -166.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.5 -167.08 32.02 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.49 168.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.52 140.95 41.42 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.7 124.84 20.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.682 1.593 . . . . 0.0 106.955 -165.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.36 149.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 110.74 17.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.861 0.864 . . . . 0.0 108.761 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.29 106.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.08 133.88 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.51 149.63 44.71 Favored Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 125.661 1.584 . . . . 0.0 108.094 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.37 156.54 32.86 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.305 2.67 . . . . 0.0 109.559 -170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -84.88 83.17 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.79 13.35 5.34 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.622 -1.099 . . . . 0.0 113.222 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 56.65 126.74 0.0 OUTLIER 'General case' 0 C--O 1.234 0.27 0 C-N-CA 130.203 3.401 . . . . 0.0 112.072 -153.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.9 16.64 74.76 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.223 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.7 t -75.88 103.09 5.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.201 1.0 . . . . 0.0 108.438 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -113.74 11.54 18.11 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -15.18 8.66 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -166.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.75 -43.81 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.264 1.426 . . . . 0.0 111.085 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.16 -54.4 30.26 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.363 1.065 . . . . 0.0 111.86 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.46 -48.09 37.9 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.892 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.47 -45.14 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.64 -1.172 . . . . 0.0 111.896 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -41.54 68.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.407 1.003 . . . . 0.0 110.314 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.45 48.73 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.658 1.183 . . . . 0.0 111.84 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.58 84.81 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.0 -1.062 . . . . 0.0 110.054 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.71 -29.63 65.96 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 121.769 -0.582 . . . . 0.0 110.945 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.52 -49.48 73.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.502 1.046 . . . . 0.0 109.629 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.28 66.85 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 110.366 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -76.24 -22.54 55.07 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.29 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 114' ' ' ILE . 30.3 m-85 -118.45 78.17 14.39 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 121.742 2.064 . . . . 0.0 112.314 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.63 159.87 49.84 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.731 2.287 . . . . 0.0 112.499 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.48 -7.95 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.98 -30.82 12.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.715 0.806 . . . . 0.0 111.1 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.21 47.46 7.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.279 2.232 . . . . 0.0 112.93 170.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.8 t -67.81 101.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.69 123.83 23.01 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.096 1.359 . . . . 0.0 107.632 167.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -94.78 112.7 24.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.134 1.373 . . . . 0.0 107.69 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.21 164.32 16.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.217 162.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -11.01 55.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.18 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -91.43 -76.86 1.34 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 170.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -123.79 -173.14 2.68 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.931 1.692 . . . . 0.0 109.46 -167.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.82 154.73 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 161.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.75 147.15 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.598 1.959 . . . . 0.0 107.844 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -148.64 133.12 17.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.19 -33.08 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.459 ' HD2' ' OD2' ' A' ' 135' ' ' ASP . 5.6 mtp180 64.66 -66.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.141 1.777 . . . . 0.0 111.71 -164.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.8 p -80.07 156.47 74.38 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.065 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.53 174.85 9.56 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.27 1.314 . . . . 0.0 109.746 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 95' ' ' PHE . 12.9 mm -68.98 149.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.108 0.963 . . . . 0.0 109.667 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.45 155.23 46.77 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.621 1.169 . . . . 0.0 109.942 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.91 174.61 11.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.38 2.272 . . . . 0.0 108.598 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.78 -176.29 30.66 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.657 -1.277 . . . . 0.0 112.056 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.04 150.96 96.16 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.099 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.69 171.89 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.719 2.279 . . . . 0.0 112.95 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.8 t -109.38 8.38 25.43 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 65.01 168.15 0.18 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.665 1.186 . . . . 0.0 111.123 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -152.77 -175.7 24.54 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.425 1.964 . . . . 0.0 109.897 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -71.98 -24.11 61.53 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.336 1.454 . . . . 0.0 113.28 -170.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 17.75 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.617 2.367 . . . . 0.0 110.706 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.2 171.12 14.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.936 2.494 . . . . 0.0 106.911 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -125.96 172.26 10.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.37 126.71 10.71 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.27 1.428 . . . . 0.0 107.777 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.82 144.33 28.68 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.05 0.94 . . . . 0.0 109.991 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.03 112.21 3.05 Favored 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 125.385 4.057 . . . . 0.0 110.57 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.14 133.54 50.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.5 p -166.26 167.72 15.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 112.237 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 164.74 29.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.247 1.819 . . . . 0.0 109.833 162.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.45 174.52 54.35 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 123.964 0.792 . . . . 0.0 111.175 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -158.77 156.51 29.91 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.082 0.941 . . . . 0.0 109.091 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 111' ' ' ARG . 2.9 p30 -133.01 172.84 12.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.134 2.174 . . . . 0.0 111.44 172.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.65 122.27 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.562 1.945 . . . . 0.0 108.499 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -74.84 170.24 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.1 39.71 0.85 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.908 2.483 . . . . 0.0 111.172 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -57.33 150.38 43.36 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.788 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.74 149.75 61.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.548 1.499 . . . . 0.0 110.427 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 124.363 1.065 . . . . 0.0 110.588 166.628 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.889 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.9 mmt -126.54 -73.07 0.63 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.075 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.459 ' HA ' HD12 ' A' ' 6' ' ' LEU . 14.9 m 63.53 -71.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.81 1.244 . . . . 0.0 112.701 -172.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -58.84 -35.99 73.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.927 1.239 . . . . 0.0 111.236 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.1 -36.72 8.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.832 1.653 . . . . 0.0 113.159 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 3' ' ' SER . 11.1 mt -87.51 -53.55 4.75 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.411 2.284 . . . . 0.0 107.417 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mt -46.55 -56.45 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.842 1.257 . . . . 0.0 109.209 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -58.95 -37.02 75.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.839 1.656 . . . . 0.0 111.247 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.65 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.843 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.51 72.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.951 1.25 . . . . 0.0 111.916 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -52.23 19.58 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.572 1.549 . . . . 0.0 107.279 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 70.8 mt-10 -59.38 -32.14 69.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.961 1.305 . . . . 0.0 112.148 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.01 -65.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -52.13 64.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.302 -171.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' CH2' ' A' ' 30' ' ' TRP . 15.6 tp -56.81 -52.8 63.67 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.598 0.636 . . . . 0.0 109.674 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -66.72 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.348 0.977 . . . . 0.0 112.438 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -64.45 -31.63 72.92 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.248 0.619 . . . . 0.0 110.597 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 t90 -72.07 -51.63 20.69 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.063 0.945 . . . . 0.0 110.317 165.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.64 -15.61 58.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.153 -0.927 . . . . 0.0 113.175 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -16.98 14.22 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 119.516 1.053 . . . . 0.0 113.258 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.84 72.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 110.64 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -59.17 154.06 16.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.474 0.71 . . . . 0.0 109.525 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.6 m -62.12 -66.11 1.74 Allowed Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 124.214 1.006 . . . . 0.0 112.047 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.67 -11.28 31.2 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.772 1.648 . . . . 0.0 114.006 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.78 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.565 2.746 . . . . 0.0 113.412 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.09 154.97 88.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.112 -166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.59 152.91 26.38 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.212 2.608 . . . . 0.0 109.994 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.8 78.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.94 113.0 16.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.784 -0.572 . . . . 0.0 109.738 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 15' ' ' LEU . 85.5 m95 -80.25 176.71 9.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.761 1.624 . . . . 0.0 111.106 168.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -52.26 147.08 8.25 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.538 -0.726 . . . . 0.0 110.224 157.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.57 -10.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.948 2.899 . . . . 0.0 115.317 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.9 t -67.03 155.95 37.31 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.638 -1.289 . . . . 0.0 108.919 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.09 125.95 30.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 166.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -136.3 175.71 9.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.139 0.576 . . . . 0.0 110.104 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 74.04 156.47 0.16 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.325 1.85 . . . . 0.0 110.336 -164.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.48 166.15 65.92 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 CA-C-N 118.802 0.608 . . . . 0.0 112.757 -6.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.18 177.7 8.46 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.183 3.255 . . . . 0.0 112.182 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.35 81.72 4.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 163.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.33 29.04 18.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 113.536 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.6 -5.03 50.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.485 1.517 . . . . 0.0 112.958 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.1 141.01 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.982 1.713 . . . . 0.0 108.308 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.93 166.01 13.52 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.218 0.607 . . . . 0.0 110.023 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.68 144.09 40.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.469 1.108 . . . . 0.0 108.475 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.5 97.86 4.35 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.43 161.96 29.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -83.71 133.05 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' A' ' 68' ' ' VAL . 5.1 ptp -131.51 76.59 74.99 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.33 143.16 17.23 Favored 'Trans proline' 0 N--CA 1.448 -1.156 1 C-N-CA 125.642 4.228 . . . . 0.0 109.362 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.85 149.4 31.49 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.873 0.368 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.23 13.91 2.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 113.367 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -88.24 42.74 1.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 110.527 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.26 128.5 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t 64.6 179.97 0.18 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.825 2.45 . . . . 0.0 111.183 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 62.39 13.95 6.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.349 1.859 . . . . 0.0 113.25 -171.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.13 152.84 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.333 0.653 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.19 63.91 0.28 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.74 1.216 . . . . 0.0 110.235 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.88 14.33 0.22 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.059 0.944 . . . . 0.0 112.446 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.13 42.72 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 120.728 -1.233 . . . . 0.0 110.556 -159.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.36 -14.66 10.39 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.72 1.608 . . . . 0.0 112.409 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.15 128.4 33.66 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 59.08 20.53 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.422 1.489 . . . . 0.0 113.054 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -88.19 110.23 20.53 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 119.771 -1.831 . . . . 0.0 107.61 169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.87 140.7 29.35 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.855 0.862 . . . . 0.0 109.029 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -152.19 173.14 15.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.731 2.012 . . . . 0.0 108.125 -172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.52 173.77 46.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 163.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 49' ' ' MET . 46.2 t -126.56 154.39 36.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -139.31 107.03 5.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -104.75 145.04 30.92 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 107.544 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.23 118.55 20.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -92.42 109.36 20.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.54 122.84 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 158.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.52 136.05 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.53 76.09 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.55 170.91 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.85 2.366 . . . . 0.0 110.269 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.9 105.91 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.2 -17.25 5.13 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.942 0.782 . . . . 0.0 112.53 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 48.58 1.55 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.439 1.119 . . . . 0.0 109.818 -169.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.95 68.74 1.53 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -167.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -169.07 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.41 13.47 8.11 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 119.668 -1.895 . . . . 0.0 113.288 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -64.11 -12.22 37.42 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.631 -1.293 . . . . 0.0 113.105 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.61 -45.12 63.1 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 126.089 1.756 . . . . 0.0 112.126 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.38 -55.01 40.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.444 0.698 . . . . 0.0 111.347 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -47.16 43.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.249 1.02 . . . . 0.0 110.826 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.7 t -78.01 -35.07 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.707 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.52 78.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 120.343 1.429 . . . . 0.0 109.91 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.48 98.44 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.551 1.14 . . . . 0.0 112.103 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.03 -53.57 12.52 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 121.799 -0.563 . . . . 0.0 110.315 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.59 -36.33 66.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.683 1.593 . . . . 0.0 111.801 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.4 -61.74 2.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.0 -13.5 61.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.05 -33.48 73.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.278 1.031 . . . . 0.0 110.788 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.14 76.53 41.63 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.419 1.488 . . . . 0.0 111.157 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.65 160.95 47.76 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.717 2.945 . . . . 0.0 111.746 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.39 16.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.094 2.558 . . . . 0.0 115.979 -170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -113.35 -55.89 2.47 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.327 1.451 . . . . 0.0 108.448 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 46.56 82.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.324 2.25 . . . . 0.0 111.388 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.0 84.21 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -135.92 164.63 27.52 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.416 1.087 . . . . 0.0 109.698 166.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -148.34 -175.98 5.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.448 2.299 . . . . 0.0 107.765 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -141.64 -154.55 0.52 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 162.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.26 -8.24 36.13 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.242 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.98 -48.03 1.2 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-N 120.463 2.132 . . . . 0.0 113.117 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 175.01 166.08 0.28 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 127.674 2.39 . . . . 0.0 108.29 -164.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 167.27 3.96 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.998 1.319 . . . . 0.0 111.97 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.85 116.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.203 1.001 . . . . 0.0 110.267 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -114.17 157.95 21.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.486 1.115 . . . . 0.0 109.53 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.03 -22.45 7.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.68 -67.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.42 2.288 . . . . 0.0 111.703 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 p -82.89 159.96 61.92 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.36 -168.67 0.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.471 1.448 . . . . 0.0 108.504 155.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.17 165.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.637 1.175 . . . . 0.0 110.182 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.04 158.37 44.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.008 1.723 . . . . 0.0 107.417 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.32 175.74 12.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.539 1.535 . . . . 0.0 109.865 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.3 177.34 39.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.81 148.23 96.43 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.0 0.52 . . . . 0.0 109.73 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.37 155.15 55.94 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.043 1.828 . . . . 0.0 112.67 -171.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 m -81.91 123.38 28.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 155.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 m -86.23 146.32 26.59 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 158.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.71 -163.04 10.26 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 126.117 1.818 . . . . 0.0 110.56 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.98 -57.0 4.1 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.837 1.255 . . . . 0.0 112.387 -170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.99 14.85 1.71 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.503 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.69 153.42 51.7 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.803 1.183 . . . . 0.0 107.957 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -132.8 148.61 52.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.261 0.625 . . . . 0.0 110.376 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 121.36 13.31 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -166.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.1 143.5 29.89 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.77 131.85 6.32 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.886 3.057 . . . . 0.0 109.718 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.05 135.41 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.56 172.4 18.37 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 111.094 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 169.8 16.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.112 2.565 . . . . 0.0 108.966 165.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.0 88.75 0.28 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 124.54 1.067 . . . . 0.0 112.231 -170.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -73.88 173.62 9.67 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.69 1.996 . . . . 0.0 112.661 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -177.22 5.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.535 1.134 . . . . 0.0 110.333 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.61 150.87 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 109.591 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -155.47 157.02 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.645 2.378 . . . . 0.0 108.861 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.95 4.27 38.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 112.596 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 166.15 0.11 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 127.964 2.506 . . . . 0.0 110.193 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.24 172.94 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.566 1.511 . . . . 0.0 109.819 173.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.245 0.846 0 C-N-CA 126.563 1.945 . . . . 0.0 111.8 -171.463 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.0 ttt -87.84 43.3 1.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.149 -1.207 . . . . 0.0 111.19 -164.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 6' ' ' LEU . 12.3 t 65.7 -69.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.613 1.965 . . . . 0.0 110.914 -170.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -27.11 68.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.612 1.096 . . . . 0.0 111.827 -171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -58.29 -46.8 85.4 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.752 0.705 . . . . 0.0 109.392 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' SER . 14.3 mt -64.36 -49.03 73.26 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.004 1.722 . . . . 0.0 108.747 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 106' ' ' LEU . 14.5 mt -54.0 -37.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.834 1.253 . . . . 0.0 111.924 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -74.74 -48.46 25.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.341 1.428 . . . . 0.0 109.981 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.86 -27.36 60.28 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 111.715 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.25 95.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.403 -0.811 . . . . 0.0 111.192 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -68.82 -38.59 79.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.03 0.932 . . . . 0.0 110.459 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 8.8 pt-20 -85.42 -2.7 58.39 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -93.94 3.61 55.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -114.9 -53.03 2.67 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.578 -0.701 . . . . 0.0 111.705 160.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.25 -50.58 73.07 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.03 0.377 . . . . 0.0 110.705 -163.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -56.85 -42.77 80.28 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.137 0.575 . . . . 0.0 110.5 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.46 -26.68 66.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.005 1.322 . . . . 0.0 111.08 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -77.74 -44.61 27.22 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.458 -0.776 . . . . 0.0 110.96 166.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.03 -44.62 91.78 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.769 -0.582 . . . . 0.0 111.514 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.74 70.92 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.576 1.151 . . . . 0.0 112.704 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.79 -10.51 55.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.389 0.995 . . . . 0.0 112.709 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 154.69 35.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 m -57.01 -63.23 3.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.608 171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -11.81 30.71 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.792 1.318 . . . . 0.0 113.048 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.05 105.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.841 2.856 . . . . 0.0 112.382 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -96.67 150.99 37.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 121.225 -0.922 . . . . 0.0 110.759 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.28 154.78 36.85 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.661 2.241 . . . . 0.0 109.849 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.05 97.17 3.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.0 97.17 9.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.263 1.425 . . . . 0.0 110.786 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 12' ' ' GLU . 73.9 m95 -64.71 -178.86 0.44 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.066 1.346 . . . . 0.0 112.274 172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -53.88 -77.48 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.676 1.59 . . . . 0.0 112.412 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -92.6 -13.08 30.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.592 0.757 . . . . 0.0 110.385 -166.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -75.07 174.62 9.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.978 2.111 . . . . 0.0 109.247 170.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 154.97 47.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.552 1.941 . . . . 0.0 108.572 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.41 120.64 12.26 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 m -159.18 158.57 28.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 107.988 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.63 164.93 60.34 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 118.926 0.652 . . . . 0.0 111.805 -18.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.37 173.53 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.852 2.368 . . . . 0.0 112.345 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.73 73.01 9.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.115 1.366 . . . . 0.0 107.872 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 48.73 61.75 2.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.563 1.945 . . . . 0.0 110.846 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 -5.14 29.13 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.688 1.137 . . . . 0.0 115.108 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.8 143.27 11.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -158.56 178.99 9.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -121.06 161.89 20.94 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.7 100.44 5.51 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.94 79.12 2.87 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.87 1.668 . . . . 0.0 108.695 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -79.85 151.88 29.99 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.549 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.51 125.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -126.0 83.51 63.0 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.861 1.265 . . . . 0.0 109.489 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.77 179.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.32 3.347 . . . . 0.0 112.328 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.47 8.98 31.07 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 112.958 166.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.96 135.97 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.37 2.668 . . . . 0.0 111.746 -169.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -74.97 63.58 1.23 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.521 1.528 . . . . 0.0 110.944 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.293 0.7 OUTLIER -121.43 104.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 1 C-N-CA 132.572 4.349 . . . . 0.0 107.022 179.107 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -171.69 177.83 3.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 124.65 1.218 . . . . 0.0 108.682 -170.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -103.79 91.13 3.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 171.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.9 171.7 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 164.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.12 26.27 4.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.243 1.017 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.97 149.17 28.6 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.216 1.406 . . . . 0.0 109.124 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.61 7.75 65.86 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 125.007 1.289 . . . . 0.0 113.628 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -143.02 40.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.939 0.869 . . . . 0.0 109.51 -159.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.19 151.33 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.447 1.099 . . . . 0.0 108.929 167.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.24 -167.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.819 1.647 . . . . 0.0 111.536 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.35 171.21 12.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.39 1.476 . . . . 0.0 108.976 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.18 168.83 9.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.786 1.634 . . . . 0.0 110.892 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 177.15 4.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 108.154 168.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.08 173.1 38.57 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 163.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.02 157.67 17.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -121.33 138.01 54.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -130.95 123.48 28.94 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -133.23 92.06 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.969 0.89 . . . . 0.0 109.494 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -78.3 103.6 8.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.4 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -75.91 102.94 3.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.39 139.95 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.438 1.495 . . . . 0.0 107.216 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 151.58 40.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.481 1.513 . . . . 0.0 108.422 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.65 142.96 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 125.532 4.155 . . . . 0.0 111.039 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -92.02 87.93 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -171.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 -88.18 0.82 Allowed Glycine 0 C--O 1.229 -0.219 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.56 104.08 11.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 154.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.91 -59.13 2.64 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.033 1.301 . . . . 0.0 114.336 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.8 t 61.42 -68.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.782 3.233 . . . . 0.0 111.371 -165.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.12 2.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.324 2.25 . . . . 0.0 114.953 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 t -52.14 -35.92 49.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.489 1.515 . . . . 0.0 111.954 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -55.56 -21.52 17.56 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.857 1.208 . . . . 0.0 113.724 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.15 -57.95 3.06 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -54.38 -45.0 72.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 111.574 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -42.27 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.153 1.381 . . . . 0.0 110.503 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.08 79.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.727 0.694 . . . . 0.0 109.793 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.55 47.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.902 0.881 . . . . 0.0 112.682 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.55 -52.6 64.87 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.29 -35.0 78.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.976 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.43 -45.87 92.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.943 1.247 . . . . 0.0 111.006 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.1 -19.84 65.54 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.515 -0.74 . . . . 0.0 112.767 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.4 tp -88.88 -27.25 21.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.391 -0.818 . . . . 0.0 111.033 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -127.63 64.62 64.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.299 1.44 . . . . 0.0 112.47 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 169.04 22.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 111.257 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.56 12.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 130.327 3.451 . . . . 0.0 115.661 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -110.96 -60.75 1.79 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.771 1.628 . . . . 0.0 107.918 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.55 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.2 tp 52.87 36.76 22.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.576 0.751 . . . . 0.0 111.996 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.11 89.21 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.325 . . . . 0.0 108.468 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.3 mtt -84.34 118.84 24.47 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.99 113.68 5.89 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 150.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.91 156.01 48.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.729 1.612 . . . . 0.0 107.206 170.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.6 -20.79 59.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.145 -159.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.52 -70.2 1.32 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -171.69 155.15 3.9 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.511 1.524 . . . . 0.0 109.549 -155.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.98 117.61 22.33 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.317 -0.864 . . . . 0.0 111.143 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -83.38 170.49 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 125.321 1.448 . . . . 0.0 109.179 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -141.05 153.03 45.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.4 p -73.87 -16.84 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? 69.78 -42.56 0.51 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.65 2.38 . . . . 0.0 112.836 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -128.4 164.24 39.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 127.044 2.138 . . . . 0.0 108.09 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.46 -178.66 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.707 1.605 . . . . 0.0 110.095 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.45 146.52 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.725 0.81 . . . . 0.0 109.082 166.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.21 155.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.93 0.892 . . . . 0.0 109.596 164.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.4 146.33 18.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 128.921 2.888 . . . . 0.0 104.531 -163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.33 33.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 118.559 0.618 . . . . 0.0 112.273 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 145.36 97.58 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.79 178.19 4.21 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.144 2.562 . . . . 0.0 113.014 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 127' ' ' THR . 5.0 t -124.45 21.35 8.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.139 2.576 . . . . 0.0 110.199 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.6 t -50.66 146.08 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.358 1.075 . . . . 0.0 113.767 -161.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.48 -159.27 18.38 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.546 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -43.7 -53.27 5.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.87 3.668 . . . . 0.0 110.98 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.07 34.51 0.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.616 1.566 . . . . 0.0 108.75 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 77' ' ' ILE 0.256 0.0 OUTLIER -144.32 125.37 14.46 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 163.794 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.485 ' H ' HD11 ' A' ' 77' ' ' ILE . 1.8 m-70 -90.42 152.81 20.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.161 0.913 . . . . 0.0 108.633 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' THR . 7.4 m -142.86 98.6 3.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -71.34 143.66 88.32 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.65 -0.656 . . . . 0.0 110.024 176.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -87.08 114.24 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.435 3.423 . . . . 0.0 110.847 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.0 mt -134.83 128.02 49.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.8 p -157.92 170.92 21.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.068 0.947 . . . . 0.0 110.569 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.9 146.21 20.38 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.842 1.257 . . . . 0.0 109.788 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.72 100.89 0.85 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -105.97 167.95 9.45 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.432 1.893 . . . . 0.0 112.274 -165.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -141.9 145.33 34.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.955 1.36 . . . . 0.0 111.507 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.7 145.75 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.604 1.562 . . . . 0.0 108.016 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -138.78 160.47 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.26 2.224 . . . . 0.0 107.685 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -73.03 -11.62 60.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.043 0.838 . . . . 0.0 111.133 167.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.3 t80 58.74 61.33 4.96 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 127.467 2.307 . . . . 0.0 111.234 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.41 139.87 67.12 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.948 1.765 . . . . 0.0 110.718 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.564 2.346 . . . . 0.0 111.109 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.968 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 57.5 mtm -153.78 66.01 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.277 1.431 . . . . 0.0 109.717 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.4 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.429 1.891 . . . . 0.0 112.413 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -37.02 5.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.512 2.725 . . . . 0.0 112.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -55.56 -53.22 59.11 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.194 0.997 . . . . 0.0 109.714 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.34 -43.48 27.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.116 2.167 . . . . 0.0 109.127 -167.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.1 mt -45.45 -55.92 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.817 1.647 . . . . 0.0 110.849 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -55.98 -42.65 76.62 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 120.768 1.622 . . . . 0.0 111.109 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.05 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.217 0.462 . . . . 0.0 111.892 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.77 -23.22 62.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.519 1.054 . . . . 0.0 112.882 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.09 -37.99 87.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.905 0.775 . . . . 0.0 109.732 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -58.52 -46.59 86.46 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -57.64 -60.27 3.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -70.17 -25.18 63.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 115.922 -2.311 . . . . 0.0 112.832 -167.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.8 tp -87.92 -54.61 4.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 121.411 1.914 . . . . 0.0 112.74 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 t -65.5 -43.46 90.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.832 1.253 . . . . 0.0 110.801 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.39 -20.03 64.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.341 0.656 . . . . 0.0 111.868 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -87.74 -51.53 5.81 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.203 1.801 . . . . 0.0 110.185 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.16 79.13 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.274 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.69 -34.03 74.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.734 0.813 . . . . 0.0 111.804 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.52 60.35 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.563 1.145 . . . . 0.0 111.513 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -63.36 158.85 19.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.252 0.549 . . . . 0.0 109.715 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.6 m -63.93 -57.0 20.42 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.88 -15.79 51.11 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 120.988 1.389 . . . . 0.0 112.703 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.15 95.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.391 2.676 . . . . 0.0 112.674 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.95 144.55 39.35 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 121.035 -1.041 . . . . 0.0 111.497 -165.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.71 151.1 36.04 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.695 2.263 . . . . 0.0 109.267 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.48 108.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -167.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.4 159.76 26.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 167.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -138.78 22.0 2.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.958 1.303 . . . . 0.0 113.344 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 71.13 123.09 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.258 2.223 . . . . 0.0 108.965 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 74.07 -28.2 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.321 1.848 . . . . 0.0 113.775 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.2 m -57.76 151.61 17.27 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 128.037 2.535 . . . . 0.0 112.758 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 123.52 17.02 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.502 1.521 . . . . 0.0 107.286 174.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -151.19 170.94 18.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -169.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 72.55 160.63 0.16 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.714 1.606 . . . . 0.0 110.628 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.83 163.27 76.02 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 119.256 0.77 . . . . 0.0 112.434 -3.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.52 177.14 5.71 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.971 2.447 . . . . 0.0 112.499 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.66 79.52 5.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.5 19.98 4.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.691 1.596 . . . . 0.0 113.146 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.92 -12.39 62.43 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.056 1.313 . . . . 0.0 112.715 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -84.86 138.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -163.82 166.76 21.61 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.046 0.938 . . . . 0.0 109.27 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.96 155.87 21.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -138.42 102.97 4.76 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 148.23 40.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -138.59 109.37 6.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 161.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.59 114.36 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 127.288 2.235 . . . . 0.0 107.346 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 mtm -110.59 85.75 5.01 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.998 1.319 . . . . 0.0 108.1 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.68 169.7 20.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.847 2.364 . . . . 0.0 112.444 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.02 -177.05 3.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.644 1.577 . . . . 0.0 109.848 167.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.93 59.98 4.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.765 2.026 . . . . 0.0 110.609 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -71.38 -179.14 2.35 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.284 1.034 . . . . 0.0 109.32 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.1 mt -54.58 140.96 11.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -150.53 178.42 9.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.014 1.726 . . . . 0.0 108.01 168.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.65 13.57 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.339 1.056 . . . . 0.0 110.964 167.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -130.9 164.28 25.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.06 15.56 1.05 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.39 1.076 . . . . 0.0 113.43 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -17.56 63.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.893 0.877 . . . . 0.0 113.21 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.86 2.5 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.297 1.904 . . . . 0.0 112.019 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t70 63.04 102.03 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 131.187 3.795 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -69.59 159.71 32.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.382 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 61.91 15.09 6.87 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.174 1.79 . . . . 0.0 115.16 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -132.2 95.05 3.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.025 1.33 . . . . 0.0 110.215 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.05 172.27 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.776 1.23 . . . . 0.0 107.908 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.12 172.73 2.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 131.543 3.937 . . . . 0.0 105.644 167.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.74 -175.1 42.86 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 120.667 1.576 . . . . 0.0 110.573 162.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.7 131.54 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 163.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.37 144.48 25.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -130.52 141.84 50.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.267 1.427 . . . . 0.0 107.303 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 160.27 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 161.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -128.29 140.75 51.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.39 1.876 . . . . 0.0 107.193 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -111.93 77.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 126.145 1.778 . . . . 0.0 106.826 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.6 134.43 30.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.11 144.26 8.55 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.53 152.16 79.07 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.103 1.868 . . . . 0.0 111.609 -167.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.39 55.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.04 -94.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -79.17 64.55 4.11 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.993 1.717 . . . . 0.0 109.948 -165.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.78 56.16 1.26 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.329 1.443 . . . . 0.0 112.654 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.4 p -63.05 -11.66 21.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -172.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -84.08 9.3 12.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.35 -1.469 . . . . 0.0 111.123 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.76 -30.78 65.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.691 1.596 . . . . 0.0 113.555 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -54.52 -38.31 66.38 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.626 0.648 . . . . 0.0 111.845 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.88 -48.13 69.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.096 0.559 . . . . 0.0 110.668 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -51.43 49.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.083 1.353 . . . . 0.0 109.879 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.16 -48.75 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 123.562 0.745 . . . . 0.0 111.553 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.08 75.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 118.163 0.438 . . . . 0.0 111.022 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.64 -50.2 32.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.412 1.085 . . . . 0.0 109.749 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.54 -35.81 70.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.822 1.249 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.81 -38.03 39.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.366 1.067 . . . . 0.0 111.146 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.635 1.107 . . . . 0.0 111.009 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.6 -33.36 73.76 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.994 -0.441 . . . . 0.0 111.233 171.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.28 -31.26 38.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.818 0.847 . . . . 0.0 112.274 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.65 84.88 8.6 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 110.463 -171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.167 2.578 . . . . 0.0 110.658 163.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.96 1.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.043 1.737 . . . . 0.0 114.59 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -102.69 -50.86 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.557 -0.715 . . . . 0.0 109.833 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.89 67.32 0.72 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.049 2.54 . . . . 0.0 110.768 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.6 90.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.778 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.6 mtt -75.82 177.35 7.0 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 166.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.46 122.62 29.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.549 2.34 . . . . 0.0 105.448 156.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.94 34.1 2.88 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.197 0.599 . . . . 0.0 111.332 -171.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.71 -77.08 0.39 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.515 1.055 . . . . 0.0 111.886 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -44.62 -63.4 2.49 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 129.251 3.31 . . . . 0.0 111.383 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 166.47 23.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.878 2.071 . . . . 0.0 107.84 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.65 105.04 16.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.047 1.339 . . . . 0.0 109.113 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 1.8 p -63.83 154.15 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 122.718 0.407 . . . . 0.0 110.22 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.2 157.86 38.65 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 125.083 1.353 . . . . 0.0 109.718 169.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.24 -18.35 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 O-C-N 124.512 1.132 . . . . 0.0 113.032 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.2 -49.76 0.42 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 127.332 2.253 . . . . 0.0 114.236 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -116.91 157.42 46.44 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.266 1.026 . . . . 0.0 109.463 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.23 172.51 15.88 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.479 1.452 . . . . 0.0 108.676 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.31 119.1 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.14 144.71 25.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 162.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.08 101.85 2.6 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.271 2.228 . . . . 0.0 106.651 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -101.79 169.94 20.55 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -67.43 152.9 95.74 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 163.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.31 171.47 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.694 2.263 . . . . 0.0 113.221 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.5 t -112.68 4.69 17.31 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.572 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 32.2 m 65.92 159.02 0.12 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.061 2.544 . . . . 0.0 112.859 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.83 -157.13 9.6 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 126.545 2.021 . . . . 0.0 109.164 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -55.09 6.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.156 0.582 . . . . 0.0 110.015 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.92 41.71 0.29 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 108.135 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.56 -8.46 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 124.263 1.983 . . . . 0.0 114.837 -160.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 47.66 -176.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 130.17 3.388 . . . . 0.0 112.251 -165.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.08 105.71 2.94 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 156.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -73.53 143.81 82.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 161.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.41 135.49 2.6 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.747 3.631 . . . . 0.0 110.292 168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.67 132.22 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 166.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -159.78 172.74 17.13 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.168 0.587 . . . . 0.0 111.224 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.15 151.26 6.8 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.46 1.904 . . . . 0.0 108.573 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -120.41 65.79 0.44 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.172 1.367 . . . . 0.0 112.111 -161.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -61.26 151.81 30.74 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.134 2.574 . . . . 0.0 112.881 -174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 6.3 m-20 -113.07 -14.23 12.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 118.408 -1.317 . . . . 0.0 113.11 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 137' ' ' GLN . 11.5 t 63.81 171.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 -152.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.575 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.0 tt0 -157.63 161.93 38.67 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 129.188 2.995 . . . . 0.0 107.351 -169.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.71 94.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.931 1.692 . . . . 0.0 108.66 -164.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -66.87 157.05 85.57 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.14 152.06 76.6 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.575 1.517 . . . . 0.0 110.113 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.245 0.838 0 C-N-CA 126.318 1.847 . . . . 0.0 108.246 177.343 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.252 0.0 OUTLIER -139.79 84.14 1.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.644 1.222 . . . . 0.0 109.981 166.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . 0.274 15.5 m 49.87 -83.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.991 2.917 . . . . 0.0 113.785 170.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' HD12 ' A' ' 7' ' ' ILE . 3.6 tm0? -50.86 -40.15 55.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 121.096 1.771 . . . . 0.0 111.074 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.05 -40.91 24.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.146 2.578 . . . . 0.0 113.189 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.7 -35.53 19.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.618 1.167 . . . . 0.0 111.912 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 4' ' ' GLN . 11.8 mt -55.47 -44.39 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -31.82 59.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.393 1.077 . . . . 0.0 112.138 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.19 -33.35 14.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.725 1.61 . . . . 0.0 109.923 -168.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.45 -47.16 73.22 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.444 1.098 . . . . 0.0 110.199 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.6 -46.69 73.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.299 1.04 . . . . 0.0 111.229 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -70.79 -37.16 73.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.986 0.514 . . . . 0.0 111.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.61 -36.23 83.58 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -66.8 -55.41 15.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.891 0.314 . . . . 0.0 110.252 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.67 -47.85 61.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.621 -162.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -65.79 -39.26 90.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.669 1.122 . . . . 0.0 111.04 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -11.01 57.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.618 0.644 . . . . 0.0 112.051 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CG ' HD22 ' A' ' 94' ' ' LEU . 35.4 t90 -87.05 -53.16 5.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.413 1.006 . . . . 0.0 109.598 164.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.01 89.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.185 0.594 . . . . 0.0 112.001 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -23.1 62.03 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.138 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.66 -14.67 41.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.31 164.36 3.31 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.352 0.978 . . . . 0.0 108.862 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -60.68 -68.41 0.8 Allowed Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.605 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 -11.35 31.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.958 1.772 . . . . 0.0 113.383 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.47 169.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.106 2.563 . . . . 0.0 112.841 -156.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.3 mt -139.61 159.86 63.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.474 1.51 . . . . 0.0 111.111 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.83 169.09 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.144 2.563 . . . . 0.0 112.69 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.05 120.57 14.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.06 103.1 7.54 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 109.062 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 52.7 m95 -69.31 174.91 4.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.905 0.882 . . . . 0.0 110.664 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -44.58 -62.53 1.16 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.88 1.672 . . . . 0.0 113.669 -165.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -126.62 37.27 4.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 109.624 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 30' ' ' TRP . 1.4 t -77.03 -179.9 5.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.669 0.747 . . . . 0.0 111.191 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 63.38 7.68 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 108.202 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -87.34 171.37 10.65 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.254 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.274 0.4 OUTLIER 82.53 135.85 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 128.992 2.917 . . . . 0.0 110.849 176.297 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 36' ' ' THR . 58.6 Cg_endo -70.36 162.78 85.07 Favored 'Cis proline' 0 CA--C 1.538 0.684 0 CA-C-N 119.84 0.979 . . . . 0.0 113.956 11.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.39 -173.74 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.237 2.625 . . . . 0.0 110.291 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.16 82.66 3.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 163.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.6 35.04 17.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.894 1.678 . . . . 0.0 113.456 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.19 45.96 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.893 1.711 . . . . 0.0 113.893 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -97.37 141.67 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.114 1.366 . . . . 0.0 107.766 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -165.52 168.04 16.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.257 0.623 . . . . 0.0 110.582 169.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.4 104.08 8.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.558 1.943 . . . . 0.0 106.077 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -66.22 141.62 57.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.23 2.37 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.51 1.524 . . . . 0.0 107.349 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -79.84 92.25 5.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 p -82.57 84.21 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 165.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 146.17 91.28 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.054 171.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.35 176.32 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.398 2.732 . . . . 0.0 110.826 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.17 147.61 2.91 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 161.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.81 35.77 4.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 111.547 -168.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 t -140.64 35.91 1.82 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.945 0.898 . . . . 0.0 111.837 -153.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mt -57.13 135.2 21.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.483 0.713 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.66 -154.87 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.525 1.93 . . . . 0.0 108.447 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -108.92 10.48 26.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.066 0.947 . . . . 0.0 113.107 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -73.55 -179.95 3.78 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.009 0.524 . . . . 0.0 109.714 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.75 12.72 28.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.031 1.333 . . . . 0.0 113.285 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.68 175.53 7.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.93 2.092 . . . . 0.0 110.771 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.84 32.78 4.31 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.878 1.228 . . . . 0.0 112.809 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.28 127.44 12.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.183 2.193 . . . . 0.0 106.275 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -141.39 -178.03 5.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.478 1.511 . . . . 0.0 112.244 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.397 1.079 . . . . 0.0 109.389 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 68.85 158.15 0.15 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 131.387 3.875 . . . . 0.0 113.99 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.23 164.33 18.95 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.158 1.383 . . . . 0.0 110.324 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -160.89 177.48 10.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.143 0.977 . . . . 0.0 109.157 -176.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.74 173.85 46.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.58 157.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -133.39 124.8 27.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -124.26 101.69 7.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.439 1.496 . . . . 0.0 107.181 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.61 152.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.86 102.44 4.72 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.197 -0.939 . . . . 0.0 109.429 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 97.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 122.663 1.221 . . . . 0.0 108.085 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.81 151.73 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.777 160.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.95 150.74 68.47 Favored Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -81.5 146.47 15.31 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.896 1.731 . . . . 0.0 109.716 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -88.64 71.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -172.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.78 -93.48 2.09 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.01 71.66 3.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.581 1.552 . . . . 0.0 111.051 -171.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.57 87.02 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 112.946 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.5 p -79.35 61.09 3.33 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.986 2.114 . . . . 0.0 114.601 -169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -116.59 3.18 13.11 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.57 -1.331 . . . . 0.0 111.754 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 m -63.47 -1.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.79 -39.2 65.25 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.91 1.232 . . . . 0.0 112.535 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.72 -54.12 31.63 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.488 0.585 . . . . 0.0 110.894 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -44.96 -56.54 4.5 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 127.057 2.143 . . . . 0.0 111.011 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.47 -46.58 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.63 1.172 . . . . 0.0 110.787 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.7 69.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.126 1.33 . . . . 0.0 111.302 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.21 -30.04 64.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.442 0.697 . . . . 0.0 110.826 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -71.04 -57.05 4.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.182 0.993 . . . . 0.0 109.266 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.35 -32.97 71.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.876 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.9 -52.31 63.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.591 1.087 . . . . 0.0 108.964 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.33 70.69 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.564 -0.71 . . . . 0.0 111.798 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 18' ' ' TRP . 49.2 tp -70.19 -36.16 74.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.23 173.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD2' HD11 ' A' ' 99' ' ' LEU . 53.8 m-85 -116.16 72.74 4.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.867 1.667 . . . . 0.0 109.718 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 98' ' ' ASN . 74.0 Cg_endo -63.7 167.83 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.117 2.544 . . . . 0.0 109.594 170.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.76 10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.751 2.02 . . . . 0.0 113.782 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 96' ' ' PRO . 2.0 m-80 -104.54 -55.77 2.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.106 2.162 . . . . 0.0 109.993 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.2 mp 46.09 39.23 5.63 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.511 1.125 . . . . 0.0 112.408 -170.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.8 78.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.488 1.137 . . . . 0.0 108.276 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 18.9 mtt -81.91 172.33 13.43 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.605 1.562 . . . . 0.0 108.888 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -138.46 147.88 43.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 161.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.32 13.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.853 1.661 . . . . 0.0 107.136 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.01 4.35 10.57 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.754 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.72 -54.87 0.28 Allowed Glycine 0 C--O 1.224 -0.501 0 CA-C-N 118.865 1.333 . . . . 0.0 111.233 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 174.13 165.22 0.21 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.509 2.324 . . . . 0.0 108.028 -165.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.54 171.27 11.69 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.1 0.96 . . . . 0.0 110.979 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.25 172.69 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.986 1.714 . . . . 0.0 107.035 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' HE ' ' NE2' ' A' ' 137' ' ' GLN . 11.6 mtm180 -150.85 133.83 15.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.522 1.51 . . . . 0.0 109.924 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.484 ' HB ' HD22 ' A' ' 99' ' ' LEU . 7.3 p -63.51 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.285 1.434 . . . . 0.0 114.07 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 69.44 -30.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.386 1.874 . . . . 0.0 114.299 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.4 p -132.73 164.06 46.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 119.873 1.215 . . . . 0.0 109.431 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.83 175.94 8.98 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.833 1.689 . . . . 0.0 109.475 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mm -62.13 153.51 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 123.86 0.864 . . . . 0.0 108.861 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 151.3 51.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -148.22 176.02 10.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.468 1.507 . . . . 0.0 109.584 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.01 178.3 35.23 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.71 147.1 96.29 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.5 152.31 75.09 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.181 1.921 . . . . 0.0 111.594 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -77.28 148.55 35.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 153.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.1 m -117.28 137.4 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 162.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.46 -151.54 20.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 127.261 2.362 . . . . 0.0 109.785 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.43 -43.76 79.76 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.551 1.14 . . . . 0.0 111.955 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.9 42.57 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 128.845 2.858 . . . . 0.0 107.504 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.604 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -137.63 161.7 35.75 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 123.542 0.737 . . . . 0.0 110.878 160.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -121.41 154.23 36.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 164.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.83 115.52 6.79 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 173.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.32 144.02 86.38 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 128.12 10.27 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.505 2.804 . . . . 0.0 108.4 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.62 136.11 46.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 167.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.63 165.07 19.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.369 0.668 . . . . 0.0 111.718 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 110' ' ' VAL . 3.8 pp -156.25 160.28 39.65 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.887 2.075 . . . . 0.0 108.767 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -131.69 96.92 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.87 162.31 20.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.958 1.303 . . . . 0.0 111.0 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.9 m-20 -128.0 173.42 10.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 166.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.19 171.6 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.862 1.665 . . . . 0.0 108.152 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.487 ' NE2' ' HE ' ' A' ' 109' ' ' ARG . 17.7 pm0 -149.02 -179.66 7.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.982 1.713 . . . . 0.0 107.457 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -144.06 165.68 27.12 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 167.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -136.54 165.48 35.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.443 2.297 . . . . 0.0 108.864 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.13 144.11 74.12 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.287 1.325 . . . . 0.0 109.022 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.298 20.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 127.324 2.25 . . . . 0.0 113.317 -165.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptm -129.27 63.59 1.5 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.008 1.323 . . . . 0.0 109.734 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -154.9 -82.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.384 0.673 . . . . 0.0 111.263 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -56.06 -31.47 63.2 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.225 -1.547 . . . . 0.0 112.144 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.23 -57.41 5.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.157 1.783 . . . . 0.0 111.846 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' LEU 0.267 0.6 OUTLIER -56.07 -44.47 78.96 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.206 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 106' ' ' LEU . 16.2 mt -45.39 -60.89 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 117.191 -1.385 . . . . 0.0 111.473 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -60.55 -31.57 70.67 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.697 1.589 . . . . 0.0 112.448 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.29 64.0 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.469 -0.77 . . . . 0.0 112.855 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.68 -20.58 56.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.074 1.306 . . . . 0.0 113.225 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.05 -45.21 67.6 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.88 -38.98 76.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.459 0.704 . . . . 0.0 110.075 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -55.82 -41.57 74.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.283 0.947 . . . . 0.0 108.739 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -72.56 -56.72 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.23 -38.95 86.09 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.282 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.5 t -63.57 -56.23 17.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.795 1.238 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -36.49 71.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.504 0.721 . . . . 0.0 110.941 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CG ' HD22 ' A' ' 94' ' ' LEU . 72.2 t90 -66.62 -54.52 22.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.353 0.524 . . . . 0.0 110.513 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.89 78.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.757 0.423 . . . . 0.0 110.944 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -17.63 64.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.429 1.492 . . . . 0.0 113.906 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.99 -15.48 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.894 1.277 . . . . 0.0 112.779 -174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -59.92 157.51 12.43 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 170.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -65.11 -59.99 8.85 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 117.94 -1.028 . . . . 0.0 112.146 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.48 -15.83 50.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 CA-C-N 121.579 1.6 . . . . 0.0 114.788 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.62 115.38 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.143 2.977 . . . . 0.0 115.354 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 mt -114.13 144.35 31.47 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 119.902 -1.749 . . . . 0.0 110.824 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 71.6 Cg_endo -80.76 156.41 21.0 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.459 2.773 . . . . 0.0 110.979 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.06 89.05 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.01 83.95 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.166 -0.959 . . . . 0.0 110.384 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -64.86 174.42 1.88 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.462 1.105 . . . . 0.0 111.867 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -63.88 148.14 50.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.602 -0.686 . . . . 0.0 109.922 173.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 52.99 14.55 0.47 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.623 2.369 . . . . 0.0 113.24 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 t -78.87 -174.18 3.87 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.872 -1.143 . . . . 0.0 111.451 -172.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 115.98 22.75 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 128.398 2.679 . . . . 0.0 108.109 171.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -150.58 176.11 11.29 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.29 0.4 OUTLIER 77.35 151.94 0.13 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 129.154 2.982 . . . . 0.0 111.396 174.113 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 36' ' ' THR . 73.7 Cg_endo -66.76 162.09 74.34 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 CA-C-N 120.097 1.07 . . . . 0.0 111.76 3.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.18 -176.93 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.997 2.465 . . . . 0.0 112.055 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.8 76.06 2.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 162.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 52.75 41.87 31.65 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 112.047 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.39 -1.12 34.79 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.652 1.596 . . . . 0.0 114.272 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.79 128.58 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.803 1.241 . . . . 0.0 108.675 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -161.01 165.79 29.26 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.773 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -105.85 149.51 26.46 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 110.237 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -123.96 60.97 1.1 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.614 1.566 . . . . 0.0 108.218 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -71.58 121.76 19.31 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -135.81 108.22 7.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.591 2.357 . . . . 0.0 108.122 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.85 88.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.778 1.631 . . . . 0.0 107.456 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -61.93 154.37 68.48 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.768 0.827 . . . . 0.0 110.118 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.74 175.14 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.565 2.843 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.81 35.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.225 2.21 . . . . 0.0 114.24 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.8 71.5 0.26 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.698 2.399 . . . . 0.0 112.938 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 t -66.26 116.99 7.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.02 137.88 41.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -75.04 177.0 6.69 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 124.235 0.959 . . . . 0.0 110.665 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 75.38 112.02 0.07 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.173 2.989 . . . . 0.0 108.632 -153.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.16 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 128.619 2.768 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 58.88 18.2 5.93 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.483 1.113 . . . . 0.0 112.468 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 169.2 3.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.819 2.048 . . . . 0.0 111.65 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.95 51.54 4.44 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 126.252 1.882 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -161.34 131.77 5.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.612 3.165 . . . . 0.0 104.164 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -162.43 -27.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -159.72 173.07 16.59 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 127.664 2.386 . . . . 0.0 106.112 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.286 19.9 pt20 45.28 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 111.768 -169.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -120.87 178.12 4.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.709 1.603 . . . . 0.0 109.899 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.09 177.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.602 1.161 . . . . 0.0 109.025 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.1 -175.59 30.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.14 128.82 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 6.0 t80 -85.87 107.58 17.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.94 138.54 31.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.065 1.746 . . . . 0.0 107.544 170.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.59 133.26 18.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 166.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.22 142.84 45.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 118.821 0.737 . . . . 0.0 110.13 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.88 67.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 107.634 -168.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.52 131.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.751 0.82 . . . . 0.0 110.512 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.4 ptp -127.84 154.26 78.1 Favored Pre-proline 0 N--CA 1.465 0.301 0 C-N-CA 125.972 1.709 . . . . 0.0 108.382 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.5 -179.85 5.72 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.714 2.276 . . . . 0.0 109.202 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mt -124.46 84.72 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.68 34.97 3.26 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.606 1.098 . . . . 0.0 111.194 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 60.27 132.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 131.311 3.844 . . . . 0.0 112.148 -159.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.58 48.18 87.46 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.478 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -66.17 -59.68 3.53 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 57.36 1.03 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.091 2.557 . . . . 0.0 116.72 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 t -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.668 1.587 . . . . 0.0 113.621 -172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.54 -51.53 54.52 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.096 1.317 . . . . 0.0 111.124 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -70.35 -40.17 74.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 123.319 0.387 . . . . 0.0 111.173 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -57.87 -53.87 53.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.565 1.546 . . . . 0.0 109.838 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.15 -42.68 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.312 1.045 . . . . 0.0 109.793 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.79 -22.7 62.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.43 -28.66 21.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.832 0.853 . . . . 0.0 112.517 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.18 -57.52 6.59 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.104 -0.998 . . . . 0.0 109.635 174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.54 -25.17 59.5 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.24 -46.64 15.9 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.711 0.805 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.16 -30.72 69.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.132 -0.355 . . . . 0.0 110.718 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 18' ' ' TRP . 34.6 tp -70.04 -34.36 73.14 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 111.848 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.16 70.25 15.28 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.14 1.376 . . . . 0.0 111.477 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.3 163.2 38.5 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.795 2.33 . . . . 0.0 111.217 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.94 -13.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -161.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -86.38 -42.1 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 43.02 53.87 5.0 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 127.482 2.313 . . . . 0.0 112.763 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.4 93.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.66 141.26 52.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.519 1.127 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 1.5 pm0 -117.29 104.56 11.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -176.86 1.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.559 0.744 . . . . 0.0 109.931 172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.36 24.0 0.27 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.455 1.979 . . . . 0.0 114.657 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -145.26 -81.46 0.05 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -158.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.09 -87.1 0.26 Allowed 'General case' 0 C--O 1.231 0.086 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -170.47 -175.78 1.98 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.745 2.418 . . . . 0.0 107.585 172.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 136' ' ' VAL . 1.9 p -168.43 156.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.076 1.75 . . . . 0.0 107.946 175.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -137.54 167.34 21.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 132' ' ' LEU . 9.9 p -77.14 -26.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.414 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 72.34 -64.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.407 2.283 . . . . 0.0 111.439 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 p -109.87 155.86 40.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.102 0.961 . . . . 0.0 109.791 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.25 155.6 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.312 2.008 . . . . 0.0 109.914 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 HD23 ' A' ' 132' ' ' LEU . 3.9 mm -47.85 129.72 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.553 1.541 . . . . 0.0 110.489 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -79.47 173.0 13.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.137 0.494 . . . . 0.0 111.369 171.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.94 151.36 12.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.226 3.01 . . . . 0.0 104.424 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.67 32.87 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 163.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 145.16 78.62 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.89 179.91 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.731 2.287 . . . . 0.0 112.952 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 t -140.02 34.84 1.94 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.12 1.768 . . . . 0.0 109.174 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 98.0 m -42.43 133.96 3.14 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 130.754 3.621 . . . . 0.0 110.891 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.32 -164.46 20.14 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.744 1.64 . . . . 0.0 111.743 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -46.93 -43.42 19.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.93 1.692 . . . . 0.0 113.172 -165.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -154.91 29.83 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.235 1.414 . . . . 0.0 110.155 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.28 148.79 52.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.325 1.05 . . . . 0.0 109.251 170.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.15 149.47 32.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.6 m -148.86 126.98 12.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 m -92.66 144.82 29.28 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.118 1.367 . . . . 0.0 109.649 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 131.06 11.82 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.907 3.072 . . . . 0.0 110.994 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 mt -141.07 139.0 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 p -163.84 -177.89 5.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.363 1.065 . . . . 0.0 110.265 173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD13 HG23 ' A' ' 110' ' ' VAL . 2.7 pp -164.91 157.77 16.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.548 1.939 . . . . 0.0 110.65 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.17 94.97 0.41 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 119.194 0.906 . . . . 0.0 112.101 -173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -73.52 177.52 5.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.7 2.0 . . . . 0.0 111.761 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.0 p-10 -144.52 -17.27 0.54 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 135' ' ' ASP . 0.5 OUTLIER 76.64 170.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.858 1 C-N-CA 132.483 4.313 . . . . 0.0 110.012 -178.168 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -120.86 122.78 41.01 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.3 116.27 29.46 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 158.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -72.07 160.84 81.6 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 163.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.48 151.35 85.19 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.347 -1.787 . . . . 0.0 108.046 -176.175 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.722 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 48.65 58.65 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.882 1.273 . . . . 0.0 110.099 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -146.82 -85.99 0.1 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -27.51 68.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.657 1.571 . . . . 0.0 111.347 -168.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.35 -56.08 15.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 126.732 2.013 . . . . 0.0 110.004 170.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.3 mm? -67.5 -48.72 66.28 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.619 0.768 . . . . 0.0 111.14 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 106' ' ' LEU . 5.5 mt -51.84 -52.36 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -54.28 -50.52 67.07 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.976 0.91 . . . . 0.0 110.077 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.45 -24.34 60.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.17 -29.48 34.65 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 120.8 -1.188 . . . . 0.0 111.516 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.12 -46.29 90.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.513 0.597 . . . . 0.0 109.572 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.45 -25.51 61.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.421 -0.799 . . . . 0.0 112.952 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -69.43 -24.1 63.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.322 0.965 . . . . 0.0 111.767 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.293 159.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.85 -49.93 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.272 0.487 . . . . 0.0 112.304 -160.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 t -61.92 -48.27 81.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.147 0.979 . . . . 0.0 109.449 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.35 -35.71 81.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.934 1.294 . . . . 0.0 111.226 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -66.66 -50.96 61.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.602 1.092 . . . . 0.0 108.798 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.22 77.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.033 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.227 1.411 . . . . 0.0 113.273 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.23 50.25 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 HH21 ' NE2' ' A' ' 86' ' ' GLN . 2.9 ttt180 -73.97 161.59 29.93 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.77 -1.206 . . . . 0.0 108.391 163.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 m -50.77 -66.92 0.54 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.794 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.55 -9.31 25.86 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.643 1.562 . . . . 0.0 115.028 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.55 90.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.839 2.855 . . . . 0.0 113.583 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.5 mt -92.18 154.58 43.14 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.224 1.01 . . . . 0.0 111.089 -169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.24 -178.44 4.62 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.745 2.964 . . . . 0.0 110.548 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.36 97.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 120.604 1.547 . . . . 0.0 109.297 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.65 96.55 6.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.839 -0.538 . . . . 0.0 109.684 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -68.95 -179.37 1.46 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.154 1.381 . . . . 0.0 112.376 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.77 140.58 58.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 44.74 34.34 1.15 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.683 1.593 . . . . 0.0 111.934 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -86.3 -173.78 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.4 1.48 . . . . 0.0 107.583 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -139.56 98.95 3.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.78 101.39 4.18 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.05 157.94 23.22 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.578 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -67.37 168.56 54.8 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.793 0.962 . . . . 0.0 111.781 -1.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -65.04 178.75 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.234 1.956 . . . . 0.0 111.118 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.55 69.14 6.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 45.08 71.41 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.151 2.181 . . . . 0.0 111.277 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.02 71.6 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.993 0.806 . . . . 0.0 114.352 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.64 131.82 66.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.95 0.875 . . . . 0.0 110.389 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -160.07 164.1 33.37 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.366 1.079 . . . . 0.0 110.075 168.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.41 102.93 9.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 128.409 2.684 . . . . 0.0 105.205 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -82.86 79.79 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.127 0.571 . . . . 0.0 109.464 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.37 110.06 6.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.847 1.659 . . . . 0.0 110.533 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -128.94 90.87 3.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.681 -1.262 . . . . 0.0 110.656 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.4 m -78.98 72.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 128.465 2.706 . . . . 0.0 109.881 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -44.57 89.29 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 129.862 3.265 . . . . 0.0 112.5 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.55 176.59 2.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.393 2.062 . . . . 0.0 111.372 -175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.57 81.82 0.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.821 0.848 . . . . 0.0 109.558 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.97 135.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.605 3.162 . . . . 0.0 112.87 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 p -94.19 47.55 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.792 0.837 . . . . 0.0 112.421 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.7 mt -120.81 12.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.315 -0.865 . . . . 0.0 111.719 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -175.01 171.41 3.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.277 1.831 . . . . 0.0 108.35 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -136.13 34.42 2.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.185 1.394 . . . . 0.0 111.315 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.07 145.18 47.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.964 1.306 . . . . 0.0 111.2 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -173.67 72.49 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.314 2.245 . . . . 0.0 109.372 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.89 -0.43 29.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.693 1.197 . . . . 0.0 113.828 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.76 34.11 80.91 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.17 -77.55 0.09 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.111 -1.229 . . . . 0.0 109.027 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -71.04 119.4 15.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.64 -169.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.568 0.747 . . . . 0.0 111.816 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.82 169.87 21.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.256 1.022 . . . . 0.0 109.475 -163.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.03 121.13 38.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.308 1.043 . . . . 0.0 110.204 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -139.29 103.18 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.07 176.48 17.44 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.23 135.2 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -90.52 156.5 18.13 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -137.5 137.56 38.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 166.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.72 94.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.53 94.17 1.66 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -62.64 115.19 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.92 131.1 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.31 149.37 57.6 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.5 178.15 6.56 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.975 2.45 . . . . 0.0 110.378 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.3 78.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.1 -58.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -150.53 103.55 3.13 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.815 1.246 . . . . 0.0 107.966 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.57 22.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.673 1.13 . . . . 0.0 114.539 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 p -61.9 -33.03 73.49 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 120.481 2.14 . . . . 0.0 112.906 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.2 65.14 1.52 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -117.56 -13.46 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.44 1.496 . . . . 0.0 111.764 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.5 80.33 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.64 0.655 . . . . 0.0 111.874 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.25 -35.23 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 118.524 0.602 . . . . 0.0 110.159 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.412 ' NE2' HH21 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.84 -57.41 11.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.34 1.056 . . . . 0.0 108.89 170.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.84 -40.01 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.141 0.976 . . . . 0.0 110.779 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.51 87.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.374 0.988 . . . . 0.0 111.538 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.08 -25.71 52.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.56 0.618 . . . . 0.0 111.941 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.13 -58.41 3.3 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 109.316 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.5 mt -53.88 -39.09 65.42 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.23 1.412 . . . . 0.0 111.36 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.09 -59.04 5.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.287 1.035 . . . . 0.0 111.49 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.5 80.82 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.279 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.86 -21.09 57.57 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.315 1.446 . . . . 0.0 112.474 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -115.46 77.48 5.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 162.75 39.08 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.709 2.939 . . . . 0.0 110.443 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.18 -9.08 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -168.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -82.75 -45.26 14.62 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.97 -1.081 . . . . 0.0 111.625 169.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.65 71.85 0.22 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.542 2.737 . . . . 0.0 113.503 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 100' ' ' VAL . 19.6 m -72.61 52.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.454 2.302 . . . . 0.0 112.888 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.0 mtm -74.47 63.07 1.04 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.089 -1.632 . . . . 0.0 109.384 173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -53.15 136.95 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 157.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.84 -178.55 4.32 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.285 2.234 . . . . 0.0 107.893 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.22 4.97 0.17 Allowed Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.966 170.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.05 -69.02 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 119.741 1.77 . . . . 0.0 109.64 -157.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -130.88 -168.53 2.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.584 1.554 . . . . 0.0 108.01 -177.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.8 125.53 45.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.937 1.295 . . . . 0.0 108.337 168.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.19 160.91 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -140.63 131.92 26.64 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 164.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.95 -22.46 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 68.65 -70.7 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.633 1.973 . . . . 0.0 109.932 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 p -85.13 156.56 60.2 Favored Pre-proline 0 N--CA 1.446 -0.655 0 C-N-CA 125.177 1.391 . . . . 0.0 110.753 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.26 169.05 22.03 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.064 1.843 . . . . 0.0 109.58 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.11 147.38 12.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 143.95 51.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 168.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -151.46 140.47 21.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.462 2.705 . . . . 0.0 106.026 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.98 -173.88 13.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.955 1.741 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.67 146.73 98.96 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.798 0.799 . . . . 0.0 109.072 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.86 152.86 73.62 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.458 2.105 . . . . 0.0 112.025 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.9 t -96.7 7.68 46.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.676 1.191 . . . . 0.0 112.613 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.11 -164.39 0.14 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.248 1.019 . . . . 0.0 110.621 -168.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.33 -176.15 46.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.405 2.431 . . . . 0.0 107.462 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -44.98 -54.34 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.344 1.858 . . . . 0.0 112.733 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.47 21.83 0.93 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.663 1.185 . . . . 0.0 110.289 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -147.97 145.06 28.4 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -92.35 149.34 21.48 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.94 120.86 32.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 161.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.68 144.59 65.2 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 155.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.52 127.59 9.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.751 2.967 . . . . 0.0 107.769 162.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -144.59 121.1 4.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.7 p -161.55 170.3 20.12 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -150.23 162.28 40.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.966 2.907 . . . . 0.0 107.837 176.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.67 114.57 1.3 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -110.63 159.03 17.95 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.955 2.102 . . . . 0.0 111.499 -167.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.58 5.2 2.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.704 1.602 . . . . 0.0 110.832 -169.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p 61.55 -172.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 128.021 2.529 . . . . 0.0 109.524 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.42 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 120.887 -1.133 . . . . 0.0 108.043 142.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -100.29 2.25 42.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.948 0.899 . . . . 0.0 110.54 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.7 t80 44.34 65.69 5.77 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 129.208 3.003 . . . . 0.0 112.813 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.2 148.12 84.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.968 1.779 . . . . 0.0 110.164 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.772 160.159 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 81.9 mtp -135.7 32.45 3.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.066 0.946 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 m 59.29 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.007 1.323 . . . . 0.0 112.491 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.04 -35.31 73.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.863 1.665 . . . . 0.0 111.676 -171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -44.39 -40.46 5.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.474 1.91 . . . . 0.0 110.914 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.92 -26.68 17.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.523 1.929 . . . . 0.0 112.737 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 106' ' ' LEU . 35.2 mm -57.87 -58.08 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -41.33 77.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.849 0.459 . . . . 0.0 110.984 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 -23.93 66.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.289 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -70.01 -44.57 69.03 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.303 1.041 . . . . 0.0 110.601 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -59.2 -48.47 81.49 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.56 1.144 . . . . 0.0 108.679 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -57.68 -37.11 72.87 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.678 1.591 . . . . 0.0 111.484 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -17.49 61.55 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.669 1.187 . . . . 0.0 112.654 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -92.95 -56.88 2.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.836 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -53.71 53.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.405 0.548 . . . . 0.0 110.717 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -80.92 -3.67 52.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.92 -23.5 14.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.612 0.765 . . . . 0.0 109.625 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.434 ' CZ3' HD21 ' A' ' 91' ' ' LEU . 30.5 t90 -75.66 -48.14 23.35 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.264 1.426 . . . . 0.0 109.101 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.7 78.23 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 117.29 -1.338 . . . . 0.0 112.122 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -21.83 38.67 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.43 1.492 . . . . 0.0 113.375 173.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.9 67.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.032 0.833 . . . . 0.0 109.996 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.492 HH11 HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.6 155.6 21.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.9 m -64.7 -64.84 2.35 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.072 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.09 -6.53 13.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.017 2.478 . . . . 0.0 116.181 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.59 96.25 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.444 3.098 . . . . 0.0 114.966 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HH11 ' A' ' 22' ' ' ARG . 2.0 mm? -105.1 153.11 39.73 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -163.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.13 161.59 40.53 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.703 2.935 . . . . 0.0 110.669 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.0 t -138.61 100.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.51 94.51 7.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.965 0.906 . . . . 0.0 109.862 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -73.37 -178.51 3.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.643 1.177 . . . . 0.0 111.927 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 144.05 57.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 110.088 172.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.28 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.246 2.619 . . . . 0.0 115.285 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.4 m -57.93 151.31 18.51 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.3 2.64 . . . . 0.0 109.565 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -97.54 136.3 38.14 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.114 0.965 . . . . 0.0 109.603 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -154.5 172.26 18.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.125 2.57 . . . . 0.0 107.957 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.54 156.17 0.16 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.573 1.949 . . . . 0.0 109.736 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.77 155.22 83.56 Favored 'Cis proline' 0 CA--C 1.544 1.007 0 CA-C-N 120.356 1.163 . . . . 0.0 113.029 -3.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.1 -176.46 1.87 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.09 3.194 . . . . 0.0 112.737 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.41 -27.74 31.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 173.12 20.97 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.694 1.598 . . . . 0.0 109.415 -168.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.03 -7.92 27.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.857 2.17 . . . . 0.0 115.568 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.84 135.66 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.61 1.205 . . . . 0.0 108.619 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -166.25 165.84 17.2 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.364 0.665 . . . . 0.0 110.563 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.8 104.96 10.28 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.396 1.078 . . . . 0.0 108.911 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -69.31 112.52 5.92 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 162.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.3 130.21 53.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.88 110.38 6.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 119.345 0.975 . . . . 0.0 110.866 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.55 91.35 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 125.944 1.698 . . . . 0.0 106.608 165.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.4 mtm -73.54 144.08 83.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.55 175.36 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.175 2.583 . . . . 0.0 112.179 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.98 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.398 1.879 . . . . 0.0 112.93 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 43.37 83.49 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.846 2.458 . . . . 0.0 114.118 155.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.2 t -52.07 95.39 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.163 1.785 . . . . 0.0 112.885 -172.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.6 mt -141.35 158.64 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 129.083 2.953 . . . . 0.0 104.447 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.2 t -137.2 143.99 42.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 155.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -160.52 15.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.452 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -103.96 166.77 10.2 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.039 -1.038 . . . . 0.0 111.255 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.45 21.0 2.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 127.011 2.125 . . . . 0.0 110.601 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.08 -168.73 2.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.248 2.219 . . . . 0.0 107.441 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.48 169.37 39.22 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 159.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -135.06 -65.44 0.62 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.848 0.824 . . . . 0.0 109.506 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.49 165.82 34.66 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.283 1.433 . . . . 0.0 107.385 172.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 53.67 -177.01 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.849 2.06 . . . . 0.0 113.493 159.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -155.02 11.8 0.36 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -106.0 151.15 24.99 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.482 -0.761 . . . . 0.0 110.033 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -178.27 5.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.777 1.631 . . . . 0.0 108.429 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.02 -177.02 43.6 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 159.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.86 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -110.34 116.76 32.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.07 156.35 32.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.613 1.165 . . . . 0.0 108.817 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -157.63 162.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 125.292 1.437 . . . . 0.0 107.287 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.44 100.4 4.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -77.34 101.18 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.64 145.67 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.72 150.47 33.29 Favored Pre-proline 0 C--O 1.235 0.338 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 165.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.53 159.7 51.96 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.0 110.505 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.0 mt -103.55 75.07 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 0.0 108.401 -169.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -80.34 0.22 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.893 1.235 . . . . 0.0 111.943 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -140.69 120.55 13.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.35 -61.92 1.1 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.904 2.193 . . . . 0.0 113.021 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.47 99.25 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 131.013 3.725 . . . . 0.0 113.111 -170.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.55 10.19 5.62 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.775 1.63 . . . . 0.0 111.846 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -57.47 -22.37 43.32 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.919 -1.113 . . . . 0.0 113.838 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.13 63.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.026 1.33 . . . . 0.0 111.321 171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.22 -54.84 39.18 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.55 0.613 . . . . 0.0 110.358 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -55.21 -54.3 45.06 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.919 0.888 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -60.5 -42.08 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.673 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.85 -20.2 65.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 117.623 -1.18 . . . . 0.0 113.456 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.4 14.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.54 1.063 . . . . 0.0 110.943 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.41 -57.32 7.66 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.515 -0.741 . . . . 0.0 110.434 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 18' ' ' TRP . 27.9 mt -66.39 -23.17 66.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.685 0.794 . . . . 0.0 111.517 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -58.91 6.51 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.36 -16.81 63.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.57 -43.1 70.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.884 -1.055 . . . . 0.0 111.284 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.07 54.24 10.46 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.53 1.132 . . . . 0.0 112.998 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -77.53 178.83 7.14 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.773 2.315 . . . . 0.0 109.656 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 113' ' ' PRO . 11.9 t -45.79 -16.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -109.39 11.82 24.95 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.236 -0.915 . . . . 0.0 113.347 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -44.55 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.646 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.28 135.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -151.51 155.05 37.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.46 1.504 . . . . 0.0 107.262 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -121.87 161.44 22.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 162.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 32.4 t -149.25 -170.67 3.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.22 -18.59 60.74 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.655 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.66 -56.88 2.03 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 120.323 2.062 . . . . 0.0 109.735 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 7' ' ' ILE . 2.1 pt? 174.42 -174.31 0.07 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 128.868 2.867 . . . . 0.0 109.068 -157.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.94 168.24 16.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.485 1.514 . . . . 0.0 113.421 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.79 158.82 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.222 1.409 . . . . 0.0 107.948 167.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -135.18 -168.23 2.14 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 108.372 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.5 -34.15 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.31 1.044 . . . . 0.0 111.956 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 -43.56 0.4 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.485 1.914 . . . . 0.0 113.612 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.1 p -101.84 158.8 31.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 124.664 1.185 . . . . 0.0 110.614 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.3 Cg_endo -68.82 -179.95 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.228 1.952 . . . . 0.0 109.076 164.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -62.52 149.36 9.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.62 1.168 . . . . 0.0 108.531 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.06 159.27 30.28 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.25 1.02 . . . . 0.0 108.943 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.6 -174.65 4.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.921 1.688 . . . . 0.0 108.621 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.16 178.91 42.13 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -67.7 151.7 96.95 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.9 165.84 31.35 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.658 1.572 . . . . 0.0 111.707 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.3 m -120.38 111.03 17.24 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.35 165.41 22.46 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.552 0.692 . . . . 0.0 110.064 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.06 -172.14 17.0 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 128.235 2.826 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -57.1 -47.06 81.96 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.917 0.887 . . . . 0.0 111.985 -168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -147.48 13.64 1.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 110.716 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -132.46 160.74 35.55 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -144.07 154.23 43.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.152 0.581 . . . . 0.0 109.735 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -140.75 128.66 21.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 123.732 0.645 . . . . 0.0 110.273 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.27 144.14 35.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.26 126.52 3.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.724 3.616 . . . . 0.0 109.935 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mt -142.42 146.6 22.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 p -174.53 169.58 3.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.817 1.247 . . . . 0.0 111.694 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -140.91 166.82 23.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.835 2.454 . . . . 0.0 107.676 160.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.87 174.85 39.6 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 165.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -161.51 177.26 10.22 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.154 0.982 . . . . 0.0 108.875 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 136' ' ' VAL . 3.3 p30 -151.58 -86.93 0.07 Allowed 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.926 162.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' ASP . 19.2 t -168.36 145.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.798 3.639 . . . . 0.0 107.496 -171.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -126.29 152.98 45.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.36 121.55 37.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -65.94 164.93 24.07 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.998 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 140.16 57.3 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.299 1.999 . . . . 0.0 109.676 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 152.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.6 mmm -103.34 -10.09 18.94 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.566 1.146 . . . . 0.0 113.095 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m 47.21 -82.05 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.809 2.444 . . . . 0.0 113.655 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -49.39 -38.89 30.33 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.397 1.879 . . . . 0.0 111.938 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.41 -57.14 12.44 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.547 1.539 . . . . 0.0 111.323 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -62.26 -43.85 97.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.968 0.907 . . . . 0.0 110.097 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 106' ' ' LEU . 28.8 mt -52.92 -63.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 124.222 0.951 . . . . 0.0 108.72 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -44.45 83.54 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.959 1.304 . . . . 0.0 109.45 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.161 0.584 . . . . 0.0 111.342 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.52 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.33 -40.03 71.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.171 0.441 . . . . 0.0 110.053 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.7 -33.64 75.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -70.02 -1.85 11.01 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.629 0.772 . . . . 0.0 112.232 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.13 -60.11 1.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 118.741 0.7 . . . . 0.0 110.855 166.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -49.91 50.48 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.943 0.497 . . . . 0.0 110.111 -170.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.38 -48.02 81.58 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.3 -0.57 0.58 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.724 2.409 . . . . 0.0 114.361 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -114.45 -47.56 2.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.52 1.528 . . . . 0.0 108.412 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.6 81.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.141 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -28.19 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.925 0.784 . . . . 0.0 112.794 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.09 -28.53 27.48 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.486 0.715 . . . . 0.0 110.464 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.454 HH11 HD21 ' A' ' 26' ' ' LEU . 1.2 ttt180 -62.49 149.66 42.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.0 m -58.08 -61.59 7.16 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.0 -15.14 45.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 121.549 1.499 . . . . 0.0 113.383 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.09 101.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.05 2.54 . . . . 0.0 112.901 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD21 HH11 ' A' ' 22' ' ' ARG . 4.6 mm? -77.83 144.96 69.49 Favored Pre-proline 0 C--O 1.238 0.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.8 -173.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 87.4 Cg_endo -75.02 151.46 39.44 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.178 1.918 . . . . 0.0 108.722 161.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.98 96.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.43 82.66 6.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.265 1.026 . . . . 0.0 108.471 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -59.28 -177.59 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.722 2.009 . . . . 0.0 112.504 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -45.02 133.1 6.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.59 1.156 . . . . 0.0 110.13 167.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 48.75 14.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 127.727 2.411 . . . . 0.0 114.818 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.3 m -87.43 160.56 18.26 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -119.87 136.12 54.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.786 2.034 . . . . 0.0 105.615 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.93 94.65 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 161.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 m -142.71 130.39 11.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.19 158.61 74.83 Favored 'Cis proline' 0 CA--C 1.544 0.998 0 CA-C-N 119.842 0.979 . . . . 0.0 110.727 -12.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.59 -166.27 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 124.524 3.482 . . . . 0.0 111.954 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . . . -75.38 71.38 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.771 0.828 . . . . 0.0 108.858 159.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 50.79 38.11 18.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.461 1.504 . . . . 0.0 113.451 161.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.21 -9.09 17.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.127 2.299 . . . . 0.0 113.751 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.71 133.98 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.217 1.407 . . . . 0.0 108.586 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -154.94 171.56 19.5 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.905 -0.497 . . . . 0.0 111.49 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -140.11 83.54 1.92 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.539 1.536 . . . . 0.0 106.987 -157.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -74.22 89.63 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.156 1.383 . . . . 0.0 108.053 -167.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.41 51.81 2.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.866 1.666 . . . . 0.0 111.899 -166.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.86 149.27 49.11 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.945 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 69' ' ' PHE 0.253 0.8 OUTLIER -133.75 141.18 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 177.869 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 mtm -129.37 85.85 57.98 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.64 174.8 1.45 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.489 2.126 . . . . 0.0 110.211 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ARG . . . -55.74 108.56 0.46 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.85 19.51 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.209 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -53.11 148.62 7.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -129.77 135.66 60.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -159.08 -158.0 0.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.287 1.835 . . . . 0.0 106.967 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -74.42 5.02 5.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.002 1.321 . . . . 0.0 113.542 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -102.85 171.09 7.6 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.638 1.575 . . . . 0.0 109.719 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.01 49.48 0.51 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.24 1.416 . . . . 0.0 109.913 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.69 32.71 0.58 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -163.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.47 -62.13 4.61 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.7 t70 63.67 105.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.703 1 C-N-CA 133.223 4.609 . . . . 0.0 108.997 170.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -68.8 160.79 29.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.717 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -47.36 120.5 3.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.895 1.678 . . . . 0.0 109.929 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -146.92 168.85 20.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 127.433 2.293 . . . . 0.0 107.197 172.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD2' HD13 ' A' ' 7' ' ' ILE . 42.2 m-85 -131.32 -15.88 3.18 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 20.6 ttm180 -51.46 124.03 11.12 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 126.139 1.776 . . . . 0.0 109.48 172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.28 -153.7 6.46 Favored Glycine 0 C--N 1.313 -0.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.22 141.81 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 48' ' ' VAL . 8.6 m-30 -110.74 113.6 26.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -110.48 98.13 7.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.658 1.183 . . . . 0.0 108.136 -167.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.29 150.94 6.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.97 104.66 6.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -82.48 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 166.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.9 132.14 51.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.2 1.8 . . . . 0.0 106.948 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.4 mtm -143.82 151.34 52.86 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.05 -179.92 5.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.95 2.434 . . . . 0.0 110.551 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.04 70.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.006 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.5 -22.48 5.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.502 1.049 . . . . 0.0 112.712 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.63 25.66 1.81 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.953 1.377 . . . . 0.0 112.138 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.85 3.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.457 1.027 . . . . 0.0 111.782 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 p -73.93 40.81 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.846 1.658 . . . . 0.0 112.845 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -107.21 4.71 26.99 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.013 -1.68 . . . . 0.0 110.953 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t -66.99 -26.14 66.66 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.589 -0.695 . . . . 0.0 111.256 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.43 72.35 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 120.957 -1.089 . . . . 0.0 111.524 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.23 -19.53 53.57 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -71.58 0.28 Allowed 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 129.341 3.057 . . . . 0.0 106.81 163.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.32 -44.46 79.81 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.729 -169.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.38 70.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.751 1.159 . . . . 0.0 111.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.81 -28.09 58.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.374 0.421 . . . . 0.0 112.022 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.04 -50.66 18.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.579 0.627 . . . . 0.0 109.491 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.41 -33.41 67.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.756 1.222 . . . . 0.0 112.088 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.57 -52.55 63.96 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 109.757 174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.63 -24.7 67.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.587 0.355 . . . . 0.0 111.8 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.75 -41.44 75.2 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.031 0.832 . . . . 0.0 110.839 171.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -115.96 58.91 1.59 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.398 1.079 . . . . 0.0 113.268 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.97 167.26 27.65 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.986 2.457 . . . . 0.0 111.527 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -70.34 19.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 129.775 3.23 . . . . 0.0 115.268 -163.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -116.65 -63.91 1.38 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.487 1.115 . . . . 0.0 110.69 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.09 57.56 4.15 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.143 2.177 . . . . 0.0 114.897 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.696 HG22 ' HE ' ' A' ' 109' ' ' ARG . 2.0 t -75.52 103.41 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.18 160.19 17.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.44 97.38 5.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.691 1.597 . . . . 0.0 106.884 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.01 157.58 29.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.13 6.68 9.63 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.196 1.379 . . . . 0.0 116.317 -164.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.02 -51.31 0.41 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.765 1.174 . . . . 0.0 110.891 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.576 HD11 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -175.68 169.05 3.09 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.778 2.831 . . . . 0.0 106.476 -167.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.04 30.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.43 158.95 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 162.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.696 ' HE ' HG22 ' A' ' 100' ' ' VAL . 7.7 mtt85 -151.61 166.77 30.18 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.05 -1.031 . . . . 0.0 109.174 166.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' CE1' ' A' ' 134' ' ' TYR . 14.7 p -70.96 -39.82 75.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.41 -70.12 0.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 127.614 2.365 . . . . 0.0 111.223 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 110' ' ' VAL . 70.4 p -87.97 161.68 43.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.21 -179.96 3.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.408 1.405 . . . . 0.0 109.856 162.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.64 165.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.854 2.461 . . . . 0.0 110.21 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -154.96 169.17 24.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.283 1.033 . . . . 0.0 109.003 161.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.62 -177.71 6.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.82 1.648 . . . . 0.0 110.217 -168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -163.24 -177.7 36.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.347 0.975 . . . . 0.0 111.079 171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.65 150.99 95.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 123.274 0.629 . . . . 0.0 109.319 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -73.76 159.05 46.11 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.924 1.75 . . . . 0.0 112.264 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 127' ' ' THR . 11.5 t -92.93 35.13 1.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.34 2.256 . . . . 0.0 111.041 175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.6 m -43.76 119.2 1.62 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.139 2.176 . . . . 0.0 110.682 -171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.62 -169.22 18.55 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 127.531 2.491 . . . . 0.0 110.985 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -45.22 -52.6 9.28 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.592 1.957 . . . . 0.0 111.358 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.31 11.49 1.73 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.796 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.52 43.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.158 0.89 . . . . 0.0 109.165 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.58 141.88 39.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 109.514 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 120' ' ' THR . 7.8 m -144.82 125.82 14.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.87 147.25 38.54 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 123.379 0.672 . . . . 0.0 109.219 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.09 129.66 13.44 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.959 3.106 . . . . 0.0 108.466 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 132.82 20.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 168.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.1 p -164.63 160.31 19.91 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.818 0.847 . . . . 0.0 111.01 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.57 HD23 ' CD1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -150.39 172.63 15.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.835 2.054 . . . . 0.0 108.977 174.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.35 92.09 0.22 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.825 ' CE1' HG23 ' A' ' 110' ' ' VAL . 3.2 m-85 -73.89 173.62 9.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.49 1.916 . . . . 0.0 110.63 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.78 -173.3 4.44 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.465 1.106 . . . . 0.0 111.028 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.5 163.43 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.45 175.45 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.54 1.536 . . . . 0.0 108.255 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.93 140.21 19.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -119.16 74.67 14.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 109.194 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.2 167.75 24.1 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.059 1.173 . . . . 0.0 109.99 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.355 1.862 . . . . 0.0 109.499 -164.25 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.5 ttt -132.04 -8.2 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.413 1.107 . . . . 0.0 112.63 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 54.03 -78.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.345 1.458 . . . . 0.0 113.186 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -36.99 5.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.521 1.964 . . . . 0.0 114.468 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -47.98 -56.74 6.94 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.249 2.22 . . . . 0.0 111.388 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' C ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -71.63 -47.85 51.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 127.974 2.51 . . . . 0.0 108.744 -173.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.05 -45.6 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 121.534 -0.729 . . . . 0.0 110.246 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -57.64 -44.52 85.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 0.0 110.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.05 -32.3 63.93 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.28 -39.51 65.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.499 1.045 . . . . 0.0 111.875 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.63 -46.49 88.82 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 43.4 mt-10 -64.28 -48.94 73.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -67.6 -20.48 65.36 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.315 0.646 . . . . 0.0 111.035 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -61.62 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.143 0.883 . . . . 0.0 110.157 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.43 -52.44 61.49 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.439 1.095 . . . . 0.0 110.546 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -59.34 -46.54 88.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.664 0.745 . . . . 0.0 109.694 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.354 1.062 . . . . 0.0 111.409 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CG ' HD22 ' A' ' 94' ' ' LEU . 10.4 t90 -72.8 -43.27 62.95 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.872 0.869 . . . . 0.0 111.095 169.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.58 64.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.531 1.06 . . . . 0.0 112.865 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -17.9 17.75 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.899 1.28 . . . . 0.0 113.214 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.59 -2.0 42.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.493 1.117 . . . . 0.0 113.804 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 26' ' ' LEU . 4.7 ttt180 -70.41 177.82 3.21 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.573 -1.329 . . . . 0.0 109.167 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -71.63 -68.37 0.46 Allowed Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 120.825 -1.172 . . . . 0.0 112.175 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.9 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 115.793 -165.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.01 96.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 129.175 2.99 . . . . 0.0 113.422 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 22' ' ' ARG . 2.8 mm? -91.64 145.66 31.64 Favored Pre-proline 0 C--O 1.232 0.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.358 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.37 147.97 53.84 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.431 2.087 . . . . 0.0 109.902 163.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.13 107.77 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.74 18.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CZ2' ' HA ' ' A' ' 12' ' ' GLU . 93.2 m95 -89.16 175.86 7.2 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.506 1.522 . . . . 0.0 110.922 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.56 150.36 48.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 58.04 5.14 0.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.811 2.444 . . . . 0.0 115.242 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -76.98 177.37 7.81 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 92.61 3.84 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.62 -172.52 2.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.867 0.867 . . . . 0.0 110.149 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.17 154.98 0.15 Allowed Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.23 2.212 . . . . 0.0 110.457 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.06 154.95 88.18 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 120.035 1.048 . . . . 0.0 110.87 -7.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.21 171.59 8.83 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.123 1.216 . . . . 0.0 110.632 169.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.67 74.99 3.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.563 0.697 . . . . 0.0 109.576 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.63 53.9 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.812 2.045 . . . . 0.0 110.296 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.21 -3.84 36.46 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.252 1.406 . . . . 0.0 114.371 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -97.83 122.72 49.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -159.42 179.56 8.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 112.112 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -145.8 125.88 13.73 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.052 2.141 . . . . 0.0 107.88 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -111.44 104.96 13.44 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.317 1.047 . . . . 0.0 109.926 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.17 74.1 2.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.816 2.446 . . . . 0.0 110.96 -166.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -81.96 137.17 35.19 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.407 -0.808 . . . . 0.0 110.16 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.87 113.58 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 mtm -112.96 84.23 6.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.026 1.33 . . . . 0.0 111.261 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.7 158.94 55.29 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.765 2.977 . . . . 0.0 114.252 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 81.74 2.07 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.79 1.636 . . . . 0.0 110.213 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.54 15.68 5.98 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.134 0.974 . . . . 0.0 112.856 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.4 p -140.98 43.35 1.81 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.834 1.254 . . . . 0.0 110.693 -162.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.69 133.25 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.278 1.831 . . . . 0.0 107.247 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t 61.16 -173.27 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.027 2.931 . . . . 0.0 112.358 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -89.41 40.37 0.99 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.718 1.607 . . . . 0.0 109.088 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -143.51 169.55 17.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.8 76.33 1.29 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.51 -1.15 10.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.896 1.278 . . . . 0.0 112.028 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.9 14.27 16.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 124.686 1.136 . . . . 0.0 114.197 -172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t0 44.48 19.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.028 3.331 . . . . 0.0 112.824 -161.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.53 2.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.125 1.77 . . . . 0.0 114.992 -161.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.46 13.19 0.74 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -140.4 23.19 2.35 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 128.175 2.59 . . . . 0.0 111.74 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.11 79.33 0.23 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.566 1.174 . . . . 0.0 109.162 164.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -94.26 174.78 6.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.036 1.734 . . . . 0.0 107.483 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -173.68 46.49 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.36 144.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -113.65 150.85 32.6 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -139.12 137.15 35.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.595 1.558 . . . . 0.0 108.177 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.272 1.4 p -136.63 89.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 127.346 2.258 . . . . 0.0 107.69 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -78.15 99.14 6.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.2 127.9 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 125.114 1.366 . . . . 0.0 107.986 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.91 135.57 56.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.61 145.1 27.15 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.367 171.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.57 150.81 24.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.107 2.538 . . . . 0.0 111.363 -169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.2 mt -93.5 66.99 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.167 0.987 . . . . 0.0 108.515 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.78 60.52 0.62 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t70 45.06 92.31 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.773 3.229 . . . . 0.0 113.513 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.58 0.28 0.35 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.53 2.014 . . . . 0.0 111.941 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -3.29 0.62 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 130.525 3.53 . . . . 0.0 115.576 -166.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -86.82 14.85 6.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.619 -1.301 . . . . 0.0 113.077 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -63.85 -18.08 63.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.526 1.13 . . . . 0.0 113.956 -173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.19 68.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.194 1.398 . . . . 0.0 112.441 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.42 -50.53 67.24 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.902 0.774 . . . . 0.0 110.246 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.0 -55.95 8.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.998 1.319 . . . . 0.0 111.227 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.77 -34.29 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 117.749 -1.119 . . . . 0.0 110.143 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.199 1.363 . . . . 0.0 109.29 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.799 0.687 . . . . 0.0 111.487 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 22' ' ' ARG . 10.5 mt-10 -66.06 -42.85 88.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.054 1.297 . . . . 0.0 110.349 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -44.43 93.61 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.788 1.235 . . . . 0.0 110.263 173.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.91 -44.06 94.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.849 0.86 . . . . 0.0 110.109 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.33 -9.9 9.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.949 1.3 . . . . 0.0 112.812 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 18' ' ' TRP . 29.9 tp -107.9 -21.18 12.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.122 1.369 . . . . 0.0 112.299 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 99' ' ' LEU . 55.5 m-85 -129.27 80.95 71.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 119.935 1.243 . . . . 0.0 109.683 -174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.32 165.72 14.43 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.872 3.715 . . . . 0.0 113.384 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.17 -7.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.97 -46.35 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.007 0.923 . . . . 0.0 111.66 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 101' ' ' MET . 2.4 mm? 44.48 83.51 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.635 1.974 . . . . 0.0 110.887 -161.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 100' ' ' VAL . 11.8 m -78.31 53.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 123.206 1.479 . . . . 0.0 109.955 172.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.498 ' HG3' HD12 ' A' ' 99' ' ' LEU . 72.7 mtm -70.92 89.11 0.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.28 93.95 2.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 158.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.29 12.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 162.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.96 25.65 0.41 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.57 2.033 . . . . 0.0 116.375 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.28 -61.06 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -165.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.41 157.57 4.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.592 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.47 20.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.227 1.011 . . . . 0.0 110.367 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.77 167.06 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 166.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -148.51 128.05 13.2 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 162.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.64 -23.22 27.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.547 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 73.47 -31.72 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.652 1.581 . . . . 0.0 113.052 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 p -136.38 152.05 74.26 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.133 1.373 . . . . 0.0 110.07 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.29 160.72 46.39 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.734 2.29 . . . . 0.0 111.086 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 HD13 HD12 ' A' ' 132' ' ' LEU . 36.1 mm -53.02 139.66 10.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 154.09 48.38 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 162.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.92 169.46 18.02 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 108.675 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -133.52 171.71 21.84 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 121.867 -0.52 . . . . 0.0 112.478 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.75 145.28 97.66 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 124.694 1.197 . . . . 0.0 107.878 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.93 165.46 27.99 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.294 1.996 . . . . 0.0 111.727 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.9 t -118.16 5.37 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.689 0.796 . . . . 0.0 112.532 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 122' ' ' GLY 0.28 42.3 m 56.31 -173.95 0.06 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.291 1.436 . . . . 0.0 111.137 -176.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 121' ' ' THR . . . -170.19 -170.27 34.35 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 127.264 2.364 . . . . 0.0 107.687 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.94 -42.81 99.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.445 0.64 . . . . 0.0 112.066 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.49 21.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.121 1.768 . . . . 0.0 110.074 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.65 124.6 6.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -164.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -83.67 162.98 20.56 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.608 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.63 126.05 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.41 2.284 . . . . 0.0 105.734 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.19 144.22 27.68 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 161.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.31 127.72 9.26 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.326 2.684 . . . . 0.0 108.745 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 mt -139.42 129.57 31.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 p -173.26 157.72 3.44 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.161 1.384 . . . . 0.0 110.885 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -147.36 159.84 43.22 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.942 1.697 . . . . 0.0 110.028 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.27 82.55 0.35 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.845 0.748 . . . . 0.0 112.093 -167.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -71.08 169.77 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.159 1.784 . . . . 0.0 112.818 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.68 -172.82 3.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.916 160.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.88 154.15 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.485 1.914 . . . . 0.0 106.797 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -145.48 172.56 13.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.342 1.857 . . . . 0.0 106.403 167.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -81.63 -11.7 59.0 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.522 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.7 t80 51.33 67.09 4.54 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.315 1.846 . . . . 0.0 112.032 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.21 121.61 9.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.703 2.269 . . . . 0.0 109.96 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 . . . . . 0 C--O 1.247 0.969 0 C-N-CA 124.546 1.139 . . . . 0.0 108.78 166.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt 53.42 -163.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.676 -164.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m 48.41 43.35 19.52 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 111.587 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -59.94 0.65 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.16 0.984 . . . . 0.0 111.626 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -70.11 -18.53 63.25 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.899 1.227 . . . . 0.0 111.344 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 105' ' ' GLY . 27.1 mt -69.41 -44.16 71.94 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.68 1.192 . . . . 0.0 110.64 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 106' ' ' LEU . 43.9 mm -52.55 -63.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.818 1.647 . . . . 0.0 108.972 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -57.99 -41.77 83.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.9 -32.76 68.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.617 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 103' ' ' SER . . . -57.88 -32.78 68.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.069 0.849 . . . . 0.0 112.096 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -70.68 -55.13 9.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.75 -33.28 73.79 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.182 -0.949 . . . . 0.0 112.497 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.212 1.005 . . . . 0.0 110.1 175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -100.51 -61.0 1.42 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.391 0.996 . . . . 0.0 110.241 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.89 -37.89 83.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.603 0.761 . . . . 0.0 112.301 -171.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -62.51 -43.29 99.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.957 0.799 . . . . 0.0 109.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -5.23 28.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -95.42 -53.62 3.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.307 1.443 . . . . 0.0 109.907 164.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.28 -41.34 93.16 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.474 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -28.28 62.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.904 0.774 . . . . 0.0 112.367 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.49 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 111.528 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 HH11 HD11 ' A' ' 26' ' ' LEU . 2.9 mtp180 -58.53 159.87 6.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.506 174.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.8 m -74.79 -52.23 3.56 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.851 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.06 -15.79 47.58 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.15 1.446 . . . . 0.0 111.797 169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 48.78 93.46 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.895 2.478 . . . . 0.0 111.777 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HH11 ' A' ' 22' ' ' ARG . 95.7 mt -85.83 159.79 54.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 111.678 -164.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 174.29 12.92 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.207 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.56 117.35 17.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -109.3 95.32 5.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -65.46 115.59 5.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.241 167.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 45.71 -85.09 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.07 17.69 2.81 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.621 1.568 . . . . 0.0 110.513 -171.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.4 t -64.75 173.14 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.613 1.165 . . . . 0.0 112.371 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 113.1 1.5 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.4 -164.13 1.8 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.098 2.159 . . . . 0.0 106.672 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 77.74 151.75 0.13 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.861 2.464 . . . . 0.0 109.233 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.1 173.4 34.11 Favored 'Cis proline' 0 CA--C 1.544 0.994 0 CA-C-N 118.608 0.539 . . . . 0.0 111.099 -13.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.09 170.21 17.51 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 120.922 1.081 . . . . 0.0 109.968 163.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.31 72.59 4.52 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.84 75.09 0.18 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.683 1.993 . . . . 0.0 111.738 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.6 54.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.905 1.241 . . . . 0.0 114.55 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 130.04 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.015 1.326 . . . . 0.0 107.716 -173.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -158.45 -176.06 5.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.898 0.879 . . . . 0.0 109.635 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mt -145.85 109.41 4.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.415 1.086 . . . . 0.0 110.929 -169.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.63 101.61 13.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.75 86.0 5.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.741 . . . . 0.0 108.495 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -90.21 107.54 19.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.139 -0.976 . . . . 0.0 109.46 -175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 ' HD3' ' A' ' 50' ' ' PRO . 87.9 t -75.69 139.92 18.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.0 mtm -130.3 85.06 57.89 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.647 ' HD3' HG12 ' A' ' 48' ' ' VAL . 56.7 Cg_endo -64.16 171.68 7.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.186 2.591 . . . . 0.0 112.236 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.66 132.2 54.4 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.252 1.821 . . . . 0.0 110.408 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 89.02 1.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.076 0.951 . . . . 0.0 109.02 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -67.52 158.23 32.43 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.807 173.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.2 mt -89.22 128.64 41.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -150.98 168.83 23.36 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.643 1.977 . . . . 0.0 107.043 164.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -121.63 4.58 10.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -167.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.68 153.19 10.55 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 128.346 2.658 . . . . 0.0 104.795 -163.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.51 11.86 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.104 1.762 . . . . 0.0 114.988 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.32 170.9 0.07 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.846 2.858 . . . . 0.0 112.99 -164.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.85 34.19 4.66 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.293 1.425 . . . . 0.0 109.782 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.27 132.03 17.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -158.27 -36.28 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.429 159.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -155.38 26.78 0.4 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.782 -169.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -131.58 7.53 4.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 0.0 113.664 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.39 136.18 33.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.402 0.681 . . . . 0.0 109.543 -174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -175.69 -162.85 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.652 2.381 . . . . 0.0 107.7 -172.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.69 -160.51 23.94 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 163.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 159.08 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.01 125.62 31.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -117.01 124.19 48.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.632 1.973 . . . . 0.0 106.365 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.19 123.14 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -112.35 96.3 5.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.67 118.78 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 157.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.6 p -112.21 134.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 ptp -144.45 152.63 53.92 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.277 1.431 . . . . 0.0 108.074 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.17 168.04 23.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.928 2.418 . . . . 0.0 110.74 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.1 64.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.8 -121.5 3.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 166.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.1 -5.4 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.775 1.274 . . . . 0.0 112.5 -172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.09 20.68 9.71 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.341 1.924 . . . . 0.0 113.054 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -66.51 -179.3 0.81 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.816 1.308 . . . . 0.0 109.852 166.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 62.98 -5.07 0.22 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.704 2.002 . . . . 0.0 114.455 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 t -57.96 -15.29 8.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.526 1.53 . . . . 0.0 112.424 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -44.14 -41.78 5.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.398 1.879 . . . . 0.0 112.01 167.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -71.04 -53.07 16.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.186 0.994 . . . . 0.0 109.836 -173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -52.56 -48.25 66.29 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.124 1.37 . . . . 0.0 111.487 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.57 -42.82 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.36 68.99 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.099 1.318 . . . . 0.0 112.418 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.53 55.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 123.56 0.538 . . . . 0.0 109.891 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.29 -52.71 63.59 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 122.207 -0.308 . . . . 0.0 111.463 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.92 -36.71 72.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.412 1.085 . . . . 0.0 112.128 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.32 -52.63 61.11 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.369 1.068 . . . . 0.0 110.899 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.78 73.97 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 122.52 0.328 . . . . 0.0 111.314 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.35 -39.7 67.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.497 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 99' ' ' LEU . 81.4 m-85 -111.67 82.62 3.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.782 1.233 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.87 160.68 42.94 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.238 2.625 . . . . 0.0 111.689 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.44 -5.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 127.873 2.469 . . . . 0.0 116.606 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.62 -39.46 6.08 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.895 -1.128 . . . . 0.0 109.181 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD22 ' HB ' ' A' ' 110' ' ' VAL . 3.1 tp 43.77 38.65 2.14 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.368 2.667 . . . . 0.0 114.46 167.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.02 112.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 167.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.1 mtm -122.68 83.37 2.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.81 150.99 35.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.365 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 6.8 t -153.04 178.75 9.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.57 -38.0 51.14 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.699 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.6 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -70.73 -57.26 6.6 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.055 1.428 . . . . 0.0 110.665 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 7' ' ' ILE . 1.4 pt? 174.63 -174.43 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.497 2.719 . . . . 0.0 107.3 -159.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.09 173.47 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.768 1.227 . . . . 0.0 111.796 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.62 170.69 6.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 O-C-N 120.89 -1.131 . . . . 0.0 108.045 171.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -141.13 143.67 34.41 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 162.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.64 ' HB ' HD22 ' A' ' 99' ' ' LEU . 13.7 p -63.63 -21.03 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 68.65 -24.54 0.14 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 128.826 2.85 . . . . 0.0 114.95 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 p -137.71 162.22 55.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 126.549 1.94 . . . . 0.0 108.376 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.87 163.52 38.06 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.377 1.384 . . . . 0.0 110.195 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.63 137.74 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 109.212 173.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.34 148.58 40.45 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.134 1.374 . . . . 0.0 109.082 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -151.13 140.98 21.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.603 2.361 . . . . 0.0 107.496 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -138.21 179.65 18.11 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.2 155.23 93.78 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.83 150.16 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.717 1.611 . . . . 0.0 110.94 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 t -89.94 3.9 51.68 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 122' ' ' GLY 0.265 7.2 m 49.59 -169.86 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.26 1.824 . . . . 0.0 110.874 -167.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.43 -162.19 24.17 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.7 -56.42 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.853 0.861 . . . . 0.0 110.283 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.39 21.21 1.7 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.824 2.049 . . . . 0.0 109.797 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.63 153.01 42.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -167.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -111.71 159.63 18.05 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 164.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 113.68 6.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 128.254 2.622 . . . . 0.0 106.215 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 144.08 74.86 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.38 116.34 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.347 3.364 . . . . 0.0 110.069 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -139.59 127.97 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 p -160.72 167.48 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.276 0.63 . . . . 0.0 111.029 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -147.9 160.93 42.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.621 1.568 . . . . 0.0 110.783 171.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.29 67.7 0.55 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 123.568 0.604 . . . . 0.0 113.591 -160.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -64.12 156.84 27.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.618 1.967 . . . . 0.0 113.216 -167.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.259 0.2 OUTLIER -128.88 156.02 44.33 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.741 0.817 . . . . 0.0 111.436 164.287 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.5 t -80.49 142.28 14.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -136.13 162.8 31.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.528 0.731 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -143.77 141.49 30.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -130.4 150.9 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.69 65.97 8.87 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.418 2.746 . . . . 0.0 110.172 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.241 0.635 0 C-N-CA 128.066 2.546 . . . . 0.0 111.566 -157.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.3 mtp -72.13 -24.64 61.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.029 1.914 . . . . 0.0 111.132 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m 64.73 -66.18 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.109 2.163 . . . . 0.0 113.419 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -32.5 38.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.066 1.746 . . . . 0.0 113.888 -171.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.34 -49.94 74.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.676 1.591 . . . . 0.0 112.055 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -69.16 -46.84 66.57 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.483 -173.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.33 -55.55 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 117.332 -1.318 . . . . 0.0 111.231 168.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -47.77 -46.34 30.16 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.923 1.238 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.92 -22.08 46.93 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -83.66 -44.74 14.2 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.985 1.72 . . . . 0.0 111.181 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.35 -51.8 68.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.474 1.11 . . . . 0.0 108.432 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -61.38 -40.42 94.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.078 0.951 . . . . 0.0 111.028 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.76 -51.89 66.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 108.402 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.02 -46.78 70.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.289 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' CH2' ' A' ' 30' ' ' TRP . 61.4 tp -63.31 -53.64 49.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.932 0.787 . . . . 0.0 110.74 -175.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 t -67.99 -35.78 78.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.683 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -64.37 -21.19 66.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.185 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -74.13 -58.8 3.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.79 1.632 . . . . 0.0 108.976 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.84 -24.7 66.18 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 117.731 -1.128 . . . . 0.0 113.291 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -19.32 47.31 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.902 1.228 . . . . 0.0 112.552 170.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.45 -9.54 24.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.089 1.355 . . . . 0.0 112.689 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.55 HH12 ' CD ' ' A' ' 90' ' ' GLU 0.345 0.0 OUTLIER -63.11 159.22 17.83 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 112.964 163.608 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -61.22 -67.89 0.95 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.806 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.05 -24.46 32.92 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.339 1.514 . . . . 0.0 111.038 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.63 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.278 3.031 . . . . 0.0 112.802 -167.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -136.78 144.54 47.25 Favored Pre-proline 0 C--N 1.333 -0.119 0 O-C-N 120.768 -1.207 . . . . 0.0 108.165 -176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.11 151.0 26.67 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.61 1.54 . . . . 0.0 109.662 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 92.04 2.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.28 98.74 10.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 122.771 0.428 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.406 ' CH2' HD23 ' A' ' 15' ' ' LEU . 77.2 m95 -73.26 97.81 2.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 49.5 -75.05 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.827 2.851 . . . . 0.0 114.688 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -127.05 4.88 6.47 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.667 1.576 . . . . 0.0 112.759 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 m -59.22 157.66 10.27 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.689 1.195 . . . . 0.0 112.321 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -61.22 80.2 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.652 2.781 . . . . 0.0 114.406 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.27 80.03 0.97 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.293 0.952 . . . . 0.0 112.02 -172.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.56 144.55 10.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 108.819 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.5 162.08 79.78 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 CA-C-N 120.551 1.232 . . . . 0.0 114.41 11.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -173.05 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.659 3.573 . . . . 0.0 112.353 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.58 62.83 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.23 33.29 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.791 0.682 . . . . 0.0 110.301 -162.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.93 90.7 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.791 0.676 . . . . 0.0 114.791 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.46 119.39 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.656 1.182 . . . . 0.0 109.267 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -164.76 166.33 19.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.95 0.9 . . . . 0.0 113.091 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.59 99.95 5.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.289 2.236 . . . . 0.0 109.544 -169.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 91.49 6.9 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.186 0.994 . . . . 0.0 109.114 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.64 137.13 51.96 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -136.06 126.59 26.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.08 135.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.3 mtt -125.34 77.56 68.15 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.02 131.96 21.94 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.905 1.737 . . . . 0.0 108.654 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.3 168.63 15.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.571 -0.705 . . . . 0.0 110.385 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 52.81 74.15 0.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.061 2.144 . . . . 0.0 113.234 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -71.1 116.35 11.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -130.6 159.39 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.51 1.524 . . . . 0.0 107.167 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 m -142.17 176.03 9.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.43 2.292 . . . . 0.0 108.482 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER 46.03 39.86 6.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.608 1.563 . . . . 0.0 112.923 -172.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -148.28 171.04 16.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.804 1.642 . . . . 0.0 107.343 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.97 29.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.914 1.286 . . . . 0.0 110.084 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.7 -163.25 1.46 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.924 1.69 . . . . 0.0 109.877 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.08 -76.29 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 106.127 -2.789 . . . . 0.0 106.127 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.01 -68.25 0.13 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 130.576 3.551 . . . . 0.0 107.226 -175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.59 -178.21 4.63 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.755 1.622 . . . . 0.0 112.937 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 177.22 0.25 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.913 2.085 . . . . 0.0 111.454 166.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.46 134.98 47.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.381 1.072 . . . . 0.0 109.309 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.58 152.79 39.23 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 163.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -166.67 -176.5 3.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.208 1.803 . . . . 0.0 109.558 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.78 -171.27 43.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.427 0.558 . . . . 0.0 113.094 163.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.98 149.34 25.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 162.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -122.84 147.66 46.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -141.2 144.09 34.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.04 94.86 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 167.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -79.4 91.68 5.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.57 131.51 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -117.02 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 126.759 2.024 . . . . 0.0 105.749 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.55 151.74 54.83 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 163.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.59 150.59 40.53 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.287 1.991 . . . . 0.0 109.68 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.1 73.54 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.32 -71.27 1.16 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -130.64 85.47 2.28 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.8 -9.88 0.26 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.938 1.732 . . . . 0.0 115.15 -177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 p 45.06 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 129.369 3.068 . . . . 0.0 113.788 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -96.53 -4.43 41.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.235 0.614 . . . . 0.0 111.759 -172.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -13.05 10.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.76 -27.82 60.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.852 1.205 . . . . 0.0 112.009 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.07 -35.05 64.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 110.846 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -58.64 5.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.213 165.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.71 -41.05 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.91 0.884 . . . . 0.0 111.69 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.65 78.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.756 0.707 . . . . 0.0 111.342 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.48 28.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.086 0.403 . . . . 0.0 110.226 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.55 ' CD ' HH12 ' A' ' 22' ' ' ARG . 5.4 mm-40 -62.25 -52.99 61.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.89 1.276 . . . . 0.0 110.84 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.19 -42.27 98.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.246 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.92 -55.22 37.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.597 1.09 . . . . 0.0 110.569 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.66 -11.87 29.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 0.0 112.457 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -88.24 -36.89 16.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.139 0.976 . . . . 0.0 110.522 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -110.43 80.77 2.09 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.479 1.512 . . . . 0.0 111.67 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.93 169.91 21.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.105 3.203 . . . . 0.0 111.845 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.42 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 114.523 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -124.97 -42.46 2.03 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.644 1.978 . . . . 0.0 111.46 -172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.457 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 mp 44.52 61.28 2.49 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.979 1.312 . . . . 0.0 111.427 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.4 85.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 69.2 mtm -106.93 99.07 8.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -73.28 147.35 44.61 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.68 169.02 21.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.461 0.704 . . . . 0.0 110.703 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.54 15.9 0.14 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.649 2.071 . . . . 0.0 116.177 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -138.53 -55.51 0.05 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -171.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 177.55 -175.3 0.15 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.279 1.832 . . . . 0.0 108.243 -159.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.17 -178.34 3.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.861 2.465 . . . . 0.0 111.195 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.21 167.34 13.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -138.75 151.86 47.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 155.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 99' ' ' LEU . 11.6 p -69.44 -19.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.535 -0.728 . . . . 0.0 110.654 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 69.83 -42.34 0.51 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 127.092 2.157 . . . . 0.0 112.852 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.2 p -128.59 162.14 52.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.964 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.41 165.17 25.75 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.31 1.34 . . . . 0.0 109.921 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 132' ' ' LEU . 10.7 mm -61.67 148.28 10.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.71 174.0 10.57 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 167.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -157.86 144.31 17.67 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.011 2.124 . . . . 0.0 105.926 -163.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.33 172.69 23.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.844 1.202 . . . . 0.0 112.81 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -62.42 144.82 95.12 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.17 172.33 6.44 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.883 1.722 . . . . 0.0 111.477 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -135.85 11.29 3.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.279 1.031 . . . . 0.0 111.156 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 122' ' ' GLY 0.252 1.2 m 63.19 -165.84 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.169 1.388 . . . . 0.0 111.561 168.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.99 -167.98 33.64 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 129.243 3.306 . . . . 0.0 107.135 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -64.15 -56.12 17.05 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 0.0 109.993 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.14 24.82 1.03 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.235 1.814 . . . . 0.0 109.697 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -133.39 141.73 48.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.71 151.63 23.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.61 130.67 34.79 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.56 144.44 28.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 126.352 1.861 . . . . 0.0 108.093 170.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.45 131.27 12.52 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.434 2.756 . . . . 0.0 109.838 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.76 131.31 28.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 160.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.6 p -168.72 162.74 11.83 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.367 1.467 . . . . 0.0 109.839 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.584 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -152.39 160.3 43.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.411 2.284 . . . . 0.0 110.117 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.91 92.02 0.57 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -78.91 167.44 21.13 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.947 1.299 . . . . 0.0 112.536 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.61 178.86 7.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.323 1.449 . . . . 0.0 110.794 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.2 p -99.68 155.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -164.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -136.08 160.05 39.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 122.093 0.949 . . . . 0.0 110.869 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.36 157.74 36.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -154.13 158.18 32.43 Favored Pre-proline 0 N--CA 1.442 -0.844 0 C-N-CA 123.992 0.917 . . . . 0.0 109.292 175.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.32 172.49 13.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.996 2.464 . . . . 0.0 111.358 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 126.408 1.883 . . . . 0.0 107.556 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.63 -164.57 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 117.995 0.897 . . . . 0.0 109.821 -164.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 62.98 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.687 1.595 . . . . 0.0 112.645 163.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -55.5 -31.3 61.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.472 1.487 . . . . 0.0 111.274 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.23 -51.31 55.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.804 0.842 . . . . 0.0 111.378 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.8 mm? -62.29 -46.79 87.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.198 0.999 . . . . 0.0 110.822 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 106' ' ' LEU . 5.8 mt -56.4 -42.8 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 118.337 -0.84 . . . . 0.0 111.402 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -56.6 -55.14 37.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.09 74.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.587 0.755 . . . . 0.0 112.221 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.261 1.024 . . . . 0.0 112.568 -172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.46 -51.33 63.59 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.19 -28.9 68.33 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.187 0.995 . . . . 0.0 111.904 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.58 -18.96 62.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.785 1.634 . . . . 0.0 111.837 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmt-85 -104.76 -44.97 4.71 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.174 166.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -59.67 3.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.808 1.185 . . . . 0.0 110.987 -169.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.1 -45.03 87.9 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.28 -22.15 66.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.279 1.831 . . . . 0.0 112.54 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -85.96 -47.49 9.57 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.51 -1.369 . . . . 0.0 110.02 168.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.92 85.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.247 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -28.85 68.77 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 113.533 174.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.6 44.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.786 0.834 . . . . 0.0 111.355 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -64.59 166.67 8.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.501 0.721 . . . . 0.0 111.242 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 m -66.26 -69.15 0.59 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.0 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.65 -6.51 16.88 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.609 1.967 . . . . 0.0 115.34 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 93.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 129.301 3.04 . . . . 0.0 113.957 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.09 148.59 48.14 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -165.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 153.71 59.59 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.592 2.861 . . . . 0.0 110.819 159.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.98 101.85 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -169.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.18 103.76 15.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.037 1.335 . . . . 0.0 111.117 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -75.87 97.58 3.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.62 0.768 . . . . 0.0 109.771 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 58.62 -85.07 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.476 1.911 . . . . 0.0 112.708 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -130.11 1.45 4.72 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.891 2.076 . . . . 0.0 110.961 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -55.57 132.85 49.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 170.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 145.84 33.41 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.687 1.242 . . . . 0.0 112.35 -163.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -166.89 172.74 10.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.59 1.556 . . . . 0.0 108.596 -165.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 37' ' ' PRO 0.279 0.4 OUTLIER 81.61 144.97 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.552 2.741 . . . . 0.0 111.009 172.251 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 36' ' ' THR . 70.6 Cg_endo -69.32 159.71 87.87 Favored 'Cis proline' 0 C--N 1.349 0.568 0 CA-C-N 119.789 0.96 . . . . 0.0 111.455 5.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.14 -176.27 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.825 2.35 . . . . 0.0 112.726 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 -26.72 57.82 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.62 30.27 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.281 0.988 . . . . 0.0 109.804 -160.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 -28.34 2.01 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.095 1.331 . . . . 0.0 113.564 -160.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.9 140.61 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 127.962 2.505 . . . . 0.0 110.916 -175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -163.26 -175.38 4.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.772 0.829 . . . . 0.0 111.617 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -128.19 142.98 51.01 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 127.495 2.318 . . . . 0.0 105.915 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -127.64 106.18 8.98 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.107 1.363 . . . . 0.0 107.79 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 69' ' ' PHE . . . -109.65 131.17 55.3 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.14 97.59 4.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.268 1.027 . . . . 0.0 109.035 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.9 120.18 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.872 1.669 . . . . 0.0 106.913 167.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 mtm -116.23 85.59 15.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 126.926 2.09 . . . . 0.0 106.179 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.0 154.81 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.711 2.274 . . . . 0.0 110.625 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -44.74 103.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.001 1.721 . . . . 0.0 112.543 -168.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.99 62.2 1.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 109.105 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 156.49 17.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 152.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.62 170.32 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 -167.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t 65.41 -154.38 0.27 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.763 0.825 . . . . 0.0 109.838 173.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -91.02 23.65 3.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 112.667 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.55 -169.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.663 1.985 . . . . 0.0 110.265 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.78 82.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.79 -168.68 1.08 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.929 2.091 . . . . 0.0 111.938 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.89 177.92 17.82 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.58 1.562 . . . . 0.0 109.453 164.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -155.35 -82.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.838 1.655 . . . . 0.0 107.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -36.83 69.11 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -161.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -176.6 122.63 0.15 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.031 2.132 . . . . 0.0 107.62 -166.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -154.73 149.94 27.06 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.992 1.317 . . . . 0.0 108.491 167.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -144.21 8.95 1.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.733 0.813 . . . . 0.0 111.224 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 66' ' ' ARG . 3.1 mtp180 -65.21 85.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.712 2.005 . . . . 0.0 108.85 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.23 -169.61 13.11 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 125.175 1.369 . . . . 0.0 110.609 -167.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.87 161.82 40.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 29.5 t80 -142.93 112.57 6.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.57 143.05 36.83 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.79 95.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 122.339 1.066 . . . . 0.0 109.067 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.66 161.34 13.71 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.174 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.42 96.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 -166.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.69 132.18 32.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.74 148.16 59.86 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.218 -0.927 . . . . 0.0 108.59 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.14 154.96 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.928 3.086 . . . . 0.0 111.819 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.39 71.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.26 3.1 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -148.2 118.92 7.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.26 -67.53 3.6 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.085 0.85 . . . . 0.0 112.448 173.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t 69.0 44.41 1.02 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.236 2.214 . . . . 0.0 110.863 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -95.9 12.89 28.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.822 1.649 . . . . 0.0 112.178 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -72.51 -5.3 35.99 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.97 -55.72 29.29 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.496 1.118 . . . . 0.0 111.608 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.65 -27.87 69.52 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 111.897 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -63.23 1.23 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.74 1.616 . . . . 0.0 110.017 170.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.45 -40.97 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 0.0 110.028 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.15 69.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.205 0.911 . . . . 0.0 111.928 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.14 -29.24 48.68 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.063 0.392 . . . . 0.0 111.766 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.84 -49.56 20.16 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.434 -0.791 . . . . 0.0 110.426 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.34 -55.55 20.8 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.199 1.8 . . . . 0.0 112.012 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 114' ' ' ILE . 10.2 t0 -58.09 -41.87 84.41 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.34 0.656 . . . . 0.0 111.576 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.71 -6.82 28.48 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -109.99 -18.23 13.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.617 1.567 . . . . 0.0 110.894 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.608 ' HD2' HD11 ' A' ' 99' ' ' LEU . 96.7 m-85 -124.54 56.22 11.88 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.659 1.183 . . . . 0.0 112.46 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.42 170.31 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.349 2.7 . . . . 0.0 112.287 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 p -63.61 -7.35 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -158.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -47.9 6.7 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.949 -1.095 . . . . 0.0 110.159 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD11 ' HD2' ' A' ' 95' ' ' PHE . 1.2 tp 55.52 31.05 16.31 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.942 1.697 . . . . 0.0 115.441 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.3 t -60.67 116.98 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.94 0.791 . . . . 0.0 110.347 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mtm -128.02 88.42 2.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -68.79 116.44 9.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.86 19.08 3.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -166.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.93 -13.05 45.62 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.563 1.077 . . . . 0.0 113.508 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.01 -79.09 0.99 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.14 -167.67 2.21 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.876 2.07 . . . . 0.0 110.161 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.54 83.25 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.905 2.482 . . . . 0.0 109.383 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -57.79 159.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.161 1.384 . . . . 0.0 111.458 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.2 160.3 40.4 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.645 1.178 . . . . 0.0 111.122 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.84 -21.89 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.211 2.204 . . . . 0.0 113.297 175.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 65.84 -55.74 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.233 1.813 . . . . 0.0 113.672 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.1 p -117.81 155.7 50.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 119.965 1.257 . . . . 0.0 110.293 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 161.63 41.75 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.277 1.985 . . . . 0.0 110.567 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 132' ' ' LEU . 25.5 mm -58.2 124.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.15 1.38 . . . . 0.0 109.967 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 156.14 21.73 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.567 1.175 . . . . 0.0 111.248 173.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -149.41 153.76 37.84 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.662 2.385 . . . . 0.0 108.989 -163.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.31 172.51 44.9 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.627 2.061 . . . . 0.0 108.604 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.78 150.45 97.63 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.305 0.642 . . . . 0.0 109.789 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -66.05 159.71 48.06 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.617 1.545 . . . . 0.0 112.307 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 t -111.92 165.97 11.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 163.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.7 m -105.39 155.47 19.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.58 -137.26 6.17 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.397 1.951 . . . . 0.0 108.902 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.85 -48.86 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.75 25.59 1.3 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 128.763 2.825 . . . . 0.0 108.701 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.43 168.64 19.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.537 1.935 . . . . 0.0 107.771 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -127.71 175.81 8.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.369 1.068 . . . . 0.0 108.911 165.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.47 138.04 13.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.12 2.168 . . . . 0.0 107.639 -177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 143.8 27.1 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 125.187 1.395 . . . . 0.0 110.666 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.15 99.14 1.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.818 2.345 . . . . 0.0 109.008 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.12 121.43 57.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 169.76 19.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.043 0.937 . . . . 0.0 109.396 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -144.25 169.0 18.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.423 1.089 . . . . 0.0 110.492 164.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.96 86.0 0.3 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.395 0.998 . . . . 0.0 113.014 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -64.47 163.87 12.59 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 127.431 2.293 . . . . 0.0 112.199 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.42 -14.66 3.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.197 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 73.8 t 54.91 162.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.746 1.618 . . . . 0.0 109.959 -156.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -145.11 153.59 41.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 163.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -147.71 130.63 16.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -64.01 162.02 34.13 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 162.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -56.21 143.04 86.44 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 162.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 147.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.41 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.1 mtt 60.9 -63.76 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.802 2.441 . . . . 0.0 111.089 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m 67.32 -65.77 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.342 2.257 . . . . 0.0 109.43 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -44.55 -50.79 9.43 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 129.16 2.984 . . . . 0.0 111.05 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.66 -34.67 71.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 111.075 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -81.79 -32.63 31.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.772 1.229 . . . . 0.0 110.877 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -58.73 -43.16 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -62.67 -47.87 81.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.619 0.645 . . . . 0.0 110.135 171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.38 -29.42 68.92 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 -45.57 77.89 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -62.9 -42.5 99.8 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.766 0.826 . . . . 0.0 110.35 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -57.25 -43.44 82.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.65 1.98 . . . . 0.0 111.064 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.785 1.234 . . . . 0.0 111.938 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.09 -62.75 1.46 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.655 0.661 . . . . 0.0 110.176 161.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -54.51 44.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.911 0.323 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -62.42 -40.01 95.16 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.905 0.32 . . . . 0.0 110.267 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.83 -36.05 81.47 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 122.296 0.238 . . . . 0.0 111.062 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -69.11 -48.77 61.68 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.817 0.447 . . . . 0.0 110.633 169.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.29 -35.99 76.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.803 0.441 . . . . 0.0 111.675 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -76.61 -37.87 55.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.337 0.655 . . . . 0.0 111.007 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.61 -13.85 60.04 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.951 0.901 . . . . 0.0 112.765 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 166.93 5.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.971 0.805 . . . . 0.0 110.105 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -52.5 -72.98 0.16 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.733 -1.127 . . . . 0.0 111.759 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.19 -16.73 31.65 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.812 1.683 . . . . 0.0 113.534 -168.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.19 158.07 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.807 2.443 . . . . 0.0 112.577 -148.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.4 mt -143.13 157.52 60.29 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 110.397 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.48 166.79 22.61 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.241 1.961 . . . . 0.0 111.528 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -133.17 104.79 7.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 104.13 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -63.98 -164.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.238 1.015 . . . . 0.0 111.379 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -44.63 -65.51 0.51 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.293 -0.879 . . . . 0.0 111.561 164.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -144.7 66.27 1.26 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.534 1.933 . . . . 0.0 106.872 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -102.02 176.31 5.25 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.345 -0.847 . . . . 0.0 110.969 168.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.85 42.62 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.967 1.707 . . . . 0.0 114.78 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -74.52 173.24 10.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.439 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 86.48 150.27 0.09 OUTLIER Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 129.21 3.004 . . . . 0.0 109.124 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 168.22 68.55 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.525 0.866 . . . . 0.0 113.697 0.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 -171.51 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.631 3.554 . . . . 0.0 112.007 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.83 79.78 1.35 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.207 1.803 . . . . 0.0 108.358 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 49.28 61.7 3.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.257 1.423 . . . . 0.0 111.998 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 -7.65 48.07 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.669 1.604 . . . . 0.0 114.063 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -103.96 141.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.781 1.632 . . . . 0.0 108.01 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -171.55 179.73 2.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.155 1.382 . . . . 0.0 108.571 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.7 mt -135.73 152.02 50.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.307 1.443 . . . . 0.0 107.634 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -131.93 98.19 4.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.96 70.35 4.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.12 3.368 . . . . 0.0 108.564 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.89 126.06 30.19 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.966 -1.084 . . . . 0.0 108.121 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -102.53 139.68 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -125.48 78.49 68.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 125.779 1.632 . . . . 0.0 108.26 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.86 156.42 66.17 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.666 2.244 . . . . 0.0 112.103 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.19 164.73 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.452 1.101 . . . . 0.0 110.969 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.11 31.89 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.031 0.932 . . . . 0.0 112.687 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.59 68.24 1.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.246 -0.909 . . . . 0.0 110.821 -169.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.4 mt -135.28 141.43 42.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.2 m -70.92 -165.66 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.14 1.776 . . . . 0.0 111.972 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -129.6 24.99 5.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.899 2.08 . . . . 0.0 108.511 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -141.41 171.53 13.93 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.529 1.932 . . . . 0.0 108.772 -151.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 38.76 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.347 1.059 . . . . 0.0 111.243 168.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.36 -0.54 1.9 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.229 2.212 . . . . 0.0 113.876 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.77 -25.27 8.73 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.324 1.44 . . . . 0.0 112.629 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 46.43 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 131.029 3.732 . . . . 0.0 111.665 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -57.23 -35.75 70.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.061 -170.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.89 137.35 11.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.57 1.548 . . . . 0.0 110.057 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -72.27 -175.98 1.7 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.418 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.3 136.65 57.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 111.637 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -140.32 -177.01 4.83 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.975 1.71 . . . . 0.0 110.431 -174.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.66 20.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 149.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.02 154.05 26.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -129.94 137.22 50.23 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.82 131.85 46.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.15 1.78 . . . . 0.0 106.377 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.14 94.42 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 125.538 1.535 . . . . 0.0 107.256 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -84.23 97.15 9.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.14 132.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.66 147.85 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.251 1.42 . . . . 0.0 107.866 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 152.76 45.62 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.32 157.32 33.21 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.45 2.767 . . . . 0.0 109.74 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.39 68.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.2 -116.32 3.76 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 106.051 -2.82 . . . . 0.0 106.051 163.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -120.74 -5.61 9.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.726 1.21 . . . . 0.0 112.381 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.56 16.3 59.44 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.888 2.185 . . . . 0.0 112.092 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 p -64.94 174.22 2.0 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.323 1.449 . . . . 0.0 109.31 169.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 63.39 -26.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.042 2.537 . . . . 0.0 114.03 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.72 2.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.115 2.166 . . . . 0.0 115.233 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -56.12 -41.05 74.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.872 1.215 . . . . 0.0 111.222 161.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -57.14 -43.92 82.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.373 1.469 . . . . 0.0 109.67 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -61.17 2.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.173 2.189 . . . . 0.0 109.985 172.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 91' ' ' LEU . 21.4 t -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 117.585 -1.198 . . . . 0.0 110.651 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.13 67.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.058 0.844 . . . . 0.0 111.129 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.34 -37.6 52.03 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.67 -40.32 80.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.818 0.735 . . . . 0.0 111.12 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 87' ' ' VAL . 8.4 mt -55.24 -53.89 50.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.47 1.508 . . . . 0.0 108.844 171.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.48 -36.97 79.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.954 1.302 . . . . 0.0 111.639 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.28 66.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.139 0.976 . . . . 0.0 112.792 173.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.75 -34.64 22.8 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.047 0.939 . . . . 0.0 110.462 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -123.26 59.44 14.75 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 126.86 2.064 . . . . 0.0 111.043 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.27 165.12 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.633 1.555 . . . . 0.0 110.239 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.46 ' HA ' HG11 ' A' ' 110' ' ' VAL . 9.4 p -52.86 -2.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.846 2.858 . . . . 0.0 115.341 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.75 -45.98 5.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.743 1.617 . . . . 0.0 110.604 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tp 49.9 28.83 3.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.534 2.334 . . . . 0.0 115.49 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.5 t -62.66 124.71 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.767 0.712 . . . . 0.0 109.814 -166.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -151.96 166.34 31.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.335 1.454 . . . . 0.0 110.421 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.9 158.05 44.7 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.264 1.826 . . . . 0.0 108.968 165.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -145.42 -170.48 3.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.47 -26.08 58.98 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.596 1.57 . . . . 0.0 113.64 -169.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.57 -84.29 0.7 Allowed Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -170.95 3.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.782 1.633 . . . . 0.0 110.047 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.63 164.67 15.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.77 153.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.76 1.224 . . . . 0.0 107.912 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -142.66 154.66 44.55 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.452 1.478 . . . . 0.0 108.854 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 132' ' ' LEU . 9.1 p -66.38 -22.61 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.646 1.178 . . . . 0.0 113.33 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.71 -69.06 0.11 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.519 2.328 . . . . 0.0 111.08 -177.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -80.05 164.6 51.88 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 126.811 2.044 . . . . 0.0 108.756 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -67.14 179.41 2.38 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.484 1.456 . . . . 0.0 109.299 157.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -54.04 158.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.328 1.051 . . . . 0.0 108.311 161.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.91 155.2 47.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 156.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.24 101.04 3.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.745 2.418 . . . . 0.0 105.412 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.71 -179.36 51.28 Favored Glycine 0 CA--C 1.523 0.594 0 O-C-N 121.299 -0.876 . . . . 0.0 111.185 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.61 144.13 89.48 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -65.58 -179.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.684 2.256 . . . . 0.0 113.09 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -142.06 158.37 43.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 155.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 t -130.08 151.99 50.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.88 -73.14 1.22 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.23 -47.19 0.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.491 -1.354 . . . . 0.0 109.651 -143.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 5.74 0.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.86 137.99 22.81 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.24 143.54 32.81 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -122.41 114.37 20.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 108.721 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.647 HG21 ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -76.27 143.59 73.37 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 109.259 170.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.87 106.87 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 1 C-N-CA 125.69 4.26 . . . . 0.0 109.665 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.49 127.81 74.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -164.52 162.15 21.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.456 0.702 . . . . 0.0 111.052 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 110' ' ' VAL . 3.9 pp -152.12 160.06 43.5 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 128.197 2.599 . . . . 0.0 109.887 -172.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.31 88.85 0.34 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 124.191 0.9 . . . . 0.0 111.084 -171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -78.96 168.11 20.16 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.941 1.696 . . . . 0.0 112.725 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.36 160.29 39.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.484 1.114 . . . . 0.0 110.704 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.7 t -117.62 145.43 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.878 1.271 . . . . 0.0 107.599 -168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -103.58 178.37 4.58 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.157 0.983 . . . . 0.0 109.731 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -150.03 112.51 4.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.95 86.22 59.32 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 127.371 2.268 . . . . 0.0 106.996 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.2 -175.71 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.234 2.623 . . . . 0.0 111.011 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.224 1.81 . . . . 0.0 110.259 175.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -126.51 157.92 37.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 108.216 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.92 -85.07 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.143 2.577 . . . . 0.0 112.46 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -48.83 -31.4 7.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.292 1.837 . . . . 0.0 115.602 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -57.37 12.33 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.948 1.249 . . . . 0.0 109.982 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD21 ' HA3' ' A' ' 105' ' ' GLY . 0.3 OUTLIER -60.77 -41.72 96.05 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.142 2.177 . . . . 0.0 107.899 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.75 -48.84 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -62.15 -32.74 73.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.45 -1.406 . . . . 0.0 112.154 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.91 94.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.914 0.779 . . . . 0.0 111.043 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 103' ' ' SER . . . -58.04 -38.2 75.81 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.213 0.605 . . . . 0.0 111.768 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -69.81 -39.34 76.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.717 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.35 -39.04 81.94 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.455 1.48 . . . . 0.0 110.59 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -71.92 0.07 10.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.986 1.714 . . . . 0.0 111.237 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -114.94 -60.91 1.82 Allowed 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.553 -0.717 . . . . 0.0 109.439 164.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.93 -53.58 25.23 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 125.086 1.354 . . . . 0.0 111.08 -167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -47.29 83.48 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.1 -48.64 12.0 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.49 1.916 . . . . 0.0 110.628 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.427 ' CG ' HD22 ' A' ' 94' ' ' LEU . 16.4 t90 -72.2 -51.79 19.48 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 111.45 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . . . -67.54 -23.49 65.44 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.483 -170.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -0.62 57.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.787 1.63 . . . . 0.0 112.824 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.83 -6.3 11.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.479 1.511 . . . . 0.0 113.331 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.09 170.9 15.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -54.47 -71.14 0.25 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-O 117.711 -1.138 . . . . 0.0 113.421 169.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.64 -13.76 22.21 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.922 1.722 . . . . 0.0 112.555 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . . . 47.32 90.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.457 2.703 . . . . 0.0 114.659 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD23 HH11 ' A' ' 22' ' ' ARG . 3.6 mm? -90.57 157.0 44.89 Favored Pre-proline 0 N--CA 1.467 0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 110.738 -170.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -86.0 166.29 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.142 2.562 . . . . 0.0 111.203 164.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.4 109.7 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 125.316 1.446 . . . . 0.0 107.401 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.83 93.09 5.61 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.463 1.029 . . . . 0.0 110.588 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -66.13 99.76 0.55 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.796 -0.565 . . . . 0.0 109.679 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 58.44 -86.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.47 1.908 . . . . 0.0 112.882 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -142.33 22.51 2.03 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 0.0 110.972 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.9 m -56.37 153.6 9.5 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 159.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 145.35 44.35 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.362 0.665 . . . . 0.0 110.177 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -168.33 -178.06 3.45 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.663 1.985 . . . . 0.0 108.262 -165.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 73.71 141.3 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.095 2.558 . . . . 0.0 111.417 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.86 169.69 66.73 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.818 0.971 . . . . 0.0 113.451 5.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.04 169.62 20.14 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.723 2.282 . . . . 0.0 112.683 169.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.65 77.29 6.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 47.04 68.46 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.757 2.023 . . . . 0.0 112.62 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.7 -1.82 51.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.476 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.73 138.12 45.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 118.597 1.199 . . . . 0.0 109.19 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.42 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 44.1 p90 -163.25 171.95 15.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.411 1.084 . . . . 0.0 108.4 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.75 109.13 17.72 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -79.24 90.11 4.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 117.54 29.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.759 0.824 . . . . 0.0 109.809 -169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.93 93.89 3.88 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.458 1.503 . . . . 0.0 109.471 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -72.79 148.81 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.929 -1.107 . . . . 0.0 108.788 160.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mtt -130.03 71.03 82.31 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.357 2.263 . . . . 0.0 108.414 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.16 130.58 16.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.748 2.299 . . . . 0.0 111.196 -167.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.85 16.24 0.31 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.592 -0.692 . . . . 0.0 112.811 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.1 123.79 11.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.238 1.815 . . . . 0.0 109.003 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 160.56 24.96 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 158.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.31 130.59 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -153.13 -168.09 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.866 2.067 . . . . 0.0 107.152 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.15 5.13 18.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.885 1.274 . . . . 0.0 111.873 167.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 50.22 169.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 129.553 3.141 . . . . 0.0 112.738 -164.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -162.62 11.58 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.918 -1.114 . . . . 0.0 113.643 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.62 -174.01 4.03 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 128.082 2.553 . . . . 0.0 105.546 166.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.61 170.62 19.41 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 162.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.31 133.2 4.98 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.913 2.485 . . . . 0.0 105.301 171.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -164.75 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.017 1.727 . . . . 0.0 111.126 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.29 -173.17 0.14 Allowed 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.52 -0.738 . . . . 0.0 110.162 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -124.37 174.34 7.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.46 171.83 1.01 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.825 0.822 . . . . 0.0 109.666 175.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -163.47 169.18 19.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.923 -1.111 . . . . 0.0 108.855 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.64 -174.34 42.05 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 4.2 t -120.69 159.37 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 48' ' ' VAL . 6.2 t80 -125.14 135.54 52.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 160.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.76 140.16 53.18 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 172.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.0 t -133.67 153.12 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.02 106.62 5.09 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 -173.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -82.24 64.78 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.56 1.544 . . . . 0.0 108.038 -171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 43' ' ' TYR . 2.5 p -66.67 130.42 32.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 120.413 -1.429 . . . . 0.0 107.949 -171.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.7 ptp -138.68 150.02 64.37 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.41 152.89 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.329 2.686 . . . . 0.0 112.17 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.02 93.85 4.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.58 -95.05 1.15 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.654 -2.178 . . . . 0.0 107.654 167.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -135.59 135.76 40.53 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 129.111 2.964 . . . . 0.0 104.061 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.38 36.26 45.16 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.665 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.0 p -70.39 29.6 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.979 1.712 . . . . 0.0 112.736 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -116.15 24.89 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.207 1.803 . . . . 0.0 109.139 -166.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 m -77.59 -10.19 59.36 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.971 -1.014 . . . . 0.0 113.464 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.21 -54.36 31.91 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.398 0.999 . . . . 0.0 112.044 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.97 -46.77 84.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.146 0.43 . . . . 0.0 110.795 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -56.0 26.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.611 1.164 . . . . 0.0 111.761 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG12 HD12 ' A' ' 91' ' ' LEU . 81.2 t -66.58 -40.55 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 117.217 -1.373 . . . . 0.0 110.412 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.59 88.73 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.662 1.119 . . . . 0.0 109.861 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.37 -38.5 84.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 120.962 -1.086 . . . . 0.0 110.555 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -64.82 -56.4 13.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.111 0.564 . . . . 0.0 110.815 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.508 HD12 HG12 ' A' ' 87' ' ' VAL . 21.9 mt -61.97 -44.83 95.91 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.877 0.871 . . . . 0.0 110.988 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.81 -23.39 59.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.298 0.639 . . . . 0.0 109.79 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.88 -48.16 69.64 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.854 0.752 . . . . 0.0 109.57 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 18' ' ' TRP . 33.0 tp -63.72 -30.75 71.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.638 0.775 . . . . 0.0 112.373 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -119.06 74.81 13.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.948 1.699 . . . . 0.0 110.088 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.03 173.56 14.26 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.858 3.039 . . . . 0.0 110.649 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 p -58.07 0.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.507 2.323 . . . . 0.0 114.737 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 100' ' ' VAL . 2.2 m-80 -98.28 -56.08 2.58 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 120.222 -1.549 . . . . 0.0 109.806 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.26 35.46 24.95 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.645 1.578 . . . . 0.0 112.01 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 98' ' ' ASN . 4.2 t -68.46 120.32 15.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.8 mtm -132.25 94.87 3.53 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.84 86.1 1.26 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.641 1.976 . . . . 0.0 107.849 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -90.56 176.38 6.71 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.097 0.959 . . . . 0.0 111.962 -172.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.87 4.61 0.06 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 128.021 2.724 . . . . 0.0 117.264 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 6' ' ' LEU . . . -134.47 -73.77 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 -169.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -154.5 168.92 25.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.132 0.973 . . . . 0.0 109.844 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.25 157.45 32.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.93 1.292 . . . . 0.0 109.644 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.17 157.87 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 120.267 -1.521 . . . . 0.0 107.758 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 130.01 20.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 132' ' ' LEU . 7.6 p -62.86 -27.42 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.13 -48.16 0.67 Allowed 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.839 1.656 . . . . 0.0 112.18 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 p -106.54 165.57 12.71 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 125.426 1.49 . . . . 0.0 109.915 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.37 173.98 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.426 1.417 . . . . 0.0 109.902 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mm -57.16 145.69 7.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.03 152.76 29.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.998 0.904 . . . . 0.0 110.804 162.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -136.75 162.63 32.67 Favored 'General case' 0 N--CA 1.435 -1.176 1 C-N-CA 132.334 4.254 . . . . 0.0 106.625 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.88 178.95 35.75 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 164.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.41 146.0 80.46 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 156.46 57.95 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.889 2.393 . . . . 0.0 110.923 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.9 m -111.65 125.14 53.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -69.37 158.92 34.14 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -127.75 -164.51 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.722 1.629 . . . . 0.0 109.624 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -58.71 -47.84 83.18 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 110.513 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.47 28.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.142 1.377 . . . . 0.0 109.542 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.41 164.08 28.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.33 1.852 . . . . 0.0 110.004 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -122.28 153.04 39.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 159.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -143.78 126.32 15.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.13 144.33 50.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.628 163.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.42 116.23 3.82 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 125.213 3.942 . . . . 0.0 109.156 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.16 130.94 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 171.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 p -159.72 175.12 13.54 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.585 -0.697 . . . . 0.0 111.613 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -165.91 159.34 15.72 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 127.424 2.289 . . . . 0.0 108.91 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -132.11 87.94 0.28 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.949 0.795 . . . . 0.0 112.119 -170.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -69.15 155.18 40.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.732 1.613 . . . . 0.0 111.95 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.24 1.51 10.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.656 2.383 . . . . 0.0 109.622 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t 59.98 -170.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -148.43 -175.47 4.93 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 120.014 -1.679 . . . . 0.0 106.841 161.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.91 128.51 24.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -129.43 78.55 75.51 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.54 118.77 5.62 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.458 2.105 . . . . 0.0 107.139 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.303 1.041 . . . . 0.0 109.815 -169.509 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.763 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 48.0 mtt -84.99 36.61 0.63 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.694 1.998 . . . . 0.0 111.895 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t 72.64 -68.23 0.23 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.149 1.78 . . . . 0.0 109.679 -168.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -31.46 63.91 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.369 0.668 . . . . 0.0 112.145 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.36 -46.68 87.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.172 0.989 . . . . 0.0 109.342 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.62 -29.85 65.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.487 -1.244 . . . . 0.0 111.46 -170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mt -57.6 -60.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.147 0.979 . . . . 0.0 108.432 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -58.9 -41.44 87.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.228 0.467 . . . . 0.0 109.928 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 -16.19 62.38 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.15 -40.46 90.58 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.702 -1.249 . . . . 0.0 109.746 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -61.76 -50.27 73.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.201 1.4 . . . . 0.0 110.268 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -3.54 23.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.408 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -93.49 -3.02 53.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.465 1.106 . . . . 0.0 113.448 171.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -119.33 -55.77 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.286 1.434 . . . . 0.0 111.956 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD23 ' CH2' ' A' ' 30' ' ' TRP . 56.2 tp -65.07 -34.62 78.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -167.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -42.78 85.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.631 1.172 . . . . 0.0 109.073 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -59.46 -52.1 67.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.579 2.352 . . . . 0.0 108.042 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -61.12 -47.13 87.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.177 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.77 73.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.623 -1.656 . . . . 0.0 111.936 -167.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -26.54 24.8 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.724 1.147 . . . . 0.0 112.988 172.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.01 81.28 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.701 0.8 . . . . 0.0 110.788 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -63.12 159.01 18.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.889 0.476 . . . . 0.0 110.148 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -52.13 -63.63 2.04 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.167 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.44 -12.04 26.94 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.611 1.541 . . . . 0.0 114.227 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 44.43 90.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.891 2.876 . . . . 0.0 113.629 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.97 159.12 38.53 Favored Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 112.919 -165.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.33 166.45 12.41 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.141 2.561 . . . . 0.0 110.597 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.22 98.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.746 -1.221 . . . . 0.0 109.437 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.12 9.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CH2' HD23 ' A' ' 15' ' ' LEU . 96.1 m95 -61.41 170.04 1.98 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.266 1.027 . . . . 0.0 110.927 168.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -55.04 131.96 46.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.032 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 54.21 11.64 0.4 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.419 2.287 . . . . 0.0 114.754 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 t -72.04 172.51 9.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.063 1.301 . . . . 0.0 111.356 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.13 121.99 40.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.32 1.848 . . . . 0.0 108.432 164.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.06 14.72 1.33 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 t -92.85 145.17 29.72 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -68.4 153.82 89.08 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.13 1.082 . . . . 0.0 111.019 -6.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.03 177.05 9.12 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.449 2.099 . . . . 0.0 110.4 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 75.58 6.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.204 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 59.95 36.53 21.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.744 1.217 . . . . 0.0 109.882 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.92 89.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.423 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.54 132.89 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.44 -179.92 8.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.423 0.689 . . . . 0.0 110.765 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -153.56 102.47 2.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.672 2.389 . . . . 0.0 107.606 -156.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -78.13 83.64 4.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.552 1.141 . . . . 0.0 108.557 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.77 77.28 9.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.161 1.384 . . . . 0.0 107.761 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.23 93.38 4.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.9 1.333 . . . . 0.0 110.114 -163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' VAL . 11.0 m -73.84 67.78 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.882 2.873 . . . . 0.0 110.811 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mtm -50.2 144.99 10.51 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.177 1.391 . . . . 0.0 110.553 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.76 -176.33 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.701 2.934 . . . . 0.0 110.483 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' H ' ' A' ' 66' ' ' ARG . . . -69.85 163.41 25.95 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.355 -0.841 . . . . 0.0 111.966 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 27.48 0.33 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.664 1.586 . . . . 0.0 111.274 165.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.55 152.4 43.0 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.183 -0.948 . . . . 0.0 110.536 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 55' ' ' SER . 5.9 mm -72.67 -174.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 107.862 167.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -56.46 108.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 107.913 164.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -153.49 37.76 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.583 1.553 . . . . 0.0 107.742 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -132.47 160.65 35.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 108.513 -158.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.66 64.89 6.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.442 1.497 . . . . 0.0 110.889 -162.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.36 44.02 30.26 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.577 1.951 . . . . 0.0 111.517 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.44 -52.27 4.64 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 126.152 1.834 . . . . 0.0 110.663 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.452 2.701 . . . . 0.0 108.295 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.65 -30.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 111.94 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.19 144.06 49.19 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 124.429 1.091 . . . . 0.0 109.513 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -144.19 40.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.642 1.577 . . . . 0.0 109.01 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -76.12 105.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 68.2 mtt180 -144.38 75.83 1.48 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.478 0.711 . . . . 0.0 112.918 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.71 -176.89 45.49 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.064 0.84 . . . . 0.0 113.893 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 124.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -102.25 115.87 31.46 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 131' ' ' SER . 2.3 mt-30 -103.25 146.44 28.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.07 1.748 . . . . 0.0 108.534 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.29 86.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 84.05 3.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 170.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.36 119.54 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 126.147 1.779 . . . . 0.0 108.414 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.02 133.09 62.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.855 1.262 . . . . 0.0 108.633 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.07 150.91 36.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.61 146.83 39.5 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.87 2.38 . . . . 0.0 111.401 -173.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.15 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.64 -68.22 1.37 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 168.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.37 4.29 5.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.79 -10.07 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-O 118.121 -1.377 . . . . 0.0 115.053 169.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t 44.89 91.85 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.118 2.167 . . . . 0.0 114.315 165.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.91 0.29 29.93 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.348 -0.845 . . . . 0.0 111.62 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -65.63 -14.52 61.36 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -171.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.1 68.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.835 1.198 . . . . 0.0 112.285 169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.18 -50.05 13.82 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.936 0.894 . . . . 0.0 109.318 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -46.89 68.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.456 1.102 . . . . 0.0 109.913 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.11 -42.36 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.28 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.36 77.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.953 0.797 . . . . 0.0 110.875 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.67 -39.2 64.59 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.274 0.63 . . . . 0.0 111.657 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.44 -49.51 76.55 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.062 0.945 . . . . 0.0 110.656 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -57.63 -59.97 4.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.988 1.715 . . . . 0.0 110.702 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.97 -35.55 61.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.596 1.544 . . . . 0.0 113.197 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.77 -21.76 64.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.114 0.87 . . . . 0.0 113.009 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.97 -28.07 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.137 2.175 . . . . 0.0 110.967 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.03 63.67 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 129.161 2.984 . . . . 0.0 108.87 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.69 172.0 12.31 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.706 1.604 . . . . 0.0 109.832 169.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.68 16.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.609 2.764 . . . . 0.0 115.088 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.61 -59.28 1.83 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.822 2.049 . . . . 0.0 109.839 -172.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.6 66.35 0.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.895 1.278 . . . . 0.0 112.717 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -74.56 88.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.255 3.3 ptt? -105.12 82.99 1.92 Allowed 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 14.8 pt20 -80.46 80.0 6.98 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.412 1.085 . . . . 0.0 108.706 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -177.73 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.047 1.339 . . . . 0.0 109.499 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.51 -10.97 6.52 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.689 1.137 . . . . 0.0 115.69 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.74 -64.61 0.56 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 176.29 11.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.187 0.995 . . . . 0.0 109.96 -168.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . . . -100.59 102.35 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.489 1.516 . . . . 0.0 109.804 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -69.05 169.84 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -147.06 151.46 36.93 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.369 1.867 . . . . 0.0 107.451 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.73 -23.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 118.539 -0.744 . . . . 0.0 112.999 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttp85 70.94 -55.35 0.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.555 1.542 . . . . 0.0 112.517 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -94.29 165.35 17.74 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 125.102 1.361 . . . . 0.0 109.756 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.98 -175.24 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.849 1.7 . . . . 0.0 109.83 153.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mm -85.24 160.62 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.42 1.488 . . . . 0.0 108.482 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -139.05 161.36 37.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 109.742 161.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.75 150.23 30.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.193 2.197 . . . . 0.0 108.069 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.27 -174.45 13.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.228 1.394 . . . . 0.0 111.005 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.92 149.91 97.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.078 0.951 . . . . 0.0 110.002 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.14 145.32 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.797 2.331 . . . . 0.0 113.52 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -72.33 111.49 7.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 161.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 m -72.23 125.69 27.96 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.25 -167.25 27.84 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.275 1.417 . . . . 0.0 110.728 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -50.23 -55.04 16.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.232 1.413 . . . . 0.0 111.224 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.63 18.11 0.81 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.419 1.888 . . . . 0.0 110.614 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -128.98 170.09 13.88 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -148.85 156.04 41.76 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 121.581 -0.699 . . . . 0.0 110.915 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -140.45 115.62 9.85 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.456 0.702 . . . . 0.0 109.812 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.74 153.91 83.29 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.537 0.735 . . . . 0.0 110.231 170.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.71 90.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 1 C-N-CA 125.539 4.16 . . . . 0.0 111.03 174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.72 129.97 60.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 70' ' ' GLN . 14.8 p -169.34 165.23 10.76 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.883 0.873 . . . . 0.0 112.911 171.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 166.18 25.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.946 2.098 . . . . 0.0 109.57 173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -126.96 89.79 0.35 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.078 0.847 . . . . 0.0 111.96 -166.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -82.54 173.59 11.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.776 1.63 . . . . 0.0 112.51 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.22 -161.86 1.43 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.899 2.08 . . . . 0.0 109.867 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.22 165.15 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -173.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -111.19 173.88 6.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 126.366 1.866 . . . . 0.0 110.243 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.93 39.05 0.22 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.658 2.783 . . . . 0.0 109.656 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -60.38 157.3 35.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 O-C-N 121.556 -0.715 . . . . 0.0 110.811 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.85 125.84 15.52 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.889 1.726 . . . . 0.0 108.514 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 123.903 0.881 . . . . 0.0 111.393 178.115 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.65 161.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 111.098 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m 68.73 -69.88 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.046 1.739 . . . . 0.0 109.8 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -45.11 -45.14 11.05 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.36 1.864 . . . . 0.0 112.863 -175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.29 -38.76 59.26 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.437 1.095 . . . . 0.0 110.515 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.84 -48.09 33.7 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.372 1.069 . . . . 0.0 108.752 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.33 -43.67 72.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.421 -0.799 . . . . 0.0 110.736 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.98 -48.91 77.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.165 0.893 . . . . 0.0 109.463 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.05 65.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.78 59.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.748 -1.22 . . . . 0.0 111.645 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -78.36 -39.05 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.553 0.615 . . . . 0.0 109.76 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.7 -36.17 80.14 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.323 -0.861 . . . . 0.0 111.51 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -68.37 -4.35 14.27 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.63 1.172 . . . . 0.0 111.556 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -70.18 0.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -64.0 -47.17 81.37 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.071 0.549 . . . . 0.0 111.601 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 t -68.73 -48.04 64.8 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.59 -26.29 68.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.22 1.008 . . . . 0.0 113.038 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -75.56 -54.5 6.9 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.309 1.444 . . . . 0.0 111.063 166.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -58.44 -20.89 48.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -86.62 -19.71 28.94 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.09 4.13 36.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.26 2.224 . . . . 0.0 110.908 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.863 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -72.05 170.51 13.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.635 2.774 . . . . 0.0 109.678 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.0 m -78.07 -68.79 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.934 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.64 -6.7 18.46 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 122.493 1.926 . . . . 0.0 114.749 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.83 101.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 130.371 3.469 . . . . 0.0 115.865 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.1 mm? -111.65 148.3 38.6 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.39 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.94 167.84 26.25 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.85 3.033 . . . . 0.0 111.013 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.03 71.0 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.68 95.43 4.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.151 0.98 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -66.61 155.89 36.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 164.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.85 153.88 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.301 1.441 . . . . 0.0 112.145 163.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 59.56 -40.86 0.08 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.913 3.685 . . . . 0.0 114.49 -173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.3 m -60.46 153.06 24.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 129.464 3.106 . . . . 0.0 110.61 -171.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 140.16 54.68 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.478 1.511 . . . . 0.0 108.559 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 175.76 10.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.472 1.109 . . . . 0.0 111.043 -177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.14 155.56 0.15 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.483 2.313 . . . . 0.0 110.808 -170.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.48 159.58 74.52 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.726 0.938 . . . . 0.0 111.886 -3.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 177.18 5.45 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.652 1.568 . . . . 0.0 109.49 167.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 81.01 1.63 Allowed 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.91 47.16 7.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.649 1.58 . . . . 0.0 111.349 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.43 -7.84 50.96 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.037 1.303 . . . . 0.0 113.931 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.9 t -105.53 137.59 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -164.61 178.29 7.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.981 0.912 . . . . 0.0 110.054 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 mt -125.22 129.41 50.03 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.912 1.685 . . . . 0.0 109.362 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -111.9 105.76 14.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.145 0.884 . . . . 0.0 109.298 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.22 129.38 44.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 110.808 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 13.0 t80 -129.94 117.8 20.68 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.919 1.287 . . . . 0.0 110.083 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.5 112.06 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.429 2.692 . . . . 0.0 107.871 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 19.2 mtm -104.68 83.39 0.78 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.631 -1.293 . . . . 0.0 108.262 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.45 154.58 50.58 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.987 1.791 . . . . 0.0 109.141 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.77 133.11 50.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 92.9 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.694 1.997 . . . . 0.0 107.41 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -62.04 150.43 38.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 124.742 1.217 . . . . 0.0 109.685 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 54' ' ' ILE . 2.9 mp -75.93 133.7 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.7 m -74.8 4.35 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.257 4.7 ppt_? -140.58 21.69 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.408 1.883 . . . . 0.0 113.393 170.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.24 175.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.205 2.202 . . . . 0.0 112.571 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.45 71.28 0.38 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.122 1.369 . . . . 0.0 109.813 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 51.52 -154.53 0.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.944 1.297 . . . . 0.0 113.282 165.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.72 10.69 5.47 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.598 1.57 . . . . 0.0 112.538 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.76 -21.19 10.3 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.978 1.311 . . . . 0.0 112.289 -164.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -130.61 -8.01 4.09 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.657 0.783 . . . . 0.0 112.574 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 145.09 15.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.181 -0.949 . . . . 0.0 111.153 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.22 177.0 8.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.892 1.277 . . . . 0.0 111.82 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.47 165.53 6.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.578 1.151 . . . . 0.0 110.555 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.98 174.54 4.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.23 -174.66 42.03 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 121.91 0.728 . . . . 0.0 112.595 165.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -131.38 153.48 39.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 157.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -118.91 146.46 44.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.75 1.62 . . . . 0.0 106.679 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.54 148.82 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.631 0.772 . . . . 0.0 109.459 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t -132.98 166.23 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 163.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -133.32 147.44 51.86 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.326 1.45 . . . . 0.0 109.898 157.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.07 73.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 131.463 3.905 . . . . 0.0 105.477 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.42 125.34 29.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.8 mtm -141.1 145.22 37.97 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.34 167.3 24.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.839 2.36 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.82 81.82 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.715 1.206 . . . . 0.0 108.01 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.63 31.65 6.72 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.547 1.546 . . . . 0.0 112.653 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 46.15 69.13 0.5 Allowed 'General case' 0 C--O 1.243 0.745 0 C-N-CA 127.139 2.176 . . . . 0.0 110.534 -161.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.1 22.8 0.02 OUTLIER Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.916 -0.935 . . . . 0.0 114.621 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.37 6.73 47.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.677 1.239 . . . . 0.0 113.506 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.63 -0.5 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 119.849 -1.782 . . . . 0.0 111.828 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.0 m -55.91 -16.24 4.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.776 . . . . 0.0 113.898 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.96 -45.28 20.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.32 1.048 . . . . 0.0 112.45 171.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.79 -52.78 47.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 118.629 0.65 . . . . 0.0 109.578 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -53.8 16.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.299 1.04 . . . . 0.0 110.848 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 78.8 t -59.87 -50.71 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.946 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.79 68.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.197 0.908 . . . . 0.0 111.465 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.22 27.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.314 1.046 . . . . 0.0 111.731 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.0 -42.33 99.81 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.263 1.03 . . . . 0.0 109.909 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -58.4 -52.8 64.11 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.558 1.943 . . . . 0.0 110.467 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.34 -41.75 85.31 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.219 -1.551 . . . . 0.0 112.262 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.78 -15.73 63.59 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.429 0.692 . . . . 0.0 112.226 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.27 -34.84 14.08 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.052 0.941 . . . . 0.0 111.314 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.45 71.91 3.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.228 1.411 . . . . 0.0 110.336 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -69.27 174.59 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.182 2.588 . . . . 0.0 110.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.28 3.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 127.011 2.124 . . . . 0.0 113.909 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -99.34 -58.22 1.98 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.077 1.351 . . . . 0.0 109.036 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER 55.67 40.8 30.93 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 110.171 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -77.19 104.08 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.4 mtm -124.07 92.94 3.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.881 1.272 . . . . 0.0 107.978 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.09 117.82 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.369 -0.832 . . . . 0.0 109.094 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -84.47 -165.77 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.33 0.514 . . . . 0.0 109.953 167.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.66 71.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.915 1.722 . . . . 0.0 112.208 161.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.78 -99.56 2.35 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 104.732 -3.347 . . . . 0.0 104.732 163.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -179.38 5.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.871 1.668 . . . . 0.0 109.595 -167.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.98 158.09 17.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.623 1.201 . . . . 0.0 112.604 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.29 163.32 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.832 2.053 . . . . 0.0 106.679 -176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -141.76 144.75 34.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.151 0.98 . . . . 0.0 109.666 163.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HB ' HD22 ' A' ' 99' ' ' LEU . 8.9 p -71.32 -35.06 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 122.187 0.195 . . . . 0.0 111.151 172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 66.71 -52.3 0.45 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.816 2.046 . . . . 0.0 111.73 -167.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -90.83 164.31 26.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 126.195 1.798 . . . . 0.0 111.683 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.2 174.17 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.508 1.472 . . . . 0.0 110.852 162.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.3 mm -50.27 146.5 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 126.412 1.885 . . . . 0.0 110.399 162.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t -114.24 162.18 16.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 155.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.67 150.27 5.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 130.976 3.71 . . . . 0.0 104.552 -165.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.79 -173.98 28.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 120.645 1.566 . . . . 0.0 113.584 168.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.14 144.74 98.5 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.12 1.368 . . . . 0.0 110.084 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.27 144.35 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.578 2.186 . . . . 0.0 109.642 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -98.69 1.21 45.97 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.786 1.279 . . . . 0.0 111.82 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 122' ' ' GLY . 15.9 m 55.76 176.38 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.099 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' H ' HG22 ' A' ' 121' ' ' THR . . . -173.65 -168.01 34.12 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -170.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.96 -43.83 98.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.089 0.955 . . . . 0.0 112.045 -165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.34 22.8 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.139 1.776 . . . . 0.0 109.395 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 130.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -161.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.85 170.46 9.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.224 1.012 . . . . 0.0 108.753 162.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.38 123.09 9.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 169.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 84' ' ' ALA . 12.9 m -89.5 142.84 29.85 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.344 0.657 . . . . 0.0 110.411 170.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.55 123.66 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.439 2.759 . . . . 0.0 111.577 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.08 126.14 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.31 1.444 . . . . 0.0 108.258 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -163.05 164.88 25.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.884 0.874 . . . . 0.0 111.397 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.93 149.02 33.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.635 1.574 . . . . 0.0 110.52 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.2 172.36 47.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -161.34 162.94 31.02 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.532 -0.981 . . . . 0.0 109.374 155.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 173.01 10.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.353 1.461 . . . . 0.0 109.1 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.08 121.01 5.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -163.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -124.97 145.82 49.69 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.356 0.663 . . . . 0.0 109.863 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -67.1 -20.41 65.78 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.446 ' CD2' ' HD2' ' A' ' 140' ' ' PRO . 1.0 OUTLIER 59.98 144.07 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 130.72 3.608 . . . . 0.0 110.788 -167.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.446 ' HD2' ' CD2' ' A' ' 139' ' ' TYR . 57.2 Cg_endo -72.31 158.62 51.27 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.562 2.175 . . . . 0.0 112.412 -175.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 C--O 1.256 1.441 0 C-N-CA 127.337 2.255 . . . . 0.0 110.904 -177.632 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.759 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.31 162.87 40.83 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.978 0.511 . . . . 0.0 109.755 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m 45.31 -85.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.278 2.231 . . . . 0.0 114.122 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HA ' HE21 ' A' ' 4' ' ' GLN . 1.0 OUTLIER -52.5 -35.25 52.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 120.43 1.468 . . . . 0.0 112.385 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -52.26 -61.61 2.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 128.156 2.582 . . . . 0.0 109.906 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' CA ' ' A' ' 105' ' ' GLY . 11.1 mt -61.9 -50.59 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.118 1.767 . . . . 0.0 109.855 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 mt -45.98 -50.78 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.421 1.489 . . . . 0.0 111.054 175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -61.12 -42.04 97.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.543 1.065 . . . . 0.0 111.101 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -44.69 -45.81 9.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.645 1.578 . . . . 0.0 111.981 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.21 79.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.425 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.56 -40.49 84.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -66.62 -42.51 86.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.331 1.453 . . . . 0.0 110.153 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -68.11 1.45 2.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.322 2.249 . . . . 0.0 111.471 171.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -108.11 -68.45 0.9 Allowed 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.799 -1.188 . . . . 0.0 110.716 160.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.58 -51.67 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.712 1.142 . . . . 0.0 112.132 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -67.24 -38.2 84.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.26 0.482 . . . . 0.0 110.314 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -39.94 95.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.304 1.842 . . . . 0.0 110.738 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CZ3' ' NH2' ' A' ' 22' ' ' ARG . 34.7 t90 -69.74 -57.89 4.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 126.04 1.736 . . . . 0.0 109.179 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.51 71.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.844 -1.074 . . . . 0.0 110.763 -169.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -28.19 61.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.078 1.308 . . . . 0.0 113.872 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.55 -30.57 37.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.95 0.9 . . . . 0.0 111.859 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.735 ' NH2' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.99 168.07 1.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.384 2.274 . . . . 0.0 111.696 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -65.86 -74.23 0.18 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.121 -1.418 . . . . 0.0 113.405 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.99 -11.85 32.83 Favored 'Trans proline' 0 C--N 1.348 0.524 0 CA-C-N 122.237 1.835 . . . . 0.0 113.552 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.25 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.94 2.896 . . . . 0.0 113.403 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.735 HD12 ' NH2' ' A' ' 22' ' ' ARG . 52.4 mt -99.45 158.1 32.8 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 127.671 2.389 . . . . 0.0 111.284 -169.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.34 162.53 17.35 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.073 2.516 . . . . 0.0 112.427 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.22 96.21 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 108.875 -169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.31 97.68 10.09 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.79 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.11 178.24 5.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.162 0.985 . . . . 0.0 111.94 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.24 -61.27 2.51 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.679 0.791 . . . . 0.0 111.767 -164.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -105.26 35.22 2.9 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.83 0.852 . . . . 0.0 109.527 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -127.03 162.33 26.27 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.288 1.835 . . . . 0.0 106.972 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.65 154.48 35.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.515 1.126 . . . . 0.0 108.706 171.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.65 101.93 2.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 168.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.2 m -153.25 144.86 16.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 128.288 2.635 . . . . 0.0 105.767 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.39 161.99 56.56 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-N 120.652 1.269 . . . . 0.0 111.69 -6.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.63 177.49 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.067 2.512 . . . . 0.0 111.775 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.82 71.62 2.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.206 1.002 . . . . 0.0 108.35 164.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.17 14.98 3.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.143 2.177 . . . . 0.0 114.452 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.67 -9.8 9.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.695 1.617 . . . . 0.0 113.673 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.3 t -88.78 144.19 9.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -168.14 -175.42 2.62 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.294 1.038 . . . . 0.0 109.288 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 44' ' ' LEU . 12.1 tp -144.65 127.9 16.75 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.475 1.51 . . . . 0.0 107.441 -166.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -122.24 89.32 3.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.82 146.22 53.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.061 0.945 . . . . 0.0 109.723 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -138.34 145.67 41.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.45 108.63 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mtt -81.83 143.53 50.33 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.62 -177.7 2.96 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.641 2.894 . . . . 0.0 110.559 168.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.88 148.99 32.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.96 0.904 . . . . 0.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.82 55.64 1.72 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.288 1.435 . . . . 0.0 107.941 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 t -137.56 126.72 24.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.0 mt -140.92 140.04 33.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.93 7.29 3.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.153 2.181 . . . . 0.0 114.955 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -131.7 81.4 1.97 Allowed 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 129.282 3.033 . . . . 0.0 106.474 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -146.02 160.82 41.34 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.14 14.69 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -172.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 163.53 25.47 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.138 0.881 . . . . 0.0 109.31 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.33 42.02 2.54 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.92 171.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -163.89 145.33 8.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.496 2.319 . . . . 0.0 105.898 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 163.54 20.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.226 1.41 . . . . 0.0 112.148 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 63.63 -174.92 0.16 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.038 1.735 . . . . 0.0 111.794 166.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.58 173.52 12.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.588 1.955 . . . . 0.0 106.473 164.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.01 172.63 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 144.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.59 177.89 0.57 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.4 1.48 . . . . 0.0 108.071 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.91 -169.05 37.98 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 157.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.59 136.01 46.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 170.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -98.45 148.96 23.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 168.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -142.92 143.84 32.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.0 108.265 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.35 90.08 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.826 0.822 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.87 116.63 7.23 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 109.395 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.81 127.01 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.941 1.296 . . . . 0.0 107.762 161.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.32 134.04 50.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.27 148.99 64.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 165.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 178.8 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.557 2.838 . . . . 0.0 111.168 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.28 97.76 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.56 -111.33 0.24 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.37 10.9 4.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 113.913 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.15 59.51 0.2 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 120.015 -1.678 . . . . 0.0 113.139 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 p -76.89 -30.47 56.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.954 1.377 . . . . 0.0 113.995 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -91.83 14.59 15.05 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.909 -1.12 . . . . 0.0 112.035 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.0 m -57.12 -16.23 7.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.185 0.994 . . . . 0.0 112.789 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -47.74 -36.9 12.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.833 1.653 . . . . 0.0 112.568 167.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.93 -53.94 22.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.891 0.476 . . . . 0.0 110.083 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.38 -58.39 3.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.67 1.588 . . . . 0.0 109.731 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.59 -54.49 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.972 1.709 . . . . 0.0 111.358 -174.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.85 -30.89 71.16 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.04 0.836 . . . . 0.0 110.527 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.54 65.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.558 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.27 -55.88 21.13 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 118.563 0.62 . . . . 0.0 109.48 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.6 mt -56.98 -39.35 74.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.193 0.997 . . . . 0.0 110.497 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.71 -48.15 78.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.218 1.007 . . . . 0.0 112.317 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.54 67.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.2 -25.68 34.02 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.913 0.885 . . . . 0.0 111.347 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -121.84 55.56 5.99 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 112.252 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.92 170.24 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.549 2.166 . . . . 0.0 111.977 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.24 -1.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.326 1.85 . . . . 0.0 114.824 -164.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -97.39 -32.06 12.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.599 -1.313 . . . . 0.0 112.25 173.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.625 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.3 tp 44.42 68.15 0.58 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.287 2.235 . . . . 0.0 111.305 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 100' ' ' VAL . 14.1 m -75.1 53.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 125.386 2.517 . . . . 0.0 111.173 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.502 ' HE2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -76.68 73.33 3.36 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 128.671 2.788 . . . . 0.0 107.68 172.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -65.67 152.0 45.21 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.996 0.918 . . . . 0.0 110.567 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.42 173.22 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.579 1.151 . . . . 0.0 109.981 -176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.0 12.37 0.85 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.498 -1.168 . . . . 0.0 115.53 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.471 ' CA ' HD13 ' A' ' 6' ' ' LEU . . . -124.36 -64.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.77 179.39 4.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.15 2.18 . . . . 0.0 107.961 -173.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.56 130.1 49.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.818 0.847 . . . . 0.0 109.003 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 101' ' ' MET . 1.4 p -71.95 171.4 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -143.44 134.78 26.01 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 120.612 -1.305 . . . . 0.0 108.876 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' HB ' HD22 ' A' ' 99' ' ' LEU . 14.3 p -65.05 -34.08 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.733 0.813 . . . . 0.0 113.128 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.7 -33.52 0.15 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.375 1.87 . . . . 0.0 113.897 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.0 p -117.68 161.55 33.37 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.554 1.525 . . . . 0.0 110.007 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.34 175.27 11.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.735 1.623 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.81 150.44 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.99 1.716 . . . . 0.0 108.255 164.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 167.52 21.92 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -156.67 177.54 11.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 109.04 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.49 -173.95 19.02 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 120.895 -1.128 . . . . 0.0 110.888 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.23 155.85 91.15 Favored Pre-proline 0 N--CA 1.447 -0.62 0 C-N-CA 124.03 0.932 . . . . 0.0 110.736 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -74.1 150.39 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.686 1.591 . . . . 0.0 110.709 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 t -101.08 3.79 41.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.91 0.862 . . . . 0.0 112.803 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 122' ' ' GLY . 1.5 m 53.54 -164.99 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.392 1.077 . . . . 0.0 110.218 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 121' ' ' THR . . . -172.47 -159.85 19.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 127.142 2.306 . . . . 0.0 107.462 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -58.5 -53.86 53.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.903 0.881 . . . . 0.0 109.987 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.34 34.83 0.46 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.938 1.695 . . . . 0.0 109.227 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.67 165.24 26.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.708 1.603 . . . . 0.0 108.42 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -126.2 156.04 40.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.631 -0.668 . . . . 0.0 111.017 160.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.38 109.97 6.02 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.582 2.353 . . . . 0.0 108.322 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.37 143.06 51.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.1 137.84 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.793 3.662 . . . . 0.0 108.657 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.6 mt -148.34 124.05 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -151.39 162.06 41.59 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.071 0.948 . . . . 0.0 111.314 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.429 HD13 HG23 ' A' ' 110' ' ' VAL . 1.4 pp -148.46 142.75 26.18 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.209 1.804 . . . . 0.0 109.918 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 174.61 54.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -158.66 170.15 22.82 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 167.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.35 -172.99 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.939 2.495 . . . . 0.0 107.195 160.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -101.58 171.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 120.446 -1.409 . . . . 0.0 108.631 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -140.61 169.73 17.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.877 2.071 . . . . 0.0 107.113 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -125.94 156.33 39.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -127.23 81.25 70.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.593 1.957 . . . . 0.0 106.399 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.75 -171.27 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.802 2.334 . . . . 0.0 109.274 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 153.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -176.69 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m 45.89 -85.53 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.927 2.091 . . . . 0.0 113.303 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -60.03 -25.6 65.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 121.333 1.879 . . . . 0.0 112.475 -172.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.63 -61.49 1.55 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 123.193 1.473 . . . . 0.0 108.642 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -73.27 -33.17 65.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.57 -175.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 106' ' ' LEU . 29.5 mm -56.48 -53.47 40.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -34.04 76.94 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.535 0.684 . . . . 0.0 109.349 -173.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.05 -24.96 66.84 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 123.805 0.842 . . . . 0.0 111.412 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.97 70.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.543 1.065 . . . . 0.0 111.624 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.04 -52.5 55.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -73.32 -23.7 60.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.104 -0.998 . . . . 0.0 111.67 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -65.13 -7.3 11.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 111.211 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -122.75 -54.48 1.84 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.956 0.902 . . . . 0.0 113.1 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.89 -53.58 55.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.008 1.276 . . . . 0.0 111.007 -171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 t -63.95 -36.54 84.3 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.689 -0.632 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.57 -39.75 81.18 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.038 0.935 . . . . 0.0 112.126 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CB ' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -75.89 -46.23 31.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.141 0.577 . . . . 0.0 110.461 173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -40.52 92.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.045 -0.978 . . . . 0.0 111.189 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -37.31 79.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.476 0.58 . . . . 0.0 111.36 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -13.32 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.402 1.081 . . . . 0.0 112.803 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.51 164.95 24.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 93.3 m -46.66 -75.63 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.755 2.022 . . . . 0.0 112.794 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 69.4 Cg_endo -72.34 -14.57 28.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.061 1.772 . . . . 0.0 113.5 -169.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.64 111.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.803 2.841 . . . . 0.0 112.54 -164.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.31 145.8 31.36 Favored Pre-proline 0 C--O 1.234 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 111.173 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.36 155.49 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.109 2.539 . . . . 0.0 110.513 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.3 89.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.316 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.74 119.92 23.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.648 1.579 . . . . 0.0 109.716 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -104.93 -174.98 2.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.946 0.898 . . . . 0.0 109.803 169.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -47.42 -59.89 2.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.266 1.827 . . . . 0.0 114.288 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -120.22 52.22 1.15 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.902 1.281 . . . . 0.0 107.576 -160.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -142.97 163.78 31.86 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.083 -159.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.27 159.48 31.2 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 164.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -157.41 17.02 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.171 0.989 . . . . 0.0 112.913 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.9 158.64 32.53 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.525 -0.735 . . . . 0.0 109.672 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -67.08 159.53 80.42 Favored 'Cis proline' 0 C--O 1.238 0.495 0 CA-C-N 120.681 1.279 . . . . 0.0 110.297 -3.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 177.95 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.875 1.717 . . . . 0.0 111.06 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.36 79.47 1.26 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.826 1.651 . . . . 0.0 108.406 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 56.4 49.64 14.61 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.106 1.763 . . . . 0.0 110.358 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.38 -10.5 28.9 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.835 1.683 . . . . 0.0 114.622 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.61 127.63 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -156.89 173.79 16.47 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.4 mt -118.33 165.08 14.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -128.31 138.04 52.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 158.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.91 82.37 1.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -104.77 103.94 13.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 p -71.53 149.62 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 165.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 mtm -131.89 156.61 79.89 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.168 1.387 . . . . 0.0 108.405 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.91 173.47 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.273 2.649 . . . . 0.0 111.265 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.58 103.04 4.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.376 0.67 . . . . 0.0 110.002 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 31.43 0.07 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.648 1.179 . . . . 0.0 112.469 169.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 p -112.78 174.81 5.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.574 1.55 . . . . 0.0 109.291 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.2 mt -66.39 142.56 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 O-C-N 120.9 -1.125 . . . . 0.0 108.635 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.29 12.47 3.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.084 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -101.63 4.87 41.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.642 1.577 . . . . 0.0 112.74 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 128.75 53.48 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 55.43 7.17 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.21 167.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 131.488 3.915 . . . . 0.0 115.829 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.26 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.882 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 56.82 12.68 1.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.015 2.926 . . . . 0.0 111.023 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.98 4.49 0.64 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.854 1.261 . . . . 0.0 113.04 168.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.09 -170.16 3.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.073 1.306 . . . . 0.0 111.327 -164.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.257 3.2 pt20 57.18 36.54 27.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.81 2.844 . . . . 0.0 116.51 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -70.02 144.63 52.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.718 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 135' ' ' ASP . 6.5 ptp180 177.94 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 129.875 3.27 . . . . 0.0 109.916 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.36 -169.88 43.38 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 112.292 -2.231 . . . . 0.0 112.091 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.91 166.01 17.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -134.88 139.2 44.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.593 1.957 . . . . 0.0 106.255 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -137.63 116.9 12.67 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -166.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -122.3 144.09 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.16 0.984 . . . . 0.0 109.169 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.99 96.24 3.17 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.293 1.037 . . . . 0.0 108.704 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 p -72.43 103.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.63 129.28 48.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.81 1.644 . . . . 0.0 106.763 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.04 155.54 74.45 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.03 171.12 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.832 2.355 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.34 61.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.185 -0.947 . . . . 0.0 109.234 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.9 -54.42 0.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.73 -0.606 . . . . 0.0 112.529 -166.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.83 64.43 0.86 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.192 0.996 . . . . 0.0 109.87 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.78 101.19 0.08 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -71.24 52.31 0.17 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.347 1.459 . . . . 0.0 114.332 -173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -111.56 3.29 17.88 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 119.875 -1.765 . . . . 0.0 111.707 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 m -70.84 -11.01 60.71 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.4 -42.37 63.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.76 -45.58 71.03 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.913 0.485 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -48.3 61.87 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.423 0.689 . . . . 0.0 110.81 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.09 -43.58 57.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.0 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.08 -39.92 75.94 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.044 0.838 . . . . 0.0 110.733 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.66 -50.34 31.51 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.42 1.488 . . . . 0.0 111.066 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.56 -49.45 67.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.565 1.146 . . . . 0.0 110.331 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.7 -36.59 73.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.465 0.706 . . . . 0.0 111.219 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.81 -42.0 98.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.955 1.252 . . . . 0.0 110.978 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.19 78.11 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.384 0.273 . . . . 0.0 110.409 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 95' ' ' PHE . 18.8 tp -74.01 -38.65 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.31 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 94' ' ' LEU . 97.7 m-85 -117.9 66.98 5.83 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.203 1.401 . . . . 0.0 110.399 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.98 171.07 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.289 2.659 . . . . 0.0 110.768 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 110' ' ' VAL . 4.9 p -56.37 6.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 130.321 3.449 . . . . 0.0 116.806 -172.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -113.29 -47.07 3.03 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.638 -1.289 . . . . 0.0 109.989 172.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 ' HE1' ' A' ' 101' ' ' MET . 3.7 mt 45.01 86.33 0.02 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 127.521 2.328 . . . . 0.0 110.335 -158.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.57 70.76 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.653 ' HE1' HD13 ' A' ' 99' ' ' LEU . 2.7 ptt? -112.71 125.36 54.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -98.28 -178.66 4.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . 58.6 p -146.79 178.69 8.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.75 -31.69 79.0 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.931 164.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.65 -55.51 2.99 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -163.08 -88.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 179.25 176.9 0.57 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.24 -2.162 . . . . 0.0 110.053 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.39 169.57 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.877 1.271 . . . . 0.0 108.565 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -140.24 -178.97 5.72 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.758 1.623 . . . . 0.0 107.393 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' HB ' HD12 ' A' ' 99' ' ' LEU . 9.5 p -101.66 -26.26 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.241 0.473 . . . . 0.0 111.804 175.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 66.77 -38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.28 2.232 . . . . 0.0 115.22 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.5 p -131.19 160.24 67.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 118.54 0.609 . . . . 0.0 111.378 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.88 161.8 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.882 1.722 . . . . 0.0 109.584 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.79 131.73 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.64 144.49 26.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.24 150.94 31.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.156 2.182 . . . . 0.0 107.64 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.83 -176.19 25.12 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.871 0.748 . . . . 0.0 111.445 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -69.92 148.18 96.22 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.637 0.775 . . . . 0.0 110.658 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.97 -179.16 5.15 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.425 2.75 . . . . 0.0 112.352 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.7 t -135.24 26.65 3.51 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.041 1.736 . . . . 0.0 110.4 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -46.04 143.92 2.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.845 2.058 . . . . 0.0 112.937 -170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.65 -87.4 1.81 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -141.85 -38.8 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 125.191 1.171 . . . . 0.0 112.437 -157.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.5 0.15 1.63 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.062 -0.494 . . . . 0.0 112.203 -170.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.17 146.08 25.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 128.243 2.617 . . . . 0.0 109.828 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -135.76 132.27 36.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.485 0.714 . . . . 0.0 110.976 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -137.87 103.84 5.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.328 1.451 . . . . 0.0 109.031 -167.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -78.03 147.27 73.16 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.9 132.18 10.5 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 124.023 3.148 . . . . 0.0 108.867 171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.01 140.39 47.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 166.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 p -160.82 169.84 21.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.836 0.454 . . . . 0.0 110.812 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -161.99 151.76 16.46 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.074 1.35 . . . . 0.0 110.311 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.1 109.69 1.0 Allowed Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -168.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -118.27 -167.13 1.3 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.716 1.606 . . . . 0.0 109.286 -161.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 4.1 p-10 -152.14 -87.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.532 1.533 . . . . 0.0 107.919 171.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 179.54 -179.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -161.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -148.17 150.27 33.49 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.199 2.2 . . . . 0.0 112.925 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' A' ' 140' ' ' PRO . 0.6 OUTLIER 67.96 154.0 0.14 Allowed Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 130.058 3.343 . . . . 0.0 115.102 171.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 139' ' ' TYR . 79.7 Cg_endo -72.36 64.6 3.62 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.634 2.89 . . . . 0.0 110.67 162.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . 0.257 12.0 pt-20 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 131.238 3.815 . . . . 0.0 117.128 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.481 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 53.87 -163.12 0.11 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.227 1.013 . . . . 0.0 110.739 -175.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.481 ' H ' ' HG3' ' A' ' 2' ' ' MET . 0.2 OUTLIER 55.39 -85.28 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.742 2.017 . . . . 0.0 114.286 169.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -25.6 65.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 121.421 1.918 . . . . 0.0 113.103 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.3 -51.27 55.82 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.593 2.357 . . . . 0.0 109.894 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 105' ' ' GLY . 7.1 mt -73.85 -37.02 64.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.802 2.441 . . . . 0.0 110.348 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 106' ' ' LEU . 32.4 mm -55.77 -62.23 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.8 mtm105 -67.08 -29.59 69.4 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.053 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.42 63.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.988 0.813 . . . . 0.0 111.606 173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' MET . . . -71.96 -29.19 64.01 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.614 -0.679 . . . . 0.0 111.738 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.61 -43.74 58.86 Favored 'General case' 0 CA--C 1.524 -0.047 0 O-C-N 121.371 -0.831 . . . . 0.0 110.311 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -66.0 -26.26 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -71.36 -7.4 46.91 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.646 -0.659 . . . . 0.0 111.331 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -117.61 -71.09 0.75 Allowed 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.409 1.004 . . . . 0.0 110.329 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.9 -48.7 80.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.532 1.06 . . . . 0.0 110.705 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -72.89 -31.92 65.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.306 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.69 -34.07 77.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.892 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CD1' ' HG ' ' A' ' 94' ' ' LEU . 29.4 t90 -76.84 -56.38 4.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.65 1.18 . . . . 0.0 109.587 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB1' HH12 ' A' ' 22' ' ' ARG . . . -60.67 -32.55 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.394 -170.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -36.99 69.35 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.213 0.915 . . . . 0.0 112.381 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.6 -14.76 60.39 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.532 1.133 . . . . 0.0 111.139 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.781 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 6.8 ttm105 -61.66 162.02 9.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.42 1.488 . . . . 0.0 110.71 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 85.8 m -59.38 -73.59 0.19 Allowed Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 128.004 2.521 . . . . 0.0 112.652 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' CD ' ' HB ' ' A' ' 23' ' ' THR . 58.2 Cg_endo -71.99 -12.16 28.02 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.998 1.799 . . . . 0.0 113.02 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.57 81.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.5 1.92 . . . . 0.0 113.63 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.781 HD23 ' CZ ' ' A' ' 22' ' ' ARG . 3.3 mm? -81.55 150.1 66.03 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.119 -174.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -68.98 172.17 12.34 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.037 1.824 . . . . 0.0 110.863 162.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -125.34 166.02 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 128.477 2.711 . . . . 0.0 105.545 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.21 150.25 36.37 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.804 -1.185 . . . . 0.0 109.038 164.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.4 173.07 11.45 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.45 . . . . 0.0 111.234 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -55.06 134.39 49.15 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.297 1.839 . . . . 0.0 112.366 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 47.92 25.25 0.72 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.034 2.133 . . . . 0.0 113.273 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.3 m -112.07 136.98 50.74 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 142.61 26.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.102 0.961 . . . . 0.0 110.771 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.13 -179.9 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.191 1.396 . . . . 0.0 109.019 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 68.85 163.6 0.14 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.707 1.603 . . . . 0.0 110.334 -172.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.46 160.79 86.56 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 -11.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.92 -178.74 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.864 2.376 . . . . 0.0 112.065 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.15 78.11 7.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 66.08 14.2 9.5 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.351 2.26 . . . . 0.0 114.566 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.54 29.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.558 1.551 . . . . 0.0 113.096 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.6 127.34 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -161.62 163.88 29.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 110.136 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.13 148.41 31.83 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -131.7 113.21 13.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 89.78 3.19 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.714 1.205 . . . . 0.0 108.757 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.54 115.57 26.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -81.42 120.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 mtm -111.96 88.33 9.9 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 126.412 1.885 . . . . 0.0 108.769 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -55.77 156.29 19.5 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.628 1.552 . . . . 0.0 111.345 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.89 121.61 10.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.765 1.226 . . . . 0.0 107.776 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 69.28 1.3 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.586 0.708 . . . . 0.0 109.469 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 t -66.82 -164.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.565 1.174 . . . . 0.0 109.64 165.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -44.84 141.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 127.748 2.419 . . . . 0.0 110.811 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.41 17.95 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.917 2.487 . . . . 0.0 110.893 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -80.99 3.55 22.6 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 170.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.81 139.81 5.39 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 128.048 2.539 . . . . 0.0 105.297 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 47.55 17.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.629 3.171 . . . . 0.0 117.875 162.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.2 174.89 0.3 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.927 2.891 . . . . 0.0 112.694 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.31 27.4 15.68 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.726 1.631 . . . . 0.0 111.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.77 146.33 24.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 129.998 3.319 . . . . 0.0 104.771 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -152.63 -37.93 0.11 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 170.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.46 14.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -173.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -148.41 138.02 22.15 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.739 1.216 . . . . 0.0 108.477 169.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.0 m-30 -112.96 91.83 3.79 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.58 2.352 . . . . 0.0 105.237 173.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -113.03 100.44 8.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.707 1.603 . . . . 0.0 107.314 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.18 -157.73 8.08 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.967 1.27 . . . . 0.0 110.445 -166.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.45 155.93 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.387 1.093 . . . . 0.0 108.706 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' ' CE1' ' A' ' 134' ' ' TYR . 14.7 m-85 -113.59 126.23 55.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -117.24 102.38 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.419 1.088 . . . . 0.0 108.32 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.79 160.9 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.94 157.09 47.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.248 1.419 . . . . 0.0 107.689 161.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.21 73.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.9 p -65.72 128.85 29.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.74 145.22 24.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.663 0.785 . . . . 0.0 109.499 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.37 159.95 32.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.806 3.671 . . . . 0.0 111.311 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.4 94.72 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.91 -91.26 0.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 168.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -2.75 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.068 1.347 . . . . 0.0 113.674 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.84 15.5 0.81 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.618 2.056 . . . . 0.0 113.032 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 p -61.65 159.1 13.93 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 120.306 2.053 . . . . 0.0 110.782 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.27 23.29 0.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.882 2.873 . . . . 0.0 114.892 171.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -68.13 -23.73 64.93 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.476 0.71 . . . . 0.0 110.622 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 128' ' ' VAL . . . -46.97 -45.6 21.0 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.411 1.484 . . . . 0.0 112.852 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.86 -54.74 26.23 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.045 0.839 . . . . 0.0 111.366 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -42.4 55.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.095 0.958 . . . . 0.0 111.853 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.04 -51.54 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.16 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.08 -33.16 64.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.79 1.177 . . . . 0.0 111.665 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.82 78.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.61 0.641 . . . . 0.0 109.987 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -58.73 -52.25 66.5 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.861 -0.524 . . . . 0.0 110.548 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.07 -41.26 74.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.916 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -40.61 97.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.033 0.833 . . . . 0.0 112.048 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -35.83 75.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.317 0.579 . . . . 0.0 111.025 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 18' ' ' TRP . 1.2 tm? -93.11 -24.56 18.23 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.632 0.773 . . . . 0.0 112.66 -170.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.598 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.1 m-85 -113.48 68.36 1.34 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.467 1.107 . . . . 0.0 112.095 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.66 159.63 51.75 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.652 2.234 . . . . 0.0 111.104 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.19 16.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 131.086 3.754 . . . . 0.0 116.044 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.95 -58.13 2.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 120.547 -1.346 . . . . 0.0 109.796 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER 44.37 59.51 3.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.087 1.755 . . . . 0.0 111.458 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.1 100.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.527 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -96.51 79.46 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.26 119.4 11.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -128.3 -178.63 4.63 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.457 1.103 . . . . 0.0 108.821 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.84 -27.75 45.05 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.568 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.479 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -80.16 -75.39 1.06 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.819 HD13 HD11 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -151.84 -166.88 2.62 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.182 1.393 . . . . 0.0 107.967 -158.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -123.99 87.1 2.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.545 1.538 . . . . 0.0 107.699 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.59 133.09 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -134.11 142.22 47.43 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.603 0.564 . . . . 0.0 110.504 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.586 HG23 HD13 ' A' ' 132' ' ' LEU . 8.3 p -75.84 -22.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -159.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -62.9 0.17 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.353 2.661 . . . . 0.0 113.64 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.4 p -83.8 157.75 63.25 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 124.689 1.196 . . . . 0.0 108.948 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -72.36 176.3 8.84 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 N-CA-C 108.136 -1.524 . . . . 0.0 108.136 162.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 95' ' ' PHE . 14.1 mm -63.74 150.28 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.329 1.452 . . . . 0.0 109.117 170.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -132.39 163.61 28.33 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.448 0.699 . . . . 0.0 109.826 168.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -157.89 139.0 13.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.596 2.358 . . . . 0.0 107.656 168.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.11 175.55 15.75 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.902 1.239 . . . . 0.0 110.752 166.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.51 156.6 76.71 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.354 1.061 . . . . 0.0 110.611 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.72 163.58 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.688 2.259 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.45 1.87 49.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.354 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 122' ' ' GLY . 2.1 m 55.66 176.6 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.586 1.554 . . . . 0.0 110.461 -164.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.561 ' H ' HG22 ' A' ' 121' ' ' THR . . . -143.5 -161.69 8.99 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 128.737 3.065 . . . . 0.0 108.553 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.39 -48.39 75.63 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.37 1.068 . . . . 0.0 111.835 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.97 22.55 0.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.548 1.939 . . . . 0.0 109.487 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -140.35 170.84 15.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 130.663 3.585 . . . . 0.0 106.033 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.9 169.2 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 162.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.75 122.63 9.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.594 2.358 . . . . 0.0 104.669 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 84' ' ' ALA . 4.8 m -103.72 142.97 25.7 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.933 1.693 . . . . 0.0 108.217 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.18 125.84 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.848 2.365 . . . . 0.0 108.525 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.4 mt -143.74 115.68 2.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.2 p -164.41 168.14 18.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.246 1.018 . . . . 0.0 111.028 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 110' ' ' VAL . 2.6 pp -155.2 153.47 30.76 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.125 1.77 . . . . 0.0 109.924 -174.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.38 82.78 0.35 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.118 1.342 . . . . 0.0 111.61 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 69' ' ' PHE . 45.2 p90 -73.69 174.38 8.46 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.407 2.683 . . . . 0.0 113.844 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -135.03 175.36 9.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.712 1.605 . . . . 0.0 110.662 165.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 65' ' ' TYR . 1.8 p -144.57 142.71 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 159.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.519 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 0.8 OUTLIER -106.53 161.84 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.5 1.52 . . . . 0.0 108.725 169.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.26 131.1 55.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -122.84 82.78 49.6 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 -171.8 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.581 1.521 . . . . 0.0 109.351 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 118.3 -0.857 . . . . 0.0 108.772 164.465 . . . . . . . . 0 0 . 1 stop_ save_